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Abstract 
Worying is a common experience that many people engage in occasionaly without issue. 
However, some individuals are chronic woriers, and some develop generalized anxiety disorder 
(GAD) due to excessive wory (American Psychiatric Association, 2013). People with GAD 
experience significant distress and physiological issues, leading to high health care service 
utilization (Bélanger et al., 2005). Two models of GAD, the Cognitive Avoidance Model 
(Sibrava & Borkovec, 2006) and the Metacognitive Model (Wels, 2009), have extensive basic 
and applied support. In addition, a smal body of research has shown that an ultra-brief treatment 
can decrease GAD symptoms and wory severity (Borkovec et al., 1983; McGowan & Behar, 
2013). Yet, this research has used short folow-ups, and the relationships between change in 
symptoms and cognitive factors have not been explored. The curent study tested two ultra-brief 
treatments based on the two models of GAD. A total of 115 participants were assigned to 
receive one of the treatments, or to a control condition. Participants in the control condition were 
assigned to one of the treatments after four weeks. Treatments were completed in less than 20 
minutes. Participants completed a diagnostic interview and self-report measures at baseline, four 
weeks, and four months post-treatment. Participants who received treatment had large decreases 
on measures of GAD symptoms, wory severity, and negative afect, as wel as on measures of 
the proposed cognitive factors, with gains maintained at four month folow-up. While the 
treatments were superior to the control condition, no diferences were found between treatments. 
Negative beliefs about wory and meta-wory were related to changes in GAD symptoms and 
wory severity, while cognitive avoidance was related to changes in wory severity. Overal, the 
results indicate that these ultra-brief treatments appear wel suited for use in primary care, and 
the findings provide support for both the Metacognitive Model and Cognitive Avoidance Model. 
ULTRA-BRIEF TREATMENTS FOR GAD  
i 
 
Acknowledgements 
 First and foremost I wish to thank my fiancée, Leanne Grover, for always making me 
smile, inspiring me, pushing me on to be the best that I can be, and giving me more love and 
support than anyone could ask for. I also wish to thank my supervisor, Dr. Dwight Mazmanian, 
for supporting me throughout my dissertation and graduate school journey. Your guidance and 
feedback was always helpful, and you wil always be a big part of who I become as a researcher 
and academic. Thank you also goes to my dissertation commitee, Dr. John Gotwals, Dr. Mirela 
Stroink, and Dr. Evelyn Behar, for agreeing to devote your valuable time to reading and 
providing feedback on this project. I would also like to thank Dr. John Jamieson for his advice 
on this dissertation during the proposal stage. I would also like to extend my appreciation to my 
felow graduate students at Lakehead University: thank you for al for the reassurances, 
motivation, and stress relief. Thank you as wel to my friends and coleagues from far and wide 
who have al inspired me and given me much joy over the years. My immense appreciation to 
the graduate students who volunteered to serve as therapists in this study: Missy Teatero, Emily 
Fawcet, Nicholas Haris, Loreta Blanchete, Megan Short, and Gregory Tippin. Thank you for 
devoting so much time to assisting me. Thanks also go out to my research assistant, Stephanie 
Cotrel, for helping with data management and completing adherence checks. Special thanks 
belong to my parents for their constant love and support. Thank you for al that you have done 
for me. I would like to also gratefuly acknowledge the Canadian Institutes of Health Research 
for honouring me with a Frederick Banting & Charles Best Canada Graduate Scholarships 
Doctoral Research Award and providing funding for this project.  
ULTRA-BRIEF TREATMENTS FOR GAD  
ii 
 
Table of Contents 
Abstract ...................................................................... i 
Acknowledgements ............................................................. i 
Table of Contents .............................................................. ii 
List of Figures ............................................................... vii 
List of Tables ................................................................. ix 
List of Acronyms ...............................................................x 
Introduction ...................................................................1 
Wory, Chronic Wory, and Generalized Anxiety Disorder .........................1 
GAD and Wory in the Medical System ........................................4 
Health-related worying ................................................4 
Increased use of health care services ......................................6 
Increased costs to the health care system ...................................8 
Recognition of GAD in primary care ......................................9 
Treatment of GAD in primary care .......................................12 
Empiricaly Supported Models and Therapies for GAD ...........................15 
The Cognitive Avoidance Model ........................................15 
Basic research ..................................................15 
Applied research ................................................20 
The Metacognitive Model ..............................................23 
Basic research ..................................................23 
Applied research ................................................31 
Research directly comparing the models ..................................33 
ULTRA-BRIEF TREATMENTS FOR GAD  
iv 
 
Additional models of GAD .............................................34 
Intolerance of Uncertainty Model ...................................34 
Acceptance-Based Model .........................................36 
Emotional Dysregulation Model ....................................37 
Prevention Outcome Studies for GAD .........................................39 
Brief and Ultra-Brief Treatments .............................................42 
Ultra-brief treatments for GAD ..........................................44 
The Present Study .........................................................47 
Modifications of the treatments for the curent study .........................47 
Research questions and hypotheses ......................................49 
Hypotheses ....................................................50 
Method .....................................................................53 
Participants ..............................................................53 
Measures ................................................................54 
Demographic characteristics measure .....................................54 
GAD symptom measures ..............................................54 
Structured diagnostic assessment of GAD criteria ......................54 
Dimensional measure of GAD symptoms .............................55 
Dimensional measure of wory severity ..............................55 
Comorbid symptom measures ...........................................56 
Measure of health anxiety symptoms ................................56 
Measure of positive and negative afect ..............................56 
Health care utilization and secondary indicators of mental health measures .......57 
ULTRA-BRIEF TREATMENTS FOR GAD  
v 
 
Primary care utilization and treatment seeking behaviours ................57 
Psychopharmacological medication use ..............................57 
Motivation for additional treatment ..................................58 
Expectancy that anxiety can be treated ...............................58 
Proposed cognitive factors measures .....................................59 
Cognitive avoidance .............................................59 
Meta-wory ....................................................59 
Metacognitive beliefs ............................................60 
Negative evaluation sensitivity .....................................60 
Treatment characteristic measures .......................................61 
Treatment credibility, expectancies, and success .......................61 
Treatment implementation .........................................62 
Problematic response styles ............................................62 
Positive impression management ...................................63 
Negative impression management ...................................63 
Random responding ..............................................63 
Supplemental measures ................................................64 
Procedure ...............................................................64 
Study design ........................................................64 
Treatments ..........................................................68 
Therapists ..........................................................71 
Treatment adherence ..................................................71 
Compensation .......................................................71 
ULTRA-BRIEF TREATMENTS FOR GAD  
vi 
 
Statistical Analyses ........................................................72 
Results ......................................................................75 
Data Screening ...........................................................75 
Participant Characteristics at Baseline .........................................76 
Therapist Efects and Treatment Adherence ....................................76 
Treatment Credibility, Expectancy, and Implementation ...........................78 
Comparison of Treatments to Waitlist .........................................79 
Completer analyses ...................................................79 
Intent-to-treat analyses ................................................83 
Comparison of CAWS to MWS ..............................................87 
Completer analyses ...................................................87 
Baseline to four weeks post-treatment ...............................87 
Four weeks to four months post-treatment ............................93 
Intent-to-treat analyses ................................................97 
Baseline to four weeks post-treatment ...............................98 
Four weeks to four months post-treatment ...........................107 
Comparison of Proposed Cognitive Factors ....................................108 
Changes in GAD symptoms ......................................108 
Changes in wory severity ........................................108 
Discussion ..................................................................111 
Theoretical Implications ...................................................112 
Treatment Implications ....................................................118 
Strengths and Weaknesses .................................................125 
ULTRA-BRIEF TREATMENTS FOR GAD  
vi 
 
Future Directions ........................................................128 
Conclusions .................................................................130 
References ..................................................................132 
Appendix A: Recruitment Materials ..............................................167 
Appendix B: Self-Report Questionnaires at Baseline .................................173 
Appendix C: Cover Leter ......................................................211 
Appendix D: List of Counseling Services Available in Thunder Bay ....................215 
Appendix E: Consent Form .....................................................217 
Appendix F: Contact Information Form ...........................................220 
Appendix G: Brief Cover Leter for Folow-ups and Debriefing Form ....................222 
Appendix H: The “Psychology Works” Fact Sheets: Generalized Anxiety Disorder .........226 
Appendix I: Self-Report Questionnaires at Four-Week Folow-up .......................228 
Appendix J: Self-Report Questionnaires at Four-Month Post-Treatment ..................266 
Appendix K: Treatment Scripts and Associated Handouts .............................304 
Appendix L: Treatment Adherence Checklists ......................................311 
 
ULTRA-BRIEF TREATMENTS FOR GAD  
vii 
 
List of Figures 
Figure 1. Progress of participants through the study ...................................69 
Figure 2. Changes in generalized anxiety disorder symptoms when comparing the delayed 
treatment condition with treatment conditions .......................................85 
Figure 3. Changes in wory severity when comparing the delayed treatment condition with 
treatment conditions ............................................................86 
Figure 4. Changes in negative afect when comparing the delayed treatment condition with 
treatment conditions ............................................................88 
Figure 5. Changes in generalized anxiety disorder symptoms due to treatment ..............99 
Figure 6. Changes in wory severity due to treatment .................................100 
Figure 7. Changes in negative metacognitions due to treatment .........................102 
Figure 8. Changes in meta-wory due to treatment ...................................104 
Figure 9. Changes in cognitive avoidance due to treatment ............................105 
Figure 10. Changes in fear of negative evaluation due to treatment ......................104 
Figure A1. Newspaper advertisement .............................................169 
Figure A2. Recruitment poster version 1 ...........................................170 
Figure A3. Recruitment poster version 2 ...........................................171 
Figure A4. Recruitment poster version 3 ...........................................172 
 
 
ULTRA-BRIEF TREATMENTS FOR GAD  
ix 
 
List of Tables 
Table 1. Characteristics of the Sample at Baseline ....................................77 
Table 2. Summary of Regression Analyses for Examining Variables Related to Change in GAD 
Symptoms ..................................................................109 
Table 3. Summary of Regression Analyses for Examining Variables Related to Change in Wory 
Severity ....................................................................110 
 
 
  
ULTRA-BRIEF TREATMENTS FOR GAD  
x 
 
List of Acronyms 
ACES  Anxiety Change Expectancy Scale  
ANOVA Analyses of Variances  
BFNE  Brief Fear of Negative Evaluation scale  
CAD   Canadian Dolars 
CAQ   Cognitive Avoidance Questionnaire  
CAWS  Cognitive avoidance wory scheduling 
CBT   Cognitive behavioural therapy 
DSM   Diagnostic and Statistical Manual of Mental Disorders 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition 
DT   Delayed treatment 
GAD   Generalized anxiety disorder 
INF  Infrequency scale 
MANOVA  Multivariate Analyses of Variance 
MCQ-30  Metacognitions Questionnaire-30 
MINI   Mini International Neuropsychiatric Interview 
MRTS  Motivation for Receiving Treatment Scale 
MWQ  Meta-Wory Questionnaire  
MWS   Metacognitive wory scheduling 
NIM   Negative Impression Management scale 
PANAS-NA  Positive and Negative Afect Schedule positive afect subscale 
PANAS-PA  Positive and Negative Afect Schedule negative afect subscale 
PIM   Positive Impression Management scale  
ULTRA-BRIEF TREATMENTS FOR GAD  
xi 
 
PMUS  Psychopharmacological Medication Use Scale  
PSWQ  Penn State Wory Questionnaire 
RCES  Revised Credibility/Expectancy Scale  
RGHAS  Revised Geting Help for Anxiety Scale 
RHCS  Revised Homework Compliance Scale 
SHAI   Short Health Anxiety Inventory 
USD   United States Dolars 
WAQ   Wory and Anxiety Questionnaire 
 
 
 
 
	  
ULTRA-BRIEF TREATMENTS FOR GAD   1 
 
A Comparison of Two Ultra-Brief Treatments for 
Generalized Anxiety Disorder Symptoms 
Worry, Chronic Worry, and Generalized Anxiety Disorder 
Worying is a common experience for many people. Wory is a cognitive phenomenon 
of repetitive thought activity, which tends to be triggered in response to internal or external 
triggers, that focuses on hypothetical negative outcomes that could occur in the present or future 
(Gladstone & Parker, 2003). As originally uncovered by Borkovec and Inz (1990), and later 
replicated by other researchers (Freeston, Dugas, & Ladouceur, 1996; Hirsch, Hayes, Mathews, 
Perman, & Borkovec, 2011), wory is dominated by verbal (i.e., linguistic) thoughts, rather than 
mental images. While wory is generaly considered to be a cognitive component of the 
experience of anxiety, worying causes increases in state negative afect (i.e., global feeling of 
distress, depression, and anger), and decreases in state positive afect (i.e., global feeling of 
satisfaction, pleasure, and excitement), in addition to increasing state anxiety (Andrews & 
Borkovec, 1988; Penney & Mazmanian, 2010c; York, Borkovec, Vasey, & Stern, 1987). As 
wel, when worying becomes an individual’s primary coping strategy, this leads to increases in 
trait symptoms of anxiety, depression, and distress (Oathes et al., 2008; Wels, 2009). Overal 
however, wory is more associated with anxiety than depression (Andrews & Borkovec, 1988; 
Zebb & Beck, 1998). 
Yet for most people, the act of worying is not harmful and can be used as a coping 
strategy to deal with potential threats. Eysenck (1992) argued that wory may function to detect 
possible threats and anticipate potential aversive outcomes. The verbal nature of wory, and the 
absence of physiological arousal when worying (Llera & Newman, 2010; Lyonfields, Borkovec, 
& Thayer, 1995; Thayer, Friedman, & Borkovec, 1996), may also function to initiate problem-
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solving behaviours without the induction of a fight-or-flight response. In fact, the beliefs that 
wory can serve as motivation, aid in problem solving, and protect from negative emotions are 
strongly held by high woriers (Holowka, Dugas, Francis, & Laugesen, 2000). While worying 
is similar to problem solving, the frequent use of worying does not tend to lead to productive 
solutions, because potential aversive outcomes are constantly revisited (Mathews, 1990), and 
high woriers tend to have a negative problem orientation (Ladouceur, Blais, Freeston, & Dugas, 
1998; Ladouceur et al., 1999; Robichaud & Dugas, 2005). 
Some individuals who experience high degrees of wory and distress develop generalized 
anxiety disorder (GAD). GAD is defined by excessive and dificult-to-control wory (American 
Psychiatric Association, 2013). In addition to experiencing excessive wory about multiple life 
domains, individuals with GAD experience significant life impairment or distress, and 
experience physiological symptoms, such as iritability, muscle tension, and sleep disturbance (a 
minimum of three of six possible physical symptoms is required to be diagnosed with GAD). 
Further, al symptoms must co-occur within the past six months, and must not be beter 
explained by another mental disorder. GAD was first recognized as a mental disorder in the 
third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM; American 
Psychiatric Association, 1980), although the definition was substantialy revised for the fourth 
edition of the DSM (DSM-IV; American Psychiatric Association, 1994). 
While some individuals develop GAD, it is also important to note that individuals can 
have high levels of trait worying without meeting criteria for a mental disorder. These “chronic 
woriers” experience very high trait worying, believe their worying is uncontrolable, and 
experience some of the symptoms of GAD (Ruscio, 2002). However, individuals with GAD 
tend to have higher levels of trait wory, believe more strongly that wory is uncontrolable, and 
ULTRA-BRIEF TREATMENTS FOR GAD   3 
 
experience more impairment and physiological symptoms than chronic woriers (Ruscio, 2002). 
Expanding on this finding, Ruscio and Borkovec (2004) found that when they matched 
individuals with GAD to chronic woriers for level of trait wory, individuals with GAD 
experienced more frequent negative thoughts folowing a wory period, and believed more 
strongly that wory is uncontrolable and dangerous than chronic woriers and an unselected 
university sample. Individuals with GAD also believed more strongly that they have poor 
atentional skils and memory, and that wory itself can prevent negative outcomes (magical-
thinking) than chronic woriers and the university sample (Ruscio & Borkovec, 2004). Chronic 
woriers were best diferentiated from the unselected university sample by the belief that wory 
is uncontrolable and dangerous. A more recent study by Hirsch, Mathews, Lequertier, Perman, 
and Hayes (2013) supported the conclusion that more negative beliefs about wory diferentiate 
GAD clients from chronic woriers. 
 In Canada, GAD has been previously found to have a lifetime prevalence of 11.5% and a 
12-month prevalence of 2.1% (Fournier, Lesage, Toupin, & Cyr, 1997; Oford et al., 1996). 
However, these studies relied on criteria from the revised third edition of the DSM (American 
Psychiatric Association, 1987). In a more recent American epidemiological survey using 
updated criteria (Grant et al., 2005) the 12-month prevalence of GAD was unchanged at 2.1%, 
while the lifetime prevalence was 4.1%. The survey also found that GAD has a mean onset of 
32.7 years old. In terms of social, emotional, and mental functioning, GAD was found to be as 
impairing as mood disorders and more impairing than other anxiety or personality disorders 
(Grant et al., 2005). GAD was also highly comorbid with mood disorders, other anxiety 
disorders, and substance abuse. The high comorbidity of GAD, especialy with depression, has 
long been documented in both community and clinical samples (Kessler & Witchen, 2002). 
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 The folowing sections criticaly review the prevalence and impact of GAD in the health 
care system, the curent models and psychotherapies for GAD, and previous GAD prevention 
research. This leads to the proposed study: a comparison of two ultra-brief1 treatments for GAD 
symptoms and chronic wory. 
GAD and Worry in the Medical System 
Health-related worrying. Given the impairment and physical symptoms that 
accompany GAD, it would be natural to assume that individuals with GAD would regularly 
wory about their physical and mental health. However, research in this area is unclear. Early 
research found that people with GAD reported worying more frequently about family, finances, 
and work than health (Sanderson & Barlow, 1990). Folow-up research also confirmed that 
people with GAD, and GAD analogue samples, were more likely to report worying about 
family, interpersonal concerns, and work than their health, and were not more likely to report 
worying about their health than non-anxious controls (Roemer, Molina, & Borkovec, 1997). 
However, Craske, Rapee, Jackel, and Barlow (1989) found that health wories were the most 
common type of wory among GAD clients, and that the clients woried about their health far 
more frequently than a non-anxious control group. Similarly, Glazier, Penney, Mazmanian, and 
Rudanycz (2011) found that a GAD analogue sample was more likely to report excessively 
worying about their health than a non-anxious control group. As wel, a recent study in Hong 
Kong has found that almost 80% of individuals with GAD reported worying about their health 
(Lee, Ma, & Tsang, 2011). 
Although the aforementioned studies measured health wories, the measures of health 
wories included lists of wory topics, obtained either through interviews or self-report, or a 
                        
1 The term “ultra-brief” is used to distinguish from “brief” treatments that include six to eight sessions, whereas the 
current study wil use only one session. See the Brief and Ultra-Brief Treatments section for further explanation. 
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colection of wories that were captured by self-monitoring. These measures were not designed 
to specificaly assess health-related wories. In the GAD literature, one measure that has been 
frequently used to measure health-related wories is the Anxious Thoughts Inventory (Wels, 
1994). Research using the Anxious Thoughts Inventory has found that when controling for 
wories about wory and trait anxiety, neither social wory or health wory predicted pathological 
wory (Wels & Carter, 1999). Extending on this finding, Wels and Carter (2001) found that 
individuals with GAD have more health wories than individuals with social phobia and non-
anxious individuals, but no more health wories than individuals with panic disorder. Further, 
they found that individuals with GAD reported roughly equivalent frequencies of health and 
social wories. Overal, while health-related worying may not be a unique characteristic of 
GAD, health wories do appear to be elevated in individuals with GAD. 
While GAD researchers have examined the occurence of health wories in GAD, other 
researchers have examined the occurence of worying in individuals with high health anxiety. 
Health anxiety is defined as experiencing anxiety about one’s health and wel-being despite a 
lack of evidence for physical health problems, or experiencing anxiety above what would be 
considered a normal amount of anxiety when there is evidence for health problems (Lucock & 
Morley, 1996). Abramowitz, Olatunji, and Deacon (2007) found that chronic wory was 
uniquely related to health anxiety when controling for other forms of anxiety such as trait 
anxiety, social anxiety, and obsessive-compulsive symptoms. However, researchers have also 
found that individuals with GAD have equivalent levels of health anxiety as clients with specific 
or social phobias, and less health anxiety than clients with panic disorder (Abramowitz et al., 
2007). Overal, this literature supports a connection between health-related worying and GAD, 
although high health anxiety does not appear to occur in al individuals with GAD. 
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Increased use of health care services. Although the literature shows a modest 
relationship between health-related worying and chronic worying, it is reasonable to expect that 
health-related worying would push individuals to seek out medical advice and treatment upon 
experiencing possible signs of poor health. When individuals search for health information 
online, those with high health anxiety are likely to decide to utilize health care services (Eastin & 
Guinseler, 2006). In addition, individuals with high health anxiety visit their general medical 
practitioners more frequently than individuals with low health anxiety (Conroy, Smyth, 
Siriwardena, & Fernandes, 1999). As wel, while Jackson and coleagues (Jackson et al., 2006) 
found that health anxiety did not predict health care utilization or health related quality of life in 
secondary and tertiary clinics, a recent large scale study found that between 17% and 25% of 
clients atending diferent types of hospital-based clinics had excessive health anxiety (Tyrer et 
al., 2011). Lucock, White, Peake, and Morley (1998) also revealed that individuals with high 
health anxiety perceived reassurance from physicians as less certain for up to one month after the 
initial meeting than individuals with low health anxiety. Looking at a more specific patient 
group, women who did not feel reassured folowing a benign diagnosis regarding breast cancer 
were characterized by high trait anxiety and high health anxiety, among other factors (Meechan, 
Colins, Moss-Moris, & Petrie, 2005). 
Given that a subset of individuals with GAD experience high health anxiety and 
excessive health-related wories, it is perhaps not surprising that individuals with GAD seek help 
from family physicians and other health care practitioners more than most people in the general 
population. A World Health Organization report found that GAD was prevalent on average in 
almost 8% of clients atending primary care clinics across multiple countries, and was the second 
most prevalent mental disorder in primary care (Goldberg & Lecrubier, 1995). As wel, Katon et 
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al. (1990) reported that the lifetime prevalence of GAD was 40.3% in heavy users of general 
health care, which is substantialy higher than the lifetime prevalence of GAD in the general 
population at 4.1% (Grant et al., 2005). However, when health care service utilization is 
examined over the past three months rather than past year, the results are equivocal. One recent 
study found that individuals with GAD, subthreshold GAD, and high woriers were no more 
likely to atend a clinic in the past 90 days than non-woriers (Kertz & Woodruf-Borden, 2011). 
However, a larger study involving 15 primary care clinics across the United States compared 
individuals with GAD to individuals with no disorder, and found that individuals with GAD had 
more physician visits over the past three months (Kroenke, Spitzer, Wiliams, Monahan, & 
Löwe, 2007). 
Looking at Canadian research, a study of 235 first-time patients consulting at anxiety 
disorder clinics across Quebec found that 34% of the sample reported using medical or mental 
health services ten times or more during the previous year, although a diagnosis of GAD was not 
uniquely related to higher service utilization (McCusker, Boulenger, Boyer, Belavance, & 
Miler, 1997). However, a study conducted by Bélanger, Ladouceur, and Morin (2005) 
involving four primary care clinics in Montreal found that 44% of the participants who met 
criteria for GAD reported five or more medical visits in the past year, while only 20% of non-
GAD patients visited a general medical practitioner five times or more in the past year. Further, 
individuals with GAD were more likely to return with the same complaint multiple times in the 
past year than non-GAD patients. 
Clients with GAD also appear to frequent specialized care. Logue et al. (1993) asked 
patients with panic disorder and patients with GAD to report their histories of medical 
evaluations for possible cardiac symptoms. Although it was predicted that panic disorder 
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patients would have had more cardiological evaluations, due to the similarities between a panic 
atack and a heart atack, approximately half of the patients in both groups had consulted a 
physician regarding cardiac symptoms. As wel, GAD patients were as likely as panic disorder 
patients to have visited a cardiologist or to have visited an emergency room due to physical 
sensations. Individuals with GAD also appear more likely to have visited gastroenterologists in 
the past year than non-patients, individuals with panic disorder, and individuals with obsessive-
compulsive disorder (Kennedy & Schwab, 1997). A study conducted in Montreal revealed that 
individuals with GAD visited family physicians and medical specialists at a higher rate than 
individuals with panic disorder, depression, or substance-related disorders (Fournier et al., 1997). 
Increased costs to the health care system. By seeking services due to excessive wory, 
individuals with GAD increase the cost of delivering health care and increase wait times for 
individuals who need specialized care. Simon, Ormel, VonKorf, and Barlow (1995) examined 
the health care utilization and associated costs of a sample of primary care patients in Seatle, 
Washington. Overal, it was found that patients with a curent anxiety or mood disorder had 
significantly higher health care costs ($2,390 USD over the past six months) than individuals 
with sub-clinical anxiety or mood disorders ($1,098 USD) and individuals with no mood or 
anxiety symptoms ($1,397 USD). More recently, Greenberg et al. (1999) found that in the 
United States the economic burden of anxiety disorders is greater than $60 bilion USD annualy, 
and the majority of this cost is due to non-psychiatric medical visits (i.e., family physicians, 
nurse practitioners, etc.). The cost of GAD specificaly was related to the high utilization of 
family physicians and medical specialists (i.e., cardiologists, gynaecologists), as individuals with 
GAD rarely sought treatment from mental health care specialists. 
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Although using smal samples, Koerner (2002) found that the annual direct cost per 
individual with GAD to the Canadian health care system was approximately $600 CAD, which is 
considerably higher than the direct cost of less than $200 CAD per individual with no mental 
disorder. Unfortunately, this is the only known study that has examined the cost of GAD in 
Canada. Recently, a comprehensive review (Konnopka, Leichsenring, Leibing, & König, 2009) 
of al anxiety disorder cost-of-ilness studies concluded that the direct costs of GAD and panic 
disorder tend to be higher than social phobia and specific phobias, and al studies reviewed 
indicate an annual cost substantialy greater than the $600 CAD figure derived by Koerner 
(2002). Given the high cost of GAD to the health care system, in addition to the potential costs 
to society at large through reduced work productivity (i.e., decreased focus on work related tasks 
due to wory) and increases in wait times (through the frequent use of medical services), one 
may wonder if individuals with GAD are recognized and treated in primary care facilities. 
Recognition of GAD in primary care. Primary-care practitioners often misdiagnose 
and consequently mistreat anxiety disorders because they are not adequately trained to recognize 
or treat them (Fifer et al., 1994; Ormel et al, 1990; Ormel, Koeter, van der Brink, & van der 
Wilige, 1991). As wel, given the high frequency of comorbid conditions experienced by 
individuals with GAD, the identification of GAD is made al the more dificult (Brawman-
Mintzer & Lydiard, 1996). 
Data from five primary care setings across Europe included in a World Health 
Organization report indicated that although 51% to 72% of clients with GAD who entered 
primary care were identified as “psychiatric cases”, less than half were identified as having an 
anxiety disorder (Weiler, Bisserbe, Maier, & Lecrubier, 1998). Only one third of GAD clients 
without comorbid disorders were identified as having an anxiety disorder (Weiler et al., 1998). 
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Similarly, a large primary care study conducted in Germany found that almost two thirds of 
patients with pure GAD (i.e., no comorbid conditions) and over half of patients with comorbid 
GAD were not diagnosed as having GAD by their physician (Witchen et al., 2002). Further, the 
false positive rate was also incredibly high, with only one out of every six clients diagnosed with 
GAD by their physician meeting DSM-IV criteria on a self-report questionnaire. Additionaly, 
researchers have found that when patients with anxiety or mood disorders characterized their 
presenting symptoms as a normal response to life circumstances, as would often be the case in 
high worry, the disorder was not detected in 85% of the patients (Kessler, Lloyd, Lewis, & Gray, 
1999). 
Further complicating the mater of making a diagnosis of GAD in primary care is the fact 
that although individuals with GAD frequently turn up in primary care setings, they are more 
likely to visit a health care practitioner due to a perceived physical pathology than due to 
concerns about their mental health. A classic finding by Bridges and Goldberg (1985) uncovered 
that among individuals with a mental disorder who sought treatment in primary care, 83% 
presented with primary complaints of physical pathology, while only 17% presented with 
primary complaints of psychological pathology. Further, of the 83% who presented with 
physical concerns, the mental disorder underlying their concerns was identified in only half of 
the cases. Converging findings from a national population study conducted by Statistics Canada 
in 2002 (Gravel & Beland, 2005) indicate that individuals with mood or anxiety disorders are 
three times more likely to have utilized services in the past year from general medical 
practitioners than from psychiatrists, psychologists, or social workers (Urbanoski, Rush, Wild, 
Bassani, & Castel, 2007). Further, when seeking services for mental health reasons, Canadians 
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as a whole are twice as likely to seek help from general medical practitioners as they are from 
specialized mental health practitioners (Vasiliadis, Lesage, Adair, & Boyer, 2005). 
Regarding individuals with GAD more specificaly, the previously mentioned primary 
care study conducted in Germany found that only 13% of patients with GAD reported anxiety as 
their primary complaint (Witchen et al., 2002). Pain, sleep disturbance, and other somatic 
symptoms were far more likely to be the primary complaints. Witchen and coleagues also 
found that less than one in every four individuals with GAD was receiving treatment for their 
worying. However, in Canada, the numbers are slightly more encouraging, with the study 
conducted at primary care clinics in Montreal finding that almost half of the individuals with 
GAD reported consulting their family physician about anxiety in the past year (Bélanger et al., 
2005). Similarly, in the United States, results of the large primary care study in the United States 
involving 15 primary care clinics (Kroenke et al., 2007) indicated that 60.3% of clients with 
GAD reported being treated with pharmacotherapy, and 27.4% reported being treated with 
counseling or psychotherapy. Although not reported for GAD specificaly, the study did report 
that of those with an anxiety disorder, almost three quarters of clients who received some 
counseling also received pharmacotherapy. Therefore, while a notable proportion of individuals 
with GAD are being left untreated, the number being treated for GAD in primary care in North 
America appears far beter than that in Germany. 
Although it may be dificult for health care practitioners to identify individuals with 
GAD, and even more so, individuals with high chronic wory who may be on a path to 
developing GAD, it would appear that in North America many individuals with GAD are 
seeking treatment for anxiety and are being recognized. The question then becomes, are these 
clients being adequately treated in a timely manner? 
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Treatment of GAD in primary care. As indicated by the findings of Kroenke et al. 
(2007), pharmacotherapy is the go-to treatment of GAD in primary care. Across the 15 primary 
care clinics, twice as many clients with GAD were being treated with medication than were 
being treated with counseling or psychotherapy (Kroenke et al., 2007). Research also indicates 
that clients may have a preference for medication over counseling (Crits-Christoph et al., 2011). 
A recent large-scale study (Berger et al., 2011) indicated that when clients diagnosed with GAD 
initiate medication use, roughly half wil be prescribed selective serotonin reuptake inhibitors, a 
third wil be prescribed benzodiazepines, and less than 10% wil be prescribed serotonin-
norepinephrine re-uptake inhibitors, among other drugs. Interestingly, when comparing the 
health care costs of these clients in the year preceding the initiation of medication use with the 
year folowing post-medication initiation, the total costs increased by over $3000 USD per client. 
Although costs are likely to improve over time, this study does indicate that at least in the short-
term, pharmacological treatments do not decrease costs for the health care system. 
While the study by Beger et al. (2011) indicates that benzodiazepines are being 
prescribed more readily for GAD than serotonin-norepinephrine re-uptake inhibitors in the 
United States, recent treatment algorithms and literature reviews recommend the use of selective 
serotonin reuptake inhibitors and serotonin-norepinephrine re-uptake inhibitors as the first-line 
psychopharmacological treatments for GAD (Davidson et al., 2010; Katzman, 2009; Koen & 
Stein, 2011). Although these medications tend to be efective both in the short-term and long-
term, there are substantial problems documented with the use of these and other medications for 
GAD (Davidson, 2009; Katzman, 2009). There are issues with a lack of response in up to 40% 
of clients, a significant delay in the onset of symptom relief, and lack of ful remission of 
symptoms despite high doses of medications. Further, discontinuation of the medications can 
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lead to a relapse of the disorder. Finaly, even when the medications are providing significant 
symptom relief, they can stil cause impairing side-efects including: agitation, insomnia, sexual 
dysfunction, weight gain, vomiting, headaches, and sweating. These and other concerns have led 
to a cal for more psychotherapy, particularly cognitive behavioural therapy (CBT) in primary 
care, as an adjunct to, or replacement for, pharmacotherapy (Demertzis & Craske, 2006). 
Although an understudied field, new research is emerging examining the efectiveness of 
CBT for anxiety disorders in primary care. A team of researchers across multiple institutions 
began their efectiveness research using a colaborative care model to treat panic disorder in 
primary care (Roy-Byrne et al., 2005), and later extended this treatment to social anxiety 
disorder, postraumatic stress disorder, and GAD (Craske et al., 2011; Roy-Byrne et al., 2010). 
In this model, patients are primarily seen by their primary care physician, while master’s level 
trained clinicians deliver CBT to the client. The clinicians utilize weekly group consultations 
with psychologists and psychiatrists, while also using a workbook and computer software, to 
guide computerized-CBT and a medication plan. Although this model increased short-term costs 
through the delivery of six sessions of CBT in addition to six folow-up phone cals, it was more 
efective in relieving symptoms of al disorders (except for postraumatic stress disorder) and 
improving quality of life across multiple domains than usual care (Joesch et al., 2012; Roy-Byrne 
et al., 2005). The clinicians and patients also rated the program highly, found the use of 
computers to be beneficial, and most patients chose to complete a trial of CBT with or without 
pharmacotherapy (Craske et al., 2009; Craske et al., 2011). 
Unfortunately, with the exception of the new research by Craske and coleagues 
discussed above, only two known studies have focused on treating GAD in primary care setings. 
In separate studies Power, Jerom, Simpson, Mitchel, and Swanson (1989) and Power, Simpson, 
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Swanson, and Walace (1990) utilized a clinical psychologist to administer medication and CBT 
for GAD in the primary care seting. The researchers found that CBT alone, with placebo, or 
with diazepam, was significantly superior to placebo alone, and trended towards being superior 
to diazepam alone at the end of active treatment and at a six- and twelve-month folow-up. 
Although these studies indicate therapy could be conducted in primary care, clinical 
psychologists are rarely employed at primary care locations (Norcross & Rogan, 2013), and 
therefore having clinical psychologists provide CBT in primary care locations is not a viable 
option in the curent health care system. 
While computerized CBT and colaborative care models may become a viable option, 
these options come with high costs to the health care system. As wel, practitioners may be 
hesitant to refer clients to such services instead of more traditional specialist services. Curently, 
as specialized mental health care workers are seldom employed in primary care facilities 
(Norcross & Rogan, 2013), general medical practitioners routinely refer clients for outpatient 
mental health services. These outpatient services tend to have long waitlists, with a curent 
Canadian average of at least four months (Barua, Rovere, & Skinner, 2011). Further, these 
services are primarily designed for clients with significant impairment and may be unnecessary 
for clients with sub-clinical conditions, such as chronic woriers. The development of CBT 
based treatments that could be implemented by practitioners in primary care setings, and 
treatments that do not require excessive practitioner time commitments, would be beneficial to 
the treatment of GAD in primary care. Therefore, new types of treatments need to be explored, 
including ultra-brief and prevention-based treatments that could be provided by a primary care 
practitioner. However, such treatments need to be developed from the curent empiricaly 
supported models of GAD, and their associated ten to twelve week therapies for GAD. 
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Empiricaly Supported Models and Therapies for GAD 
There are curently five wel-articulated and researched theoretical models of GAD (for a 
review, see Behar, DiMarco, Hekler, Mohlman, & Staples, 2009), but the curent study focuses 
on two of these models: the Cognitive Avoidance Model proposed by Borkovec and coleagues 
(Sibrava & Borkovec, 2006) and the Metacognitive Model proposed by Wels and coleagues 
(Wels, 2009). These models were chosen due to the extensive basic and applied research 
underlying each model, clear distinctions between the models, and their potential application as 
ultra-brief treatments. The theoretical components of each model, as wel as the existing 
research for the therapies associated with each model, wil be reviewed in turn. 
The Cognitive Avoidance Model. Borkovec and coleagues began developing the 
Cognitive Avoidance Model, the first model of wory and GAD, in the early 1980s. The model 
has four key elements: 1) that wory is a means to atempt to avoid negative future outcomes and 
negative images, and to cope with negative outcomes that may occur; 2) that the act of worying 
is reinforced by the rarity of catastrophic negative outcomes and the ability to beter cope with 
negative outcomes than predicted; 3) that wory functions to avoid physiological arousal and 
emotional processing; and 4) interpersonal factors contribute to increased feelings of 
responsibility, distress, and wory (Sibrava & Borkovec, 2006). 
Basic research. In one of their first published evaluations of wory, Borkovec, 
Robinson, Pruzinsky, and DePree (1983) provided a brief self-report questionnaire to a sample of 
university students and determined that the majority of wories tend to be future-oriented rather 
than present- or past-oriented. This future-oriented focus of wory has since become a key 
definitional component of wory (Gladstone & Parker, 2003). Additional early research into 
wory found that higher trait worying is related to a monitoring/information-seeking, problem 
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solving coping style, and also an avoidant, afective regulation coping style (Davey, 1992; 
Davey, Hampton, Farel, & Davidson, 1992). Davey (1992) suggested that woriers may be 
seeking out information so that they can avoid negative outcomes, and this concept has since 
become embedded in the literature. 
Borkovec and coleagues have argued that the linguistic nature of wory (Borkovec & 
Inz, 1990; Freeston et al., 1996) alows woriers to avoid distressing images, which results in less 
immediate distress (Hirsch et al., 2011). This use of wory to avoid immediate distress, which is 
akin to someone with social anxiety avoiding large crowds, was termed cognitive avoidance. 
Further support for wory functioning as a cognitive avoidance technique which maintains GAD 
is that multiple studies have shown that exposure to woried-about scenarios (through writen or 
imaginal scenarios) decrease GAD symptoms (Behar, Vescio, & Borkovec, 2005; Goldman, 
Dugas, Sexton, & Gervais, 2007). However, there is evidence that the use of wory as a 
cognitive avoidance technique may not be unique to GAD, as Ladouceur et al. (1999) found no 
diferences between clients with GAD and clients with other anxiety disorders in terms of 
cognitive avoidance. 
 Although research has shown that wory can lead to lower situational distress, many 
studies have shown that chronic woriers believe worying ofers many other benefits. Research 
by Borkovec and Roemer (1995) found that individuals with GAD believe more strongly than 
non-anxious individuals that worying helps them problem-solve, become motivated, be prepared 
if something bad occurs, and avoid or prevent negative outcomes. Individuals with GAD also 
report believing that wory helps them to distract themselves from more emotional topics, and 
make a negative outcome less likely to occur (i.e., the act of worying decreases the likelihood of 
something bad happening). Holowka et al. (2000) found that chronic woriers hold these beliefs 
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more than moderate woriers and low woriers. These beliefs also corelate with wory severity 
even when controling for depression and anxiety (Freeston et al., 1994), and these beliefs are 
held more strongly in clients diagnosed with GAD than moderate woriers (Ladouceur et al., 
1998). Overal, individuals with GAD and chronic woriers generaly believe that worying 
helps them avoid or cope with problems. Further, Davey, Talis, and Capuzzo (1996) found that 
holding positive beliefs about wory did not relate to using constructive coping strategies, and 
did relate to psychopathology and using problematic emotion-focused coping strategies. This 
research indicates that while people believe worying helps to avoid negative outcomes or cope 
with such outcomes, worying more does not appear to lead to actualy preparing for or coping 
with negative outcomes.  
However, positive beliefs about wory do not appear to be specific to GAD. Ladouceur 
et al. (1999) found no diferences between clients with GAD and clients with another anxiety 
disorder in terms of positive beliefs about wory. In addition, positive beliefs about wory were 
not related to GAD symptoms when taking trait wory and metacognitive beliefs into account in 
a student population (Penney, Mazmanian, & Rudanycz, 2013). Therefore, while positive beliefs 
about wory appear to be present in individuals with GAD and chronic woriers, these beliefs do 
not appear to be specific to GAD. 
Borkovec and coleagues (Sibrava & Borkovec, 2006), along with other researchers in the 
field (Dugas & Koerner, 2005; Wels, 2009), have argued that negative reinforcement leads to 
the formation of positive beliefs about wory. It is hypothesized that when an individual wories 
about a future negative event and the event does not occur or the individual copes with the event 
beter than expected, the tendency to wory about potential future negative events is reinforced. 
The only reported observations of this efect come from a pair of studies reported by Borkovec, 
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Hazelet-Stevens, and Diaz (1999). Samples of GAD clients and non-anxious control 
participants recorded their wories, and whether the woried about event occurred, over the 
course of two weeks. On average, when the events did occur, they were not as bad as expected 
for both groups, even though the GAD group predicted outcomes to be more negative when they 
were worying about the event occuring. In a second study, 17 clients undergoing treatment for 
GAD recorded if the outcome was worse than expected, and also recorded how wel they coped 
when the outcome was negative. Aligning with the previous results, only 15% of the outcomes 
that occured were worse than expected, but when the event did occur, the clients were able to 
cope beter than expected in 79% of the cases. Although caution is required given the smal 
samples, this research does indicate that weakening the association between worying and future 
outcomes would lead to a decreased reliance on worying in an atempt to mitigate potential 
future negative events. 
The third component of the Cognitive Avoidance Model is that wory is used to avoid 
physiological arousal and emotional processing. Because this component of the model wil not 
be specificaly addressed in the present study, it wil only be briefly reviewed here. This 
component was first proposed by Borkovec and Inz (1990) based on the findings that worying 
did not lead to an increase in heart rate (Borkovec, Wilkinson, Folensbee, & Lerman, 1983) and 
that worying prior to experiencing a phobic image led to no increase in heart rate, while being 
relaxed or in a neutral state prior to the image led to significant increases (Borkovec & Hu, 
1990). Additional research has supported the hypothesis that wory is associated with autonomic 
inflexibility and lack of emotional processing by examining vagal tone, heart rate variability, 
self-reported emotional changes, and cognitive intrusions (Llera & Newman, 2010; Lyonfields et 
al., 1995; Thayer et al., 1996; Wels & Papageorgiou, 1995). However, some contradictory 
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findings have been reported, primarily with studies measuring skin conductance (Andor, 
Gerlach, & Rist, 2008; Laguna, Ham, Hope, & Bel, 2004; Hofmann et al., 2005; Stapinski, 
Abbot, & Rapee, 2010). Overal, this component appears wel supported, but it requires 
modification to account for the findings in the area of skin conductance. 
The final component of the Cognitive Avoidance Model is also the newest component of 
the model. Sibrava and Borkovec (2006) contend that interpersonal factors, in particular those 
factors stemming from individuals’ atachment styles, lead high woriers to become overly 
nurturing and intrusive in their interpersonal relationships. This style leads to interpersonal 
problems with friends, family, and romantic partners, which cause additional wory. Converging 
with this hypothesis, Glazier et al. (2011) found that a GAD analogue group was more likely to 
report excessively worying about interpersonal relationships than a non-anxious control group. 
Further, Salzer et al. (2008) found that individuals with GAD tend to be friendly and submissive, 
which may lead to them being exploited or trying to take on the problems of others.  Individuals 
with GAD also report more interpersonal problems than low woriers, and in particular they 
report being non-assertive, overly accommodating, self-sacrificing, and intrusive, although their 
friends do not report such problems (Eng & Heimberg, 2006). However, Mickelson, Kessler, 
and Shaver (1997) found that al mood and anxiety disorders, including GAD, were positively 
related to anxious and avoidant atachment styles, and negatively related to a secure atachment 
style. Therefore, although an association between insecure atachment styles and GAD does 
appear to exist, this may be a more general diathesis for psychopathology and not unique to 
GAD. Nevertheless, there is evidence that excessive interpersonal concern may be unique to 
chronic wory and GAD, as the fear of being negatively judged by others was found to be related 
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to wory severity even when negative afect, positive afect, and anxiety sensitivity were taken 
into account (Kotov, Watson, Robles, & Schmidt, 2007). 
Overal, the literature supports the four fundamental components of the Cognitive 
Avoidance Model. It is important to note, however, that the model is a model of wory and not 
specificaly a model of GAD. Although not explicitly stated, the Cognitive Avoidance Model 
assumes that chronic wory is equivalent to GAD and focuses on positive beliefs about wory 
and interpersonal factors that are assumed to increase wory frequency and duration. By 
increasing wory frequency and duration, chronic wory is assumed to create GAD. However, as 
discussed earlier, chronic woriers can be diferentiated from individuals with GAD (Hirsch et 
al., 2013; Ruscio, 2002; Ruscio & Borkovec, 2004). While chronic wory is the core feature of 
GAD, chronic wory itself is not pathological and can be seen in other mood and anxiety 
disorders. As expected, given the focus on chronic wory, the CBT based on the Cognitive 
Avoidance Model focuses on limiting the amount of wory. 
Applied research. The first step in developing a treatment for GAD by Borkovec and 
coleagues was based on conditioned place learning and the generalizability of anxiety (Mowrer, 
1947). Based on this, and other self-control work at the time (Goldfried, 1971; Kanfer & Gaelic, 
1986; Kanfer & Karoly, 1972), the hypothesis was that if the act of worying could be restricted 
to specific locations and times, that the associations between wory and multiple places (e.g., 
while driving, at work, etc.) would be weakened. Therefore, in the initial development of a 
treatment for GAD, Borkovec et al. (1983) had undergraduate students who considered their 
wory to be problematic self-restrict their wory to one 30-minute period during the day for four 
weeks. If students began worying outside of the 30-minute period, they were told to postpone 
the wory and focus on the present-moment experience. The students were able to reduce the 
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percentage of the day they felt tense, and significantly reduce the percentage of the day spent 
worying compared to no-treatment controls. 
Although this study did not measure GAD symptoms as curently defined, it did indicate 
that individuals could be instructed to gain control over their wory. Further, while Borkovec 
and coleagues would use this “wory scheduling” technique in their ful treatment model for 
GAD, only three known studies have replicated and extended this study. The first, by Brosschot 
and van der Doef (2006), had 84 adolescents between 16 and 17 years old restrict their worying 
to a 30-minute period for six days. In comparison to another group of 88 adolescents who did 
not receive any instructions, the “wory schedulers” significantly decreased the duration of their 
daily worying, and had a significant decrease in the number of physiological issues they 
experienced. Similarly, McGowan and Behar (2013) recently compared the efectiveness of the 
wory scheduling technique to instructing participants to wory as intensely as they could 
whenever they started to wory throughout the day. Over the course of two weeks, although both 
groups of 23 undergraduate students experienced decreases in symptoms, the wory scheduling 
technique was significantly beter in decreasing anxiety, trait wory, negative afect, and 
symptoms of insomnia, although neither condition was efective in decreasing symptoms of 
depression or increasing positive afect. Finaly, another recent study found that engaging in 
wory scheduling for two weeks prior to entering into therapy resulted in greater reduction in 
anxiety and physiological symptoms at the end of therapy than having no intervention prior to 
therapy (Verkuil, Brosschot, Korelboom, Reul-Verlaan, & Thayer, 2011). 
In their first multiple session CBT outcome study, Borkovec et al. (1987) compared 12 
sessions of progressive muscle relaxation plus cognitive therapy to 12 sessions of progressive 
muscle relaxation plus nondirective therapy in 30 clients with GAD. Overal, the progressive 
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muscle relaxation plus cognitive therapy treatment was superior to the progressive muscle 
relaxation plus nondirective therapy treatment. However, a folow-up study by Borkovec and 
Mathews (1988) comparing cognitive therapy, coping desensitization, and nondirective therapy, 
each combined with progressive muscle relaxation, found no diferences between treatments. 
Yet, with only 10 clients per condition, the lack of efects may be due to low power. Indeed, 
Borkovec and Costelo (1993) found that both progressive muscle relaxation and CBT (including 
progressive muscle relaxation, cognitive therapy, and coping desensitization) were superior to 
nondirective therapy at the end of therapy, and CBT had the highest percentage of clients 
experiencing clinicaly significant change (i.e., being within one standard deviation of norms on 
symptom measures) at a 12-month folow-up, in 55 GAD clients who completed treatment. A 
final component analysis study conducted by Borkovec, Newman, Pincus, and Lytle (2002) with 
69 GAD clients revealed no diferences between clients at post-treatment or two year folow-up 
after receiving progressive muscle relaxation plus coping desensitization, cognitive therapy, or a 
combination of these methods. Although most clients saw substantial improvement in anxiety 
and depression, clients who reported interpersonal problems at baseline or post-treatment 
reported more symptoms than clients without such problems. This led to the integration of an 
interpersonal treatment component. 
Newman, Castonguay, Borkovec, Fisher, and Nordberg (2008) conducted an open trial of 
CBT with an interpersonal and emotional avoidance treatment component added to the end of 
each session. Although only 18 participants completed the treatment, almost al were 
significantly improved post-treatment, and gains were generaly maintained for up to one year. 
While efect size comparisons to previous outcome studies indicated that the additional treatment 
component improved outcome, a much larger subsequent randomized clinical trial did not find 
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any benefits of the interpersonal treatment component in comparison to the addition of a 
supportive listening component (Newman et al., 2011). However, a separate set of researchers, 
who integrated the interpersonal treatment component into the CBT rather than including it as an 
add-on, did find the integrated CBT was more eficacious than CBT alone, albeit in a smal 
sample (Rezvan, Baghban, Bahrami, & Abedi, 2008). 
Overal, the CBT protocol based on the Cognitive Avoidance Model is eficacious in 
treating GAD, although it remains unclear which components provide the greatest benefits.  The 
use of progressive muscle relaxation, wory scheduling, coping desensitization, and cognitive 
therapy al appear eficacious, while additional research is needed to examine treatment focusing 
on interpersonal dificulties and emotional avoidance. 
The Metacognitive Model. The Metacognitive Model of GAD was created through the 
research of Wels and coleagues in the early 1990s (Wels, 1995), and progressed from work on 
a larger model of atention, performance, and mental disorders known as the self-regulatory 
executive function model (Wels & Mathews, 1994, 1996; Wels, 2000). Although the self-
regulatory executive function model has been used to explain the development and maintenance 
of postraumatic stress disorder, obsessive-compulsive disorder, and major depression, only the 
model’s specific application to GAD is discussed here. The Metacognitive Model has three key 
elements: 1) that positive beliefs about wory initiate the use of worying as a coping strategy; 2) 
that negative beliefs about wory and meta-wory lead to distress, and the development and 
maintenance of GAD; and 3) that behavioural and thought control strategies utilized to deal with 
the distress help maintain the disorder (Wels, 1997; 2009). 
Basic research. As positive beliefs about wory have been previously discussed in the 
Cognitive Avoidance Model they wil not be repeated here, except where relevant for 
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comparisons to the negative beliefs about wory. It is important to note, that in contrast to the 
arguments of Borkovec and coleagues, Wels (2009) argues that positive beliefs about wory 
exist in most people, and that positive beliefs about wory are not unique to GAD. Although 
earlier forms of the model had argued that positive beliefs about wory are considered to be 
especialy influential in the development of GAD by increasing trait wory (Wels, 2004), later 
writings do not atribute such importance to positive beliefs about wory (Wels, 2009), and it 
has been argued that negative beliefs about worry may contribute to trait wory more than 
positive beliefs about wory (Penney et al., 2013). 
Before continuing it is important to define key terms used in the Metacognitive Model 
(Wels, 2009) and to discuss the hypothesized relationships between the proposed types of wory 
and beliefs about wory. In the Metacognitive Model, positive beliefs about wory are 
hypothesized to lead to Type 1 wory (i.e., wory about everyday things and events). This is the 
form of wory that is the focus of the Cognitive Avoidance Model. However, Wels (2009) also 
defines a second type of wory, Type 2 wory, also caled meta-wory, which can be defined as 
worying about wory. This represents a major departure from the work of Borkovec and 
coleagues. While Borkovec and coleagues primarily focus on the impact of wory and how 
trait wory leads to GAD, Wels focuses on how individuals negatively interpret their wory and 
how this interpretation leads to GAD. The higher level meta-wory is brought on by negative 
beliefs about wory, particularly the beliefs that wory is uncontrolable and that wory is 
dangerous. Although these two negative beliefs about wory are conceptualy distinct, they are 
considered so intertwined that they are measured together on a single scale on the Meta-
Cognitions Questionnaire (Cartwright-Haton & Wels, 1997) and the Metacognitions 
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Questionnaire-30 (MCQ-30; Wels & Cartwright-Haton, 2004). In the Metacognitive Model, 
these negative beliefs about wory play the key role in the development of GAD. 
It is also important to note that the Meta-Cognitions Questionnaire and MCQ-30 measure 
additional meta-beliefs, including positive beliefs about wory, and negative beliefs about 
cognitive self-consciousness (i.e., believing that one lacks awareness of one’s thoughts and 
thought processes), cognitive confidence (i.e., believing that one does not have a good memory), 
and thoughts in general (i.e., beliefs about superstitions, punishment, and responsibility as 
measured on the Meta-Cognitions Questionnaire; believing that one must be in control of their 
thoughts at al times as measured on the MCQ-30). While these additional beliefs are not 
hypothesized to play key roles in GAD, Wels and coleagues commonly examine them in GAD 
research. The focus of the Metacognitive Model is squarely on the influence of negative beliefs 
about wory and meta-wory in GAD. 
To develop the Meta-Cognitions Questionnaire, Cartwright-Haton and Wels (1997) 
conducted studies with both clinical and non-clinical samples. The non-clinical study found that 
positive beliefs about wory, negative beliefs about wory, and cognitive confidence al predicted 
wory severity, independent of trait anxiety. The clinical study found that individuals with GAD 
reported significantly higher negative beliefs about wory than non-clinical individuals and 
individuals with other emotional disorders, but did not difer from individuals with obsessive-
compulsive disorder. The GAD individuals also had higher scores on negative beliefs about 
cognitive confidence and thoughts in general than the non-clinical group, but did not difer from 
the other clinical groups on these measures. None of the groups difered in positive beliefs about 
wory. Additional research has also shown that of the five subscales on the MCQ-30, the 
negative beliefs about wory subscale has the strongest relationship with wory severity, 
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although the scale also has a moderate relationship with obsessional thoughts (Wels & 
Cartwright-Haton, 2004). 
Additional studies have found that beliefs about wory appear to be related to GAD and 
obsessive-compulsive disorder. Wels and Papageorgiou (1998) found that positive and negative 
beliefs about wory were both related to wory severity and obsessional thoughts and 
compulsions. However, there is evidence that the link between negative beliefs about wory and 
wory severity is independent of the relationship between negative beliefs about wory and 
obsessive-compulsive symptoms. Beloch, Morilo, and García-Soriano (2007) found that 
negative beliefs about wory were strongly related to wory severity even when taking into 
account depression and obsessive-compulsive symptoms, the other metacognitive beliefs 
measured by the Meta-Cognitions Questionnaire, and additional beliefs that were more related to 
obsessive intrusive thoughts. It has also been shown in both clinical and student samples that the 
negative beliefs about wory distinguish chronic woriers from individuals with GAD (Hirsch et 
al., 2013; Ruscio, 2002; Ruscio & Borkovec, 2004), and Nassif (1999; as cited in Wels, 2005) 
found that the negative beliefs about wory predicted the development of GAD within 12 to 15 
weeks.  
As negative beliefs about wory are strongly related to GAD, it is not surprising that the 
meta-wory generated by these negative beliefs has also been shown to relate to wory severity 
and GAD symptoms. In a study of 140 undergraduates, Wels and Carter (1999) found that 
although both Type 1and Type 2 wories corelated with wory severity, only Type 2 wories 
were related to wory severity when controling for trait anxiety. In a similar clinical study, 
individuals with GAD had significantly greater negative beliefs about wory and Type 2 wories 
than individuals with panic disorder, social phobia, and non-clinical individuals, although the 
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groups did not difer on positive beliefs about wory or Type 1 wories (Wels & Carter, 2001). 
An additional study compared 11 individuals with GAD, 22 individuals with only somatic 
anxiety, and 112 individuals with no anxiety (Wels, 2005). Although two of the groups had 
very smal samples, individuals with GAD had a greater frequency of Type 2 wories than both 
groups and believed their Type 2 wories more strongly than the non-anxious group, even when 
controling for Type 1 wories. Further, the relationship between the belief in the Type 2 wory 
and GAD symptoms was mediated by the frequency of the Type 2 wories, indicating that the 
frequency of meta-wories may have a more proximal impact on GAD symptoms than the 
underlying beliefs about meta-wory. 
Although the available research largely supports the key role of negative beliefs about 
wory and meta-wory in GAD, other findings have chalenged these hypotheses. Davis and 
Valentier (2000) argued against the key role of the negative beliefs about wory in GAD because 
they found that when controling for trait wory, of the metacognitions measured on the Meta-
Cognitions Questionnaire, only the negative beliefs about cognitive confidence predicted scores 
on the Beck Anxiety Inventory. However, it has been argued that the Beck Anxiety Inventory 
may be considered a measure of panic disorder symptoms (Cox, Cohen, Direnfeld, & Swinson, 
1996; Norton, Sexton, Walker, & Norton, 2005; Norton & Mehta, 2007; Sexton, Norton, Walker, 
& Norton, 2003), and therefore, this is not an adequate test of whether the negative beliefs about 
wory are related to the symptoms of GAD.  Further, Davis and Valentier (2000) also found that 
the negative beliefs about wory contributed the most to corectly classifying individuals with 
GAD versus individuals who did not meet criteria for GAD. 
However, de Bruin, Muris, and Rassin (2007) found that the frequency of meta-wory 
was related to both chronic wory and to obsessional thoughts. Further, Sica, Steketee, Ghisi, 
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Chiri, and Franceschini (2007) found that negative beliefs about wory at baseline, but not 
positive beliefs about wory, predicted chronic wory and obsessional thoughts four months later, 
even when controling for chronic wory, obsessional thoughts, and the other metacognitive 
beliefs measured by the Meta-Cognitions Questionnaire at baseline. These results, in addition to 
the results of some studies already discussed (Cartwright-Haton & Wels, 1997; Wels & 
Cartwright-Haton, 2004; Wels & Papageorgiou, 1998), indicate that meta-wory and negative 
beliefs about wory may be prevalent and influential in obsessive-compulsive disorder, and not 
strictly unique to GAD. Further, these meta-beliefs and meta-wories may also play a role in 
depression, as the study by Wels and Carter (2001) also included a group of clients with major 
depression for comparison, and although statistical tests were not conducted, there were no 
substantial diferences in the group means for measures of both Type 2 wory and negative 
beliefs about wory between clients with GAD and clients with major depression. 
As previously mentioned, although the negative metacognitive beliefs about cognitive 
confidence, cognitive self-consciousness, and thoughts in general are not hypothesized to play a 
role in GAD, some studies have suggested links between these meta-beliefs and GAD. Beloch 
et al. (2007) reported that both negative beliefs about wory and negative beliefs about cognitive 
self-consciousness were predictive of wory severity, even when other maladaptive beliefs and 
pathological symptoms were included as predictor variables. As wel, Davis and Valentier 
(2000) found that in addition to being higher in negative beliefs about wory, individuals with 
GAD scored higher on negative beliefs about cognitive confidence, cognitive self-consciousness, 
and thoughts in general than individuals who did not meet criteria for GAD. As wel, the 
negative belief that thoughts need to be controled, along with the negative beliefs about wory, 
mediated the relationships between wory severity and GAD symptoms (Penney et al., 2013). 
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Individuals with GAD have also been found to endorse negative beliefs about thoughts in general 
more than individuals with panic disorder or social phobia, and more than non-clinical 
individuals, although this was not found when controling for Type 1 wory (Wels & Carter, 
2001). However, many of the other studies reviewed have found that cognitive self-
consciousness, the need to control thoughts, other negative beliefs about thoughts, and cognitive 
confidence are not related to GAD symptoms or chronic wory (Cartwright-Haton & Wells, 
1997; de Bruin et al., 2007; Sica et al., 2007), and therefore, these beliefs have not been 
incorporated into the Metacognitive Model of GAD. 
While the Metacognitive Model largely focuses on beliefs and meta-wory, the model 
also discusses behavioural and thought control strategies that maintain GAD. Specificaly, Wels 
(2009) states that common strategies used by individuals that maintain GAD include: reassurance 
seeking, avoidance, information seeking, distraction, substance abuse, thought suppression, 
refusing to disengage from a wory, and so on. Although individual clients with GAD may use 
some or al of these techniques at diferent times, the research has focused on a few strategies. 
Davey et al. (1996) found that negative beliefs about wory were strongly related to a lack of 
task-oriented coping and high emotion-focused coping. Wels and Davies (1994) found that 
measures of meta-wory, social wory, wory severity, and trait anxiety were associated with 
using self-punishment and worying about more minor maters as coping strategies in a sample 
of 50 students. Meta-wory, wory severity, and trait anxiety were not related to the use of 
distraction, talking to peers, or re-appraisal coping strategies. Meta-wory and negative beliefs 
about wory are related to the use of thought suppression and cognitive avoidance strategies (de 
Bruin et al., 2007; Sexton & Dugas, 2009a). 
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Using a clinical sample, Wels and Carter (2009) found that both individuals with GAD 
and individuals with major depression used worying about minor maters as a coping strategy 
more than non-clinical individuals, and individuals with GAD also used self-punishment more 
than the other groups. The non-clinical group also used talking to peers more than both clinical 
groups, and used reappraisals more than individuals with GAD. These findings corespond with 
the findings of Coles and Heimberg (2005) who found that individuals with GAD use self-
punishment and worying about more minor maters as coping strategies more than non-clinical 
individuals, and use distraction and talking to peers less than non-clinical individuals. When the 
groups were combined, wory severity positively corelated with self-punishment and worying 
about other maters, and negatively corelated with distraction and talking to peers. However, 
Coles and Heimberg (2005) also found that depression symptoms had similar relationships to 
these coping strategies. 
The lack of a specific and consistent relationship between wory severity and particular 
coping strategies is repeated throughout the literature. In a student sample wory severity was 
related to the use of self-punishment, but not the use of worying about minor maters, while self-
punishment was also related to depression and anxiety (Fehm & Hoyer, 2004). A second study 
of clients with panic disorder, social phobia, and obsessive-compulsive disorder found that wory 
severity was positively related to the use of self-punishment and the use of worying about minor 
maters, and negatively related to the use of distraction (Fehm & Hoyer, 2004). However, the 
use of wory about minor maters was also related to anxiety, depression, and obsessions, while 
the use of punishment was also related to anxiety, depression, and obsessions, with the use of 
distraction being negatively related to depression and anxiety. A Spanish study (Luciano et al., 
2006) also did not find unique relationships between wory severity and particular behavioural or 
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cognitive coping strategies in a sample of 471 undergraduates and non-student adults. They 
found that the tendency to use thought suppression, wory about other minor maters, and self-
punishment were related to wory severity, depression symptoms, and obsessive-compulsive 
symptoms, which indicates that these strategies are not be unique to GAD. Further, additional 
research has shown that the use of distraction, talking to peers, self-punishment, re-appraisal, and 
wory to cope at baseline do not predict wory severity four months later (Sica et al., 2007). 
Overal, the main components of the Metacognitive Model are supported. Because this 
model states that positive beliefs about wory increase wory, while also arguing that these 
beliefs are not unique to GAD, it accounts for a major critique of this component of the 
Cognitive Avoidance model. Further, numerous studies have linked negative beliefs about wory 
and meta-wory with GAD symptoms, although negative beliefs about wory also appear related 
to obsessive-compulsive and depression symptoms. Due to the literature regarding other 
metacognitive beliefs and GAD being equivocal, the Metacognitive Model does not include 
them. Finaly, although research has shown that wory severity and GAD symptoms are linked 
to problematic coping strategies as hypothesized by the Metacognitive Model, these strategies 
appear to be involved in psychopathology in general and are likely not unique to GAD. 
Applied research. With meta-wory and negative beliefs about wory forming the crux 
of the Metacognitive Model, decreasing meta-wory by chalenging the negative beliefs about 
wory is central to the Metacognitive Model treatment protocol. Wels (1995) published the first 
treatment study using this model, although it was with only one patient. Although treatment 
lasted for only four sessions, the client had substantial reductions in meta-wories and health-
related wories, both of which were elevated prior to treatment. Further, the frequency and 
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duration of wories, as wel as overal anxiety, decreased substantialy from baseline throughout 
treatment, and continued to be very low at three- and six-month folow-ups. 
The first clinical trial to include multiple participants was published by Wels and King 
(2006). A sample of 10 clients with GAD completed between three and twelve sessions of 
therapy. The treatment led to significant and large decreases in trait anxiety, somatic anxiety, 
social wories, health-related wories, meta-wories, and depression symptoms. As wel, 
treatment gains were maintained over six- and twelve-month folow-ups, with the recovery rates 
dipping only slightly from 87% of clients post-treatment to 75% of clients at a twelve-month 
folow-up. Although the authors speculate that the decrease in meta-wories led to changes in al 
other areas, this was not tested. 
To extend on this initial research, Wels et al. (2010) compared the efectiveness of the 
Metacognitive Model treatment protocol with applied relaxation. However, the sample size was 
again low, with only 10 participants completing each treatment. Upon completion, the 
metacognitive treatment was superior to applied relaxation on measures of wory severity, 
somatic anxiety, trait anxiety, depression, and both positive and negative beliefs about wory. 
The metacognitive treatment also produced lasting change on al measures at six- and twelve-
month folow-ups. As wel, the metacognitive therapy led to significantly larger decreases in 
wory severity and negative beliefs about wory than the applied relaxation at a twelve-month 
folow-up. Finaly, the metacognitive therapy led to a lasting recovery in eight of ten clients, 
while applied relaxation led to recovery in only two of ten clients. However, because this study 
did not investigate changes on measures of the proposed cognitive factors, it is unclear if changes 
to negative beliefs about wory and meta-wory led to changes in GAD symptoms. 
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A limitation with these treatment outcome studies is that unlike the studies conducted by 
Borkovec and coleagues, litle research have been conducted to examine the specific 
components of the treatment protocol. It is unclear if components such as targeting positive 
beliefs about wory are necessary for efective outcomes. A study that addresses one additional 
treatment component, known as detached mindfulness, was conducted by Sugiura (2004). 
Although the study used a student population, it was found that being higher in detached 
mindfulness was negatively related to wory severity and related to having a positive problem 
orientation. Similar studies, especialy studies conducted with clinical groups and examining the 
individual components of metacognitive therapy, are needed to examine which components of 
the therapy are most efective. 
Research directly comparing the models. While the previously discussed models of 
GAD require additional research to investigate the specificity of their model to GAD, as wel as 
the eficacy and efectiveness of their associated therapies, a major issue in this field is the lack 
of studies that compare and contrast the models. With the exception of the studies that have 
included both positive and negative beliefs about wory, only one other study appears to have 
contrasted these models. 
The only study which appears to contrast the Cognitive Avoidance Model with another 
model was a comparison of CBT to brief metacognitive therapy in a general outpatient seting 
(Nordahl, 2009). Although this study did not explicitly reference the treatment protocol from the 
Cognitive Avoidance Model, the CBT treatment they describe appears to very similar to the 
treatments used in the Cognitive Avoidance Model outcome studies before the adoption of 
addressing interpersonal problems (Borkovec et al., 2002; Borkovec & Costelo, 1993; Borkovec 
& Mathews, 1988). 
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Nordahl (2009) had 30 community outpatients with a range of diagnoses (primarily major 
depressive disorder and GAD, among other mood, anxiety, and personality disorders) complete 
either metacognitive therapy or standard CBT. The metacognitive therapy led to greater 
reductions in overal anxiety and meta-wory than standard CBT. As wel, while both treatments 
decreased depression substantialy, there was no significant diference between the treatments. 
Unfortunately, no folow-up data was colected. Nonetheless, this study provides initial evidence 
for the superiority of metacognitive therapy, and in turn, the Metacognitive Model, over standard 
CBT, and the Cognitive Avoidance Model. 
Additional models of GAD. Outside of the Cognitive Avoidance Model and the 
Metacognitive Model, three other models of GAD have some empirical support. However, these 
models do not appear to be suitable for ultra-brief treatments. Each of these models, and the 
problems with applying these models to ultra-brief treatments, is briefly reviewed next. 
Intolerance of Uncertainty Model. The Intolerance of Uncertainty Model arose from the 
work of Dugas and coleagues in the early 1990s (Dugas, Letarte, Rhéaume, Freeston, & 
Ladouceur, 1995; Freeston et al., 1994). As the name implies, intolerance of uncertainty is the 
primary focus of the Intolerance of Uncertainty Model, and it is assumed that intolerance of 
uncertainty underlies al components in the model (Dugas & Koerner, 2005). Intolerance of 
uncertainty is defined by believing that uncertainty impairs actions, reflects badly on the person, 
is not fair, and is distressing (Sexton & Dugas, 2009b). Multiple studies have found elevated 
intolerance of uncertainty in individuals with GAD and a unique relationship between 
intolerance of uncertainty and GAD (Buhr & Dugas, 2006; Dugas, Gosselin, & Ladouceur, 2001; 
Ladouceur et al., 1998; Norton et al., 2005; Sexton et al., 2003). However, more recent studies 
have shown that intolerance of uncertainty is also high in individuals with obsessive-compulsive 
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disorder symptoms, social anxiety symptoms, and depression symptoms (Boelen & Reijntjes, 
2009; Carleton, Colimore, & Asmundson, 2010; Holaway, Heimberg, & Coles, 2006; Norton & 
Mehta, 2007). In addition, recent studies by Khawaja and McMahon (2011) and Khawaja, 
McMahon, and Strodl (2011) have found that meta-wory was more strongly related to GAD 
symptoms and wory severity than intolerance of uncertainty. 
Negative problem orientation, another component of the Intolerance of Uncertainty 
Model, is defined as a pessimistic set of beliefs and atitudes towards everyday problems and 
one’s ability to solve them. Although negative problem orientation does appear to have a unique 
relationship to GAD (Dugas et al., 1995, 2007; Dugas, Freeston, & Ladouceur, 1997; Ladouceur 
et al., 1998, 1999; Robichaud & Dugas, 2005), being able to explain this concept and target it in 
therapy requires multiple sessions (Dugas & Koerner, 2005). Therefore, it is unlike that primary 
care practitioners would be able to implement a technique to target this proposed cognitive factor 
in less than 20 minutes. 
The remaining components of the Intolerance of Uncertainty Model include the premise 
that the linguistic nature of wory is used as a cognitive avoidance technique and that positive 
beliefs about wory help maintain the use of wory as a primary coping strategy. These 
components are shared with the Cognitive Avoidance Model. Therefore, by testing these 
components within the Cognitive Avoidance Model, the results wil also apply to the Intolerance 
of Uncertainty Model to some extent. 
It is important to note that the therapy derived from Intolerance of Uncertainty Model 
relies heavily on cognitive therapy and exposure to uncertainty (Dugas & Koerner, 2005; Dugas 
et al., 2010; Ladouceur et al., 2000). Although this treatment does significantly decrease 
symptoms over 12 sessions, the techniques used involve understanding and implementing very 
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sophisticated concepts and strategies. Therefore, it appears that the application of this model to 
an ultra-brief treatment would be extremely dificult within primary care. Further, a recent study 
by van der Heiden, Muris, and van der Molen (2012) compared the treatments based on the 
Intolerance of Uncertainty and Metacognitive models in the treatment of 126 GAD clients. The 
results of this study indicated that metacognitive therapy is superior for treating GAD and 
superior at targeting the proposed cognitive factors than the intolerance of uncertainty therapy. 
This indicates that the application of the Metacognitive Model to an ultra-brief format is 
waranted above the application of the Intolerance of Uncertainty Model. 
Acceptance-Based Model. The Acceptance-Based Model of GAD was developed by 
Roemer and Orsilo (2002, 2005). This model focuses on the internal experiences of individuals 
with GAD. The model states that individuals with GAD negatively react to many diferent forms 
of internal experience, such as thoughts or feelings, and they experience these negative reactions 
as defining features of their character. Wory and behavioural restriction are used in an atempt 
to avoid any internal experiences. 
Because this model of GAD is stil being developed, only a few studies have directly 
examined the components of the model. Roemer, Salters, Rafa, and Orsilo (2005) found that 
experiential avoidance and negative reactions to emotions predicted GAD symptoms in a non-
clinical sample of women, but did not find these relationships in a smal clinical sample. A few 
folow-up studies also found that experiential avoidance, dificulties regulating emotions, and 
distress about emotions were related to GAD symptoms in clinical and non-clinical samples 
(Roemer et al., 2009; Lee, Orsilo, Roemer, & Alen, 2010). However, research has yet to 
examine whether these constructs are specific to GAD or emotional disorders in general, and 
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researchers have not shown that individuals with GAD negatively reaction to many diferent 
forms of internal experiences. 
Along with the basic research, only a few treatment studies for this model have been 
conducted. In both an open-trial and comparison to a wait-list control, the treatment was found 
to be eficacious in decreasing symptoms of GAD and depression, most clients no longer met 
criteria for a GAD diagnosis, and treatment gains were maintained up to nine months post-
treatment (Roemer & Orsilo, 2007; Roermer, Orsilo, & Salters-Pedneault, 2008). Treatment 
was also found to decrease experiential avoidance and fear of emotions, while also increasing 
mindfulness (Roermer et al., 2008; Roermer & Orsilo, 2007). However, the authors did not 
conduct analyses to determine if changes on measures of the proposed cognitive factors were 
related to treatment success. As wel, like the intolerance of uncertainty treatment, the 
acceptance-based treatment appears to be very complex to describe to participants. Developing 
mindfulness and learning to accept one’s emotions are deep topics that are likely to be dificult to 
teach to clients in one session. Therefore, given the lack of research into this model, and the 
apparent dificulty in condensing this treatment to an ultra-brief format, this model was not used 
in the curent study. 
Emotional Dysregulation Model. The Emotional Dysregulation Model was developed 
by Mennin and coleagues (Mennin, Turk, Heimberg, & Carmin, 2004; Turk, Heimberg, 
Luterek, Mennin, & Fresco, 2005). Like the Acceptance-Based Model, the Emotional 
Dysregulation Model focuses on internal experiences, particularly emotions. The model states 
that individuals with GAD experience more intense emotions, particularly negative emotions, 
than most people. Further, it is proposed that individuals with GAD have a poor understanding 
ULTRA-BRIEF TREATMENTS FOR GAD   38 
 
of their emotions and believe their emotions to be threatening. Finaly, the model states that 
individuals with GAD engage in dysfunctional emotion regulation strategies. 
The research conducted based on this model has found that individuals with GAD 
experience negative emotions more strongly than individuals with depression, social anxiety, and 
healthy controls (Mennin, Heimberg, Turk, & Fresco, 2005; Salters-Pedneault, Roemer, Tul, 
Rucker, & Mennin, 2006; Turk et al., 2005). Individuals with GAD also have more dificulty 
labeling their emotional experiences than healthy controls, and atempt to control their emotions 
more than individuals with depression, social anxiety, and healthy controls (Mennin et al., 2005; 
Mennin, Holaway, Fresco, Moore, & Heimberg, 2007). However, individuals with GAD do not 
appear to fear intense emotions more than individuals with depression or social anxiety (Mennin 
et al., 2007; Turk et al., 2005), and some studies have not found that individuals with GAD have 
dificulty identifying their emotions (Decker, Turk, Hess, & Muray, 2008; Novick-Kline, Turk, 
Mennin, Hoyt, & Galagher, 2005). 
 Although the basic research for the Emotional Dysregulation Model is beginning to 
accumulate, a peer-reviewed study of the treatment based on this model has not yet been 
published. Although Mennin (2004) detailed such a treatment, without a published paper on the 
eficacy of the treatment, it would be dificult to create an ultra-brief treatment, and such a 
treatment would not be empiricaly supported a priori. Therefore, due to the shortcomings of the 
literature developed from this model, the Emotional Dysregulation Model was not be used in the 
curent study. 
In sum, although other models have some empirical support, the Cognitive Avoidance 
Model and Metacognitive Model each have extensive empirical support and the therapies derived 
from these models have been researched in more detail than most other models. Further, the 
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Metacognitive Model appears to beter predict GAD severity and treatment success than the 
Intolerance of Uncertainty model. These models can also be best applied to an ultra-brief 
format. 
One domain in which the models of GAD have not been commonly employed, and that 
remains a developing area, is prevention studies targeting GAD. Although some prevention 
research has been conducted, the interventions have not been consistently guided by the primary 
theories and treatments of GAD. However, if prevention treatments have been successful, the 
results could be intertwined with the results from the models of GAD to guide the development 
of ultra-brief interventions.  GAD prevention research, and its potential utilization in the health 
care system, is expanded on next. 
Prevention Outcome Studies for GAD 
 The potential benefits of an efective prevention treatment for GAD that could be 
implemented in the health care system may be considerable. Health care and society costs could 
be dramaticaly reduced, and resources would be freed to treat other ilnesses and disorders. 
However, only a smal body of research regarding prevention studies for GAD exists. A 
thorough review of the anxiety disorder prevention literature by Feldner, Zvolensky, and 
Schmidt in 2004 found that no prevention studies that specificaly targeted GAD had been 
conducted. However, their review found that the prevention programs that targeted general 
anxiety and those that targeted specific anxiety disorders, such as panic disorder, did appear to be 
beneficial. 
Unfortunately, a recent meta-analysis of this literature (Zalta, 2011) found that overal, 
the efect size of these treatments were smal, and this was true for both the interventions that 
targeted general anxiety and those that were disorder specific. Further, the efects of treatment 
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tended to dissipate within one year. Zalta (2011) identified only one study that specificaly 
targeted GAD symptoms, which was a dissertation by Higgins (2006), and did not report on the 
efect size of prevention treatments for GAD. Another study included in the meta-analysis that 
targeted general anxiety and depression measured the impact of treatment on the development of 
GAD (Seligman, Schulman, DeRubeis, & Holon, 1999). Therefore, it is important to consider it 
as a potential GAD prevention intervention. Further, Zalta (2011) did not include two other 
studies that may be considered GAD prevention studies (i.e., Higgins & Hecker, 2008; 
Shoenberger, 2008). These prevention studies are discussed in turn. 
 Seligman et al. (1999) aimed to treat undergraduates at risk for depression.  They 
compared an eight-week two-hour workshop CBT program that targeted depression and anxiety 
to a no-treatment control. The workshop group, over a three year folow-up, had less self-
reported anxiety and depression, and fewer participants had episodes of GAD than the control 
group. Higgins and Hecker (2008) also used a workshop style prevention program, but designed 
their workshops to target undergraduates who were moderate to high woriers. The reported 
results come from a pilot study conducted before Higgins’ (2006) dissertation. This study 
included 72 participants who were randomly assigned to either receive two two-hour CBT 
workshops or to receive no treatment. Due to the low sample size, while only one participant 
who completed the workshops developed GAD over the course of 12 months, this was not 
statisticaly superior to the control condition, in which five participants developed GAD over 12 
months. 
 Aiming to build on the results of the pilot study, Higgins (2006) recruited another 78 high 
worying undergraduates, of which 38 received the two two-hour workshops, while 40 
participants were no-treatment controls. From baseline to one-month folow-up the workshop 
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led to significant decreases in trait wory, GAD symptoms, physiological symptoms of anxiety, 
and depression symptoms, while control participants largely had no changes in any symptoms. 
At six-month and twelve-month folow-ups, while the workshop group appeared to have 
maintained gains on al measures, these scores were not significantly diferent from baseline or 
from the control participants, likely due a high drop out. As wel, although not statisticaly 
diferent, at baseline three participants in both conditions met criteria for GAD, which decreased 
to one participant in the workshop condition, but increased to five participants in the control 
condition. 
 Shoenberger (2008) took a diferent approach by focusing solely on women, and by 
having participants complete either a self-help bibliotherapy or a no-treatment control. Again, 
this study targeted high worying colege students, with 30 participants completing the 
bibliotherapy, and 27 participants being controls. After four weeks the bibliotherapy group had 
significantly larger decreases in wory severity, trait anxiety, neuroticism, quality of life, use of 
thought control strategies, and negative beliefs about wory than the control group, although the 
efect sizes were smal to medium. Further, there were no diferences between the groups in 
terms of depressive symptoms, sleep disturbance, positive beliefs about wory, or the percentage 
of clients meeting criteria for GAD. However, the smal sample in this study, as wel as the lack 
of folow-up data, limits the generalizability of the findings. 
 Although it is clear that GAD prevention research is in an early stage of development, the 
reviewed literature does show promise that CBT based prevention treatments may be eficacious 
in decreasing GAD symptoms, wory severity, and the proposed cognitive factors. However, the 
methodologies used in these studies may not be optimal for primary care. For example, the use 
of workshops (Higgins, 2006; Higgins & Hecker, 2008; Shoenberger, 2008) may require 
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additional staf to coordinate and conduct the treatments, and extensive training for the 
clinicians. Similarly, providing al clients who experience chronic wory or GAD with a self-
help book (Shoenberger, 2008) would be expensive and rests on the assumption that al clients 
can read wel and can easily integrate multiple CBT skils from a manual into their daily lives. It 
is therefore interesting to examine ultra-brief treatments that could be implemented by primary 
care providers at the point of contact. 
Brief and Ultra-Brief Treatments 
Before examining the specific ultra-brief treatments that have been used in GAD 
research, it is important to establish the distinction between brief, ultra-brief, and standard 
treatments. Unfortunately, in the curent literature, the term “brief” has been applied to describe 
any treatment that is less than 20 sessions. However, for the curent study, it is proposed that 
treatments should be separated into three categories: 1) standard therapies (generaly greater than 
nine therapy sessions), 2) brief therapies (generaly between two and nine therapy sessions), and 
3) ultra-brief therapies (one therapy session). Almost al of the treatment studies discussed 
within the Cognitive Avoidance and Metacognitive models of GAD utilized between 10 and 16 
therapy sessions. 
Brief and ultra-brief therapies have the strongest base in the field of addictions. Research 
has shown brief and ultra-brief therapies can be as efective as standard therapies in the treatment 
of alcohol abuse (Moyer, Finney, Swearingen, & Vergun, 2002; Vasilaki, Hosier, & Cox, 2006) 
and pathological gambling (Carlbring, Jonsson, Jospehson, & Forsberg, 2010). Additional 
research has shown that brief therapies can also be efective in treating depression (Churchil et 
al., 2001; Daughters et al., 2008; MacPherson et al., 2010) and social anxiety (Herbert, 
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Rheingold, & Goldstein, 2002). As wel, a review of the brief therapies for depression found 
them to be very cost-efective (Churchil et al., 2001). 
To date, only a few brief CBT studies for GAD have been conducted. In the early 
development of metacognitive therapy, Wels reported successful treatment of GAD clients in 
less than 10 sessions (Wels, 1995; Wels & King, 2006). However, these studies included less 
than 12 clients in total, and some clients received between 10 and 12 treatment sessions. Kehle 
(2008) found that an eight-session CBT protocol based on Borkovec and Costelo’s (1993) study 
for GAD significantly reduced wory severity in clients with excessive wory. Unfortunately, 
only eight participants completed al eight sessions of therapy. Another brief CBT study, the 
therapy study conducted by Nordahl (2009), targeted clients with a range of diagnoses, of which 
GAD was present in 42% of clients. This study compared brief metacognitive therapy (average 
number of sessions for clients was seven) to standard CBT (average number of sessions for 
clients was 10) in a general outpatient seting. Similar to the recent treatment studies conducted 
by Borkovec and coleagues (Newman et al., 2008; 2011) and Wels and coleagues (Wels et al., 
2010; Wels & King, 2006), Nordahl’s brief treatment was found to have large effect sizes. 
However, similar to the issues that accompany the methodologies used in the prevention 
research, brief treatments may not be feasible in primary care. Hiring more staf to conduct such 
treatments may create start-up costs that governments and organizations may not be wiling to 
cover. Further, if brief treatment programs were created, waitlists to receive such services would 
be inevitable. Therefore, if ultra-brief treatments were able to significantly reduce symptoms, 
they could be implemented through general practitioners or alied service providers, which 
would eliminate many costs and possible waitlists. As wel, if ultra-brief treatments were 
efective, symptoms may decrease while individuals are on a waitlist to enter standard treatment 
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and motivation for a standard treatment may increase. Finaly, ultra-brief treatments could also 
be implemented with chronic woriers as a preventative treatment for GAD. 
Ultra-brief treatments for GAD. Only a handful of studies have examined ultra-brief 
treatments for GAD. Using an experimental approach, Mclean and Broomfield (2007) had 62 
chronic woriers either suppress a given wory during a week or simply note its occurence. The 
researchers hypothesized that the suppression group would experience an increase in the 
frequency of worying during the subsequent week and feel less able to control their thoughts 
compared to the awareness group. However, the results indicated that the suppression group had 
larger increases in the belief that wory was controlable, spent less time worying, became beter 
at suppressing the wory, and found the wory to be less distressing than the awareness group. 
Although they did not design the study as a treatment or prevention study, Mclean and 
Broomfield’s (2007) results indicate that suppressing wory could be a useful way to chalenge 
negative beliefs about wory and decreasing the frequency of wory in a short, single-session 
treatment. 
Although Mclean and Broomfield (2007) did not appear to devise their study with the 
wory scheduling research in mind, the design and results are remarkably similar to the wory 
scheduling research. As was discussed in the Cognitive Avoidance Model section, the first GAD 
treatment study developed by Borkovec and coleagues had high woriers self-restrict their wory 
to one 30-minute period each day (Borkovec et al., 1983). It was found that this treatment 
helped participants reduce their daily tension and the percentage of the day they spent worying. 
Brosschot and van der Doef (2006) found that this wory scheduling treatment was efective 
within six days in reducing daily worying and the number of physiological issues experienced 
over the past three days in adolescents. As wel, engaging in wory scheduling for two weeks 
ULTRA-BRIEF TREATMENTS FOR GAD   45 
 
prior to entering into therapy has been found to result in a greater reduction in anxiety and 
physiological symptoms at the end of therapy than having no intervention prior to therapy 
(Verkuil et al., 2011). 
These previous studies focused solely on statistical diferences, and effect sizes were not 
reported. However, when McGowan and Behar (2013) found that the wory scheduling 
treatment was efective over two weeks in reducing anxiety, trait wory, negative afect, and 
symptoms of insomnia in undergraduates, they reported medium to large efect sizes from pre-
treatment to post-treatment. Although research is needed to directly compare the eficacy of 
ultra-brief treatments to standard treatments, the efect sizes found by McGowan and Behar 
(2013) indicate that ultra-brief treatments can lead to considerable symptom changes. 
Additional recent studies focusing on other forms of psychopathology also indicate that 
ultra-brief treatments may be as efective as brief and standard therapies. Gawrysiak, Nicholas, 
and Hopko (2009) found that a single session of behavioural activation was efective in 
decreasing depression symptoms and had a large efect size. Further, Petry, Weinstock, 
Ledgerwood, and Morasco (2008) found that 10 minutes of brief advice about problem gambling 
was a more efective treatment than one 50 minute session of motivational enhancement therapy, 
or one session of motivational enhancement therapy folowed by three sessions of CBT. Given 
the scarcity of literature on ultra-brief therapies, it remains unclear how efective ultra-brief 
therapies are compared to brief or standard treatments, but these early studies indicate that ultra-
brief therapies can lead to substantial decreases in symptoms. 
Out of the available research, the wory scheduling appears to be the best option for a 
cost-efective treatment, and prevention of, GAD in primary care. This technique can be 
described to clients in primary care in less than 20 minutes and does not require extensive 
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training to be delivered. However, empirical questions remain about this technique. For 
example, while Borkovec (Borkovec et al., 1983; Sibrava & Borkovec, 2006) describes the use 
of this strategy as a way to decrease the association between wory triggers and the act of 
worying, Wels (2009) describes the use of this strategy as a way to combat the belief that wory 
is uncontrolable and dangerous. Further, while Borkovec recommends that the clients should 
shift their atention to the present moment (i.e., distraction from worying thoughts) when 
worying occurs outside of the wory period, Wels recommends that clients should shift their 
atention to the meta-cognitive level (i.e., observing the thought process non-judgmentaly) when 
worying occurs outside of the wory period. Therefore, these diferent approaches need to be 
contrasted to determine if one strategy is more eficacious than the other. 
A second empirical question regarding the wory scheduling technique is whether this 
technique has a lasting efect. As already reviewed, previous prevention studies have rarely 
found significant diferences between treatment groups and control groups in long-term folow-
ups. As wel, the longest wory scheduling study to date had participants report symptoms for 
only four weeks (Borkovec et al., 1983). Longer folow-ups are needed to examine if 
participants maintain their gains from either treatment condition. 
Finaly, it is important to examine which of the proposed cognitive factors in GAD are 
related to changes in symptoms. Due to the Cognitive Avoidance Model and Metacognitive 
Model proposing unique cognitive factors, and because these cognitive factors have not been 
examined against one another in any previous study, the examination of the proposed cognitive 
factors wil shed light on the relative strength of each model. 
  
ULTRA-BRIEF TREATMENTS FOR GAD   47 
 
The Present Study 
The goal of the present study was to compare the eficacy of two ultra-brief treatments 
for GAD to each other and to a delayed treatment (i.e., waitlist) control. Further, to examine if 
these treatments could be feasible in primary care, the treatments were delivered in less than 20 
minutes. The two treatments were derived from the treatment manuals of the Cognitive 
Avoidance Model and the Metacognitive Model. 
Modifications of the treatments for the current study. The treatments used in the 
present study were therapeutic techniques derived from the empiricaly supported treatment 
manuals developed from the Cognitive Avoidance Model (Sibrava & Borkovec, 2006) and 
Metacognitive Model (Wels, 2009). For the Cognitive Avoidance Model technique, the curent 
study folowed the wory scheduling treatment script used by McGowan and Behar (2013), with 
some modifications. First, to ensure the technique is as close to the original technique (Borkovec 
et al., 1983) as possible, the emphasis on focusing on the present moment by either focusing 
outside of the body or on physiological processes (e.g., one’s breathing) when one begins to 
wory during the day was highlighted. McGowan and Behar (2013) did not discuss this in their 
script. Second, because McGowan and Behar (2013) reported that the technique did not increase 
positive afect, the technique was modified to include the use of positive self-reinforcements for 
engaging in the treatment. This was based on previous findings that individuals with GAD 
symptoms do not have normal self-reinforcement skils, and that the use of self-management 
techniques to stop worying can lead to decreases in anxiety, decreases in negative afect, and 
increases in positive afect (Penney & Mazmanian, 2010a; 2010c). 
For the Metacognitive Model technique, the treatment was very similar to the wory 
scheduling technique described above. One of the between-session homework assignments that 
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is often conducted very early in metacognitive therapy for GAD (i.e., session one, two, or three) 
described by Wels (2009) runs paralel to the wory scheduling technique. The homework 
assignment, termed the wory postponement experiment, requires participants to restrict their 
wory to one 10-minute period a day, similar to the wory scheduling technique. However, 
rather than explaining the purpose of this technique based on the associations between wory and 
diferent locations from a learning model approach, metacognitive therapy focuses on using this 
technique as an opportunity for the client to learn that he or she has control over how much he or 
she wories. In addition to a diferent rationale, when the client wories during the day, in the 
wory postponement experiment, the client is instructed to non-judgmentaly observe the 
wories, rather than trying to focus outside of the body as done in the original wory scheduling 
technique. For the curent study, to ensure the wory period is the same in both treatments, the 
wory period was be extended to 30 minutes every day for the metacognitive treatment.  As wel, 
an emphasis on worying as intensely as possible during the wory period, in order to learn that 
wories are not inherently dangerous and to ensure similarities between treatments, was also 
added. Overal, this treatment was used to target the negative beliefs about wory in GAD and to 
help the client think on a metacognitive level. Like the original wory scheduling, the wory 
postponement experiment is typically taught in a single session. An examination of the literature 
does not indicate that the wory postponement experiment has been previously examined 
independent of the ful therapy, and this was a novel application of the technique. 
To summarize, for the treatments used in this study, there were two primary points of 
divergence. First, the rationales behind the treatments (i.e., learning theory versus metacognitive 
theory) were significantly diferent. Second, the ways in which wories outside of the wory 
period are responded to (i.e., focusing outside of the body versus simply observing the thought 
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process) were also distinct between the therapies. Both treatments were termed “wory 
scheduling” for the participants.  
Research questions and hypotheses. 
The study design consisted of baseline measurements, folowed by a randomization to the 
cognitive avoidance technique, metacognitive technique, or delayed treatment control. 
Approximately one-third of the participants were assigned to a four-week delayed treatment 
control condition before receiving treatment. This alowed for the treatments to be compared to 
the efect of receiving only an assessment, while simultaneously ensuring that al participants 
received treatment. Folow-ups were conducted at four weeks and four months post-treatment to 
provide assessment of long-term outcome. 
As GAD has a one-year incidence rate of approximately 1.1% in the general population 
(Grant et al., 2009), and because the delayed treatment control only lasted for four weeks, 
comparing incidences of GAD between the treatments and the control condition was unlikely to 
lead to significant diferences between groups. This was a problem for the aforementioned 
prevention research as wel. As wel, it was assumed that the majority of the sample would be 
sub-clinical at baseline, as recruitment would target members of the general community and 
university students. Therefore, while the number of individuals meeting criteria for GAD were 
reported for each group, it was a priori assumed that statistical diferences would not exist 
between groups. Instead of focusing on the percentage of participants in each group meeting 
criteria for GAD, this study tested the eficacy of each condition by examining changes to 
dimensional measures of GAD symptoms, wory severity, health anxiety, negative afect, and 
positive afect. It also tested the eficacy of each treatment by examining changes in secondary 
indicators of mental health, including measures of motivation for further treatment, 
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psychopharmacology, and health care utilization. Decreases on al outcome measures (except for 
the measure of positive afect, which was expected to increase) during the first four weeks, and 
maintenance of gains at four months post-treatment, served as indicators of treatment success. 
Hypotheses. 
Based on the success of the previous wory scheduling research (Borkovec et al., 1983; 
Brosschot & van der Doef, 2006; McGowan & Behar, 2013; Verkuil et al., 2011), as wel as the 
eficacy of metacognitive therapy (Wels et al., 2010; Wels & King, 2006), it was predicted that 
the treatment conditions would be superior to the delayed treatment (DT) condition in reducing 
GAD symptoms, wory severity, health anxiety, and negative afect.  
1) The cognitive avoidance wory scheduling (CAWS) and metacognitive wory 
scheduling (MWS) would lead to larger decreases in GAD symptoms, wory severity, 
health anxiety, and negative afect than the DT condition after four weeks. 
Since it was predicted that treatments would be eficacious in reducing symptoms of 
GAD, it was also predicted that the treatment conditions would lead to larger improvements on 
secondary indicators of mental health, including medication use and health care utilization, than 
the DT condition.  
2) The CAWS and MWS would lead to larger decreases in medication use and health 
care utilization than the DT condition after four weeks. 
Further based on the predicted eficacy of the treatments in reducing GAD symptoms, it 
was also predicted that the treatment conditions would lead to participants becoming more 
motivated for further treatment, such as a 12-week therapy program, and believing more strongly 
that their wory can be treated, than the DT condition. 
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3) The CAWS and MWS would lead to larger increases in motivation for more intensive 
therapy and in the expectancy that the wory can be treated than the DT condition 
after four weeks. 
With previous research supporting the superiority of the metacognitive therapy over CBT 
(Nordahl, 2009) and intolerance of uncertainty therapy (van der Heiden et al., 2012) in treating 
GAD, it was predicted that the metacognitive technique would lead to larger decreases in GAD 
symptoms and wory severity than the cognitive avoidance technique at four-week and four-
month post-treatment. 
4) The MWS would lead to larger decreases in GAD symptoms and wory severity than 
the CAWS at four weeks and four months post-treatment. 
Further based on the superiority of the metacognitive therapy over intolerance of 
uncertainty therapy in leading to decreases on measures of the proposed cognitive factors (van 
der Heiden et al., 2012), it was predicted that the metacognitive technique would lead to larger 
decreases on measures of the proposed cognitive factors in GAD than the cognitive avoidance 
technique at four-week and four-month post-treatment. 
5) The MWS would lead to larger decreases in negative beliefs about wory, meta-
wory, cognitive avoidance, positive beliefs about wory, and other metacognitive 
beliefs than the CAWS at four weeks and four months post-treatment. 
Due to the modification to the cognitive avoidance technique, and the inclusion of a self-
management component to increase positive afect, it was predicted that the cognitive avoidance 
technique would lead to larger increases in positive afect than the metacognitive technique at 
four-week and four-month post-treatment. 
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6) The CAWS would lead to larger increases in positive afect than the MWS at four 
weeks and four months post-treatment. 
Finaly, given the close associations between negative metacognitions (Beloch et al., 
2007; Cartwright-Haton & Wels, 1997; Davis & Valentier, 2000; de Bruin et al., 2007; Hirsch 
et al., 2013; Khawaja et al., 2011; Khawaja & McMahon, 2011; Penney et al., 2013; Ruscio, 
2002; Ruscio & Borkovec, 2004; Sica et al., 2007; Wels & Papageorgiou, 1998) and meta-wory 
(Wels & Carter, 1999; Wels & Carter, 2001; Wels, 2005) with GAD, it was predicted that 
these variables would be significantly related to changes in GAD symptoms and wory severity 
from baseline to four-week and four-month folow-ups. However, because the literature has 
shown a lack of specificity between cognitive avoidance (Ladouceur et al., 1999), positive 
beliefs about wory (Cartwright-Haton & Wels, 1997; Dugas, Gagnon, Ladouceur, & Freeston, 
1998; Ladouceur et al., 1999; Penney et al., 2013; Wels & Papageorgiou, 1998), and other 
metacognitive beliefs with GAD (Cartwright-Haton & Wells, 1997; de Bruin et al., 2007; Sica 
et al., 2007), and because only one study, which included few variables, found that negative 
evaluation sensitivity was associated with GAD (Kotov et al., 2007), it was predicted that these 
variables would not be related to changes in GAD symptoms and wory severity. 
7) Changes in negative beliefs about wory and frequency of meta-wory, but not 
changes in cognitive avoidance, negative evaluation sensitivity, positive beliefs about 
wory, or other metacognitive beliefs, would be related to changes in GAD symptoms 
and wory severity from baseline to four weeks and baseline to four months post-
treatment. 
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Method 
Participants 
Potential participants were recruited at Lakehead University and from the local Thunder 
Bay community. Potential participants were recruited through a variety of methods, including 
posters at Lakehead University, pamphlets being distributed by counselors at the Lakehead 
University Student Health & Counseling Centre, presentation to students in Introductory 
Psychology, advertisements in local print and online media, posters in local medical clinics, and 
displays at local health and welness expos (see Appendix A). The advertisements were aimed at 
recruiting individuals who would like to receive treatment to decrease their worying and/or 
anxiety. The advertisements asked potential participants to email or cal the researcher to receive 
instructions on how to complete the study. Potential participants who agreed to complete the 
study were also asked to give the contact information of the researcher to any individual they 
knew who would be interested in receiving a treatment for wory or anxiety. A total of 115 
participants consented to participate in the study. 
Given that there is evidence that successful CBT treatment of GAD leads to improvement 
in comorbid conditions such as social anxiety and depression, and that the occurence of these 
conditions does not impede therapy success (Borkovec, Abel, & Newman, 1995; Newman, 
Przeworski, Fisher, & Borkovec, 2010), it was determined that few exclusionary criteria should 
be used. Therefore, the entry criteria included the ability to read, write, and understand spoken 
English, an interest in decreasing wory or anxiety, being older than 17 years of age, displaying 
no indicators of suicidal intent, and reporting no history of mania, hypomania, or psychotic 
experiences. In total, one participant was screened out of the study due to a combination of 
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suicidal thoughts and history of psychotic-like experiences. Additional information about the 
movement of participants through the study is included in the Study design section. 
Measures 
 Demographic characteristics measure. A 13-item version of the Background 
Information Questionnaire, a self-report questionnaire, was used to classify participants’ sex, 
age, ethnicity, marital status, employment status, student status, and level of education (see 
Appendix B). This measure was based on the Background Information Questionnaire used by 
Penney et al. (2013). 
 GAD symptom measures. 
 Structured diagnostic assessment of GAD criteria. The Mini International 
Neuropsychiatric Interview (MINI; Sheehan et al., 1997) was used to assess if participants meet 
DSM-IV diagnostic criteria for GAD. The MINI is a clinician-administered interview, which 
generaly takes less than 20 minutes to complete, composed of 16 modules that assess a range of 
disorders and psychopathological experiences. For the curent study, the focus was on the GAD 
diagnostic module, although the major depressive disorder, panic disorder, agoraphobia, social 
anxiety, obsessive-compulsive, and postraumatic stress disorder diagnostic modules were also 
completed. The study also used the suicidality, manic/hypomania, and psychotic experiences 
modules as exclusionary measures2. Overal, the MINI has good inter-rater reliability, test-retest 
reliability, sensitivity, specificity, convergent validity, and compares favourably to other 
validated clinical interviews and expert opinion (Lecrubier et al., 1997; Sheehan et al., 1997; 
1998). The GAD diagnostic module has been found to have good sensitivity, specificity, inter-
                        
2 The MINI is not provided in the appendices because it is a protected psychiatric diagnostic interview that is not 
made available to the public at large. 
ULTRA-BRIEF TREATMENTS FOR GAD   55 
 
rater reliability, and test-retest reliability, but low to moderate agreement with other structured 
diagnostic interviews (Lecrubier et al., 1997; Sheehan et al., 1997; 1998). 
Dimensional measure of GAD symptoms. The English Wory and Anxiety 
Questionnaire (WAQ; Dugas et al., 2001b) was used to measure the symptoms of GAD, based 
on the DSM-IV criteria, on a continuum. The WAQ is an 11-item self-report questionnaire, with 
items scored on nine-point Likert-type scales (see Appendix B). Total scores can range from 0 
to 80. Higher scores indicate more GAD symptoms and impairment. Items refer to symptoms 
over the past six months or provide no time frame. The original French version (Dugas et al., 
2001a) has shown known-groups validity and good test-retest reliability (as cited in Dugas & 
Koerner, 2005). The English translation also has good internal consistency and convergent 
validity (Penney & Mazmanian, 2010b). In the present study the WAQ had a Cronbach’s alpha 
of .85 at baseline, of .91 at four weeks post-treatment, and of .92 at four months post-treatment. 
Dimensional measure of worry severity. The Penn State Wory Questionnaire (PSWQ; 
Meyer, Miler, Metzger, & Borkovec, 1990) was used to measure wory severity. The PSWQ is 
a 16-item self-report questionnaire, with items scored on five-point Likert-type scales (see 
Appendix B). Total scores can range from 16 to 80. Higher scores indicate more chronic and 
pathological wory. The measure provides no time frame. For the curent study, one item (I’ve 
been a worrier al my life) was removed at folow-ups, and retroactively removed at baseline due 
to the time frame used within the item. The PSWQ has been found to measure a single factor, 
have high internal consistency, and high test-retest reliability (Startup & Erickson, 2006). Stöber 
(1998) also found that substantial convergence between self-report and peer-report on the 
PSWQ. Further, scores on the PSWQ decrease with successful treatment of GAD (Startup & 
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Erickson, 2006). In the present study the PSWQ had a Cronbach’s alpha of .89 at baseline, of 
.91 at four weeks post-treatment, and of .92 at four months post-treatment. 
Comorbid symptom measures. 
 Measure of health anxiety symptoms. The Short Health Anxiety Inventory (SHAI; 
Salkovskis et al., 2002) was used to measure excessive concerns about one’s health. The SHAI 
is an 18-item self-report questionnaire, with each item containing four statements that vary in 
degree from no health anxiety to high health anxiety (see Appendix B). Total scores can range 
from 0 to 54. Higher scores indicate more health anxiety. The measure refers to feelings over 
the past six months. The SHAI has been found to have a supported factor structure, high internal 
consistency, and strong convergent and discriminant validity (Abramowitz et al., 2007; 
Salkovskis et al., 2002). In the present study the SHAI had a Cronbach’s alpha of .90 at 
baseline, of .89 at four weeks post-treatment, and of .90 at four months post-treatment. 
Measure of positive and negative afect. The Positive and Negative Afect Schedule 
(Watson, Clark, & Telegen, 1988) was used to measure positive affect (PANAS-PA; i.e., global 
feeling of satisfaction, pleasure, excitement, etc.) and negative afect (PANAS-NA; i.e., global 
feeling of distress, depression, anxiety, etc.). The Positive and Negative Afect Schedule is a 20-
item self-report list of feeling adjectives, with items scored on five-point Likert-type scales (see 
Appendix B). Scores on the two scales can range from 10 to 50. Higher scores indicate higher 
feelings of positive or negative afect. Participants were instructed to respond to how they felt 
during the past few weeks. The Positive and Negative Affect Schedule has been shown to have 
high internal consistencies, with low corelations between the scales, moderate test-retest 
reliabilities, two distinct factors, and high convergent and discriminant validity (Watson et al., 
1988). In the present study the PANAS-PA had a Cronbach’s alpha of .90 at baseline, of .89 at 
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four weeks post-treatment, and of .93 at four months post-treatment. The PANAS-NA had a 
Cronbach’s alpha of .85 at baseline, of .89 at four weeks post-treatment, and of .92 at four 
months post-treatment. 
 Health care utilization and secondary indicators of mental health measures. 
 Primary care utilization and treatment seeking behaviours. A revised version of the 
Geting Help for Anxiety Scale (RGHAS; Dozois, Westra, Colins, Fung, & Gary, 2004) was 
used to measure use of primary care services, other professional services, and other individual 
and group methods to decrease anxiety in the past month (e.g., reading a book, atending a self-
help group, exercising, atending a seminar, etc). The Geting Help for Anxiety Scale was 
revised to focus on the past month, reduce overlap amongst items, and remove items regarding 
medication use because medication use was measured using a separate measure. The RGHAS is 
an 11-item self-report checklist (see Appendix B). Total scores can range from 0 to 11. Higher 
scores indicate greater treatment seeking behaviours. If a participant checked an item, they were 
asked to report the number of times they engaged in that treatment seeking behaviour, although 
this is not included in the total score. The item “I have discussed how to solve or manage my 
anxiety with my family physician or other primary care provider (e.g., registered nurse, etc.)” 
was also examined independently to assess changes in primary care utilization. The original 
Geting Help for Anxiety Scale had convergent validity with a measure of stages of change 
(Dozois et al., 2004), but no other psychometric properties are known of the original scale. In 
the present study the RGHAS had a Cronbach’s alpha of .74 at baseline, of .62 at four weeks 
post-treatment, and of .73 at four months post-treatment. 
Psychopharmacological medication use. Folowing the measurement of 
psychopharmacological medication use as conducted by other researchers in the GAD literature 
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(Borkovec & Costelo, 1993; Dugas et al., 2003; Dugas et al., 2010; Ladouceur et al., 2000; 
Newman et al., 2002; Wels et al., 2010) participants were asked if they are curently taking 
psychotropic medications. In addition, participants were also asked to rate on a seven-point 
Likert-type scale (where -3 = greatly decreased the frequency/dose/amount of medication use; 0 
= no change in the frequency/dose/amount of medication use; +3 = greatly increased the 
frequency/dose/amount of medication use) any change in their psychotropic medication use 
compared to four weeks ago. However, at folow-ups, participants rated changes in their 
psychotropic medication use compared to the start of the study.  Participants were also asked to 
report the names and dosages of any psychotropic medication that they are curently taking. This 
measure was caled the Psychopharmacological Medication Use Scale (PMUS) (see Appendix 
B). 
Motivation for additional treatment. A measure developed for this study, the Motivation 
for Receiving Treatment Scale (MRTS), was used to measure how likely a participant would be 
to engage in various 12-week treatments (i.e., individual psychotherapy, self-help manual, 
support group). The MRTS is a 5-item self-report questionnaire, with items scored on seven 
point Likert-type scales (where 1 = Not very likely, 4 = Not sure, and 7 = Very likely) (see 
Appendix B). Total scores can range from 5 to 35. Higher scores indicate more motivation for 
receiving additional treatment. The measure provides no time frame. In the present study the 
MRTS had a Cronbach’s alpha of .80 at baseline, of .80 at four weeks post-treatment, and of .84 
at four months post-treatment. 
Expectancy that anxiety can be treated. The Anxiety Change Expectancy Scale (ACES; 
Dozois & Westra, 2005) was used to measure the belief that the anxiety can be treated. The 
ACES is a 20-item self-report questionnaire, with items scored on five-point Likert-type scales 
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(see Appendix B). Total scales can range from 5 to 100. Higher scores indicate more belief that 
the anxiety can be treated. The measure asks how participants feel right now. The ACES has 
been found to have high internal consistency, a single factor structure, good convergent validity, 
good divergent validity, and good predictive validity (Dozois & Westra, 2005; Westra & Dozois, 
2006). In the present study the ACES had a Cronbach’s alpha of .92 at baseline, of .91 at four 
weeks post-treatment, and of .93 at four months post-treatment. 
Proposed cognitive factors measures. 
 Cognitive avoidance. The English Cognitive Avoidance Questionnaire (CAQ; Sexton & 
Dugas, 2008) was used to measure the use of strategies to avoid negative thoughts and images. 
The CAQ is a 25-item self-report questionnaire, with items scored on five-point Likert-type 
scales (see Appendix B). Total scores can range from 25 to 125. Higher scores indicate more 
cognitive avoidance. The measure provides no time frame. The original French version 
(Gosselin et al., 2002; as cited in Sexton & Dugas, 2008) has a supported factor structure, high 
internal consistency, test-retest reliabilities, treatment sensitivity, convergent validity, and 
discriminant validity. The English translation has retained these high psychometric properties 
(Sexton & Dugas, 2008). In the present study the CAQ had a Cronbach’s alpha of .93 at 
baseline, of .94 at four weeks post-treatment, and of .95 at four months post-treatment. 
 Meta-worry. The frequency scale of the Meta-Wory Questionnaire (MWQ; Wels, 2005) 
was used to measure how frequently participants experience meta-wories. More specificaly, 
the MWQ focuses on the perceived danger of meta-wory, without measuring the perceived 
uncontrolability of meta-wory. The MWQ is a 7-item self-report questionnaire, with items 
scored on four-point Likert-type scales (see Appendix B). Total scores can range from 7 to 28. 
Higher scores indicate more frequent meta-wories. The measure provides no time frame. The 
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MWQ shows good internal consistency, a supported factor structure, and convergent validity 
(Wels, 2005). In the present study the MWQ had a Cronbach’s alpha of .86 at baseline, of .88 at 
four weeks post-treatment, and of .90 at four months post-treatment. 
 Metacognitive beliefs. The Metacognitions Questionnaire-30 (MCQ-30; Wels & 
Cartwright-Haton, 2004) was used to measure beliefs about wory, memory, and thought 
awareness. The MCQ-30 is a 30-item self-report questionnaire, with items scored on four-point 
Likert-type scales (see Appendix B). It contains five subscales, each of which range from 6 to 
24, that measure positive beliefs about wory, negative beliefs about wory being uncontrolable 
and dangerous, beliefs about the need to control thoughts, lack of confidence in memory 
(cognitive confidence), and monitoring of thoughts (cognitive self-consciousness). Higher 
scores indicate more pathological beliefs. The measure asks how much participants agree with 
each statement generaly. The MCQ-30 shows good internal consistency, a supported five factor 
structure, convergent validity, and moderate test-retest reliability (Wels & Cartwright-Haton, 
2004). In the present study the MCQ-30 subscales had Cronbach’s alphas that ranged from .70-
.91 at baseline, .74 -.94 at four weeks post-treatment, and .72-.92 at four months post-treatment. 
Negative evaluation sensitivity. The Brief Fear of Negative Evaluation scale (BFNE; 
Leary, 1983) was used to measure fear of being negatively evaluated by others. The BFNE is a 
short-form of the original Fear of Negative Evaluation scale (Watson & Friend, 1969). The 
BFNE is a 12-item self-report questionnaire, with items scored on five-point Likert-type scales 
(see Appendix B). Total scores can range from 12 to 60. Higher scores indicate more fear of 
being negatively evaluated. The measure provides no time frame. The BFNE strongly corelates 
with the original scale, has high internal consistency, test-retest reliability, convergent validity, 
and is beter at discriminating amongst participants than the original scale (Leary, 1983; 
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Rodebaugh et al., 2004). In the present study the BFNE had a Cronbach’s alpha of .93 at 
baseline, of .91 at four weeks post-treatment, and of .95 at four months post-treatment. 
Treatment characteristic measures. 
 Treatment credibility, expectancies, and success. A revised version of the newly 
redeveloped Credibility/Expectancy Scale (RCES; Devily & Borkovec, 2000) was used to 
measure how much participants believe that the technique is credible and how much they believe 
it wil change their symptoms. Rather than using the newly redeveloped version of this measure, 
which diferentiates how much a person thinks the treatment is credible and efective versus how 
much a person feels that the treatment is credible and efective, only Set I of the 
Credibility/Expectancy Scale was used, and the diferentiation between the thinking and feeling 
aspects of beliefs was not emphasized. This decision was made to return the scale to the 
originally published version (Borkovec & Nau, 1972), which has been used extensively in the 
literature, although no psychometric properties of the original version have been published. 
 The RCES is a 4-item self-report questionnaire (see Appendix B). The three credibility 
items scored on nine-point Likert-type scales, and the expectancy item scored on a percentage 
continuum in 20 point increments (e.g., -40%, -20%, 0%, 20%, 40%, and so on). Scores on the 
Credibility scale range from 3 to 27, while scores on the Expectancy Scale range from -100% to 
100%. The expectancy item was modified to include negative percentages so that participants 
could report if they believed that their symptoms would deteriorate at baseline or had 
deteriorated at folow-ups. The credibility items ask how much participants believe in the 
treatment right now. At baseline the expectancy items ask participants to estimate how much 
symptoms wil change over the next few weeks, while at folow-ups the expectancy item asks 
participants to compare their symptoms to the start of the study. The Credibility/Expectancy 
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scale has found to have high internal consistencies, strong test-retest reliability, good construct 
validity, and good predictive validity (Devily & Borkovec, 2000). 
 Treatment implementation. A revised version of the Homework Compliance Scale 
(RHCS; Westra & Dozois, 2006; Westra, Dozois, & Marcus, 2007) was used to measure how 
often participants use the technique that they are taught, and how dificult the technique is to use. 
The item “How much of the assigned homework did you complete” was removed from the RHCS 
because it was not applicable to the curent study. Further, the wording of items was changed 
from homework assignments, to worry scheduling, and from previous treatment session, to next 
week at baseline, and to last week at folow-ups. As wel, the first item of the questionnaire, 
which assesses how many days the homework was completed, was changed from the response 
options of None, Every other day, and Every day, to 0 days, 1 day, 2 days, and so on up to 7 
days. Finaly, an additional item, assessing how dificult the technique is to start or complete 
was added to the scale. The RHCS is a 4-item self-report questionnaire (see Appendix B), with 
the first item assessing the number of days the technique was used scored on an 8-point Likert-
type scale, and the remaining three items scored on a 5-point Likert-type scale. Higher scores 
indicate more use of the therapeutic technique. The original Homework Compliance Scale has 
been found to have high internal consistency, convergent validity, and predictive validity 
(Westra & Dozois, 2006; Westra et al., 2007). 
 Problematic response styles. Because the majority of the measures in the present study 
rely on self-report (which is required given the inherent impossibility of directly observing 
internal thoughts and emotions), measures of impression management and random responding 
were included to exclude data that appears to be inaccurate or biased. 
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Positive impression management. The Positive Impression Management scale (PIM) of 
the Personality Assessment Inventory (Morey, 1991) was used to measure positive impression 
management (i.e., presenting oneself in a socialy desirable light). The PIM is a 9-item self-
report questionnaire, with items scored on four-point Likert-type scales from “False” to “Very 
True” (see Appendix B). Total scores can range from 0 to 27. Higher scores indicate more 
positive impression management. The PIM has moderate internal consistency, high test-retest 
reliability, good construct validity, and an established empirical raw cut-of score of 17 or above. 
Negative impression management. The Negative Impression Management scale (NIM) 
of the Personality Assessment Inventory (Morey, 1991) was used to measure negative 
impression management (i.e., exaggerating the degree of one’s clinical symptoms). The NIM is 
a 9-item self-report questionnaire, with items scored on four-point Likert-type scales from 
“False” to “Very True” (see Appendix B). Total scores can range from 0 to 27. Higher scores 
indicate more negative impression management. The NIM has moderate internal consistency, 
high test-retest reliability, good construct validity, and an established empirical raw cut-of score 
of 11 or above. 
Random responding. The Infrequency scale (INF) of the Personality Assessment 
Inventory (Morey, 1991) was used to measure random responding. The INF is an 8-item self-
report questionnaire, with items scored on four-point Likert-type scales from “False” to “Very 
True” (see Appendix B). Total scores can range from 0 to 24. Higher scores indicate more 
random responding. Although the INF has low internal consistency and moderate test-retest 
reliability this would be expected given the nature of the items. Further, it has good construct 
validity and an established empirical raw cut-of score of 9 or above. 
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Supplemental measures. Additional measures that were not directly related to the 
hypotheses and are not key outcome measures, but were theoreticaly interesting for future 
examining, were also included. These measures include: the Inventory of Depression and 
Anxiety Symptoms (Watson et al., 2007, 2008), the Obsessive-Compulsive Inventory – Revised 
(Foa et al., 2002; Hajcak, Huppert, Simons, & Foa, 2004), and the Self-Control Self-
Management Scale (Mezo, 2009; Mezo & Short, 2012). These measures assess depression, 
social anxiety, panic disorder, obsessive-compulsive disorder, and self-management skils (see 
Appendix B). Al of these measures have strong psychometric properties. 
Procedure 
Study design. Ethical approval for this study was obtained from Lakehead University’s 
Senate Research Ethics Board in November 2012. Participant recruitment began January 2013 
and finished August 2013, with the last data colection occuring in January 2014. Upon 
contacting the researcher by telephone or email, potential participants were given a brief 
introduction into the nature of the study and treatments, the nature of randomization, and given 
the opportunity to schedule an appointment. Before atending the appointment, participants were 
randomly assigned, using a random number generator, to the CAWS treatment, the MWS 
treatment, or the DT condition. Approximately two-thirds of participants were assigned to 
receive treatment at the first appointment, while the remaining one-third of participants were 
assigned to the DT condition before receiving treatment. Participants were randomly assigned 
prior to their first appointment for ease of coordination with the therapists. 
Upon meeting with the researcher at Lakehead University in the Health, Hormones, and 
Behaviour Laboratory, the potential participants were fuly informed of the nature of study and 
the nature of randomization (see Appendix C). Any participant who did not wish to be 
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randomized, or withdrew from the study upon being explained the details of the study, was 
provided with information on how to seek professional counseling in Thunder Bay (see 
Appendix D). Participants who continued were then provided with a consent form to complete 
(see Appendix E). Consenting participants completed a contact information form (see Appendix 
F) before completing the Background Information Questionnaire online. Folowing this 
questionnaire, the researcher conducted the MINI. After the MINI was completed, participants 
completed the folowing questionnaires online in the folowing order: the WAQ, the MWQ, the 
PSWQ, the CAQ, the RGHAS, the BFNE, the MCQ-30, the MRTS, the Positive and Negative 
Afect Schedule, the PMUS, the SHAI, the ACES, the Obsessive-Compulsive Inventory – 
Revised, the Self-Control Self-Management Scale, and the Inventory of Depression and Anxiety 
Symptoms. The PIM, the NIM, and the INF items were scatered amongst the other measures. 
The measures were not counter-balanced, because of a concern of participant fatigue. The most 
important measures to the study were placed at the beginning of the set, so that if participants 
began to no longer pay close atention to the items as time went on, this would occur with the 
measures deemed less important to the study. Please see Appendix B for the baseline self-report 
measures.  Participants generaly completed this section in approximately 45 to 90 minutes. Al 
self-report questionnaires were completed online through SurveyMonkey 
(www.surveymonkey.com), a safe and secure survey hosting website that has been used 
extensively by the Health, Hormones, and Behaviour Laboratory. 
After completing the questionnaires, participants who were assigned the DT condition 
received a debriefing form (see Appendix G) and the list of available counseling services (see 
Appendix D), and were contacted after three weeks to schedule a second appointment. For these 
participants, the second appointment involved completing the MINI and al self-report 
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questionnaires a second time prior to being entered into treatment. Participants who were 
originaly assigned to either the CAWS or MWS conditions at the first appointment received 
treatment immediately upon completing the questionnaires. For treatment, participants were first 
provided with the Canadian Psychological Association’s “Psychology Works” Fact Sheets: 
Generalized Anxiety Disorder (Canadian Psychological Association, 2009). This information 
was chosen as it is publicaly available, concise, and does not exclusively endorse one etiological 
model of GAD (see Appendix H). After this brief psychoeducational component, the 
participants had one of the treatment strategies explained to them individualy by a student 
therapist in less than 20 minutes. Participants were also provided with a handout for them to 
keep to aid in remembering both the theoretical and practical elements of their assigned 
treatment. After meeting with a therapist, participants completed the RCES and the RHCS 
online (see Appendix B), which generaly took participants less than three minutes to complete. 
After completing the RCES and RHCS, participants were given the debriefing form (see 
Appendix G) and the list of available counseling services (see Appendix D). 
Participants were asked to return to Lakehead University to complete al self-report 
questionnaires and the MINI four weeks after the therapy session. Al measures were given in 
the same order at folow-ups as they were given at baseline. Again, the items were not counter-
balanced due to a concern of participant fatigue. In general, for al measures that used time 
frames of greater than one week or did not specify a time frame, these measures were changed to 
focus on the past week only (see Appendix I for the four weeks post-treatment self-report 
measures). For the PMUS, the RCES, and the RHCS, please see the descriptions of these 
measures in the Measures section for further details on changes to these measures from baseline 
to folow-up. After completing the questionnaires, participants were instructed that they could 
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continue to use the technique they were taught as long as they would like. Participants were also 
alowed to ask any question regarding the treatment that they had to the researcher. Finaly, 
participants were asked to complete the same questionnaires at a four-month folow-up. For al 
measures that used time frames of greater than one month or did not specify a time frame, these 
measures were changed to focus on the past month (see Appendix J for the four-month post-
treatment self-report measures). Again, for the PMUS, the RCES, and the RHCS, please see the 
descriptions of these measures in the Measures section for further details on changes to these 
measures from baseline to folow-up. 
If a participant was unable to meet with the researcher at Lakehead University at any 
folow-up (i.e., was out of town or was unable to come in due to other commitments), the 
participant was given the option of completing the self-report questionnaires, but not the MINI, 
online at home or wherever they were able to complete them. Participants were given a brief 
reminder of their rights as participants and requirements of the study before completing any 
measures at every folow-up, and were given debriefing leters (see Appendix G) and the list of 
available counseling services (see Appendix D) after completing the questionnaires each time 
they met with the researcher at Lakehead University or after completing the questionnaires 
online at home. Participants were also contacted once between the four-week and four-month 
folow-up to thank them for participating, to provide them information about the study, and to 
remind them when the next folow-up would be. This contact served to help participants feel 
connected and engaged in the study, and to decrease atrition rates. For the study, based on the 
dificulties with retention reported by the prevention studies, a 15% atrition rate between each 
folow-up point was anticipated. 
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See Figure 1 for a diagram of the flow of participants through the study. Across the 
entire study, 75.4% of the participants were retained from the initial screening to four months 
post-treatment. Only one participant who was assigned to the delayed treatment condition failed 
to return for the treatment session. At four weeks post-treatment, there was a higher rate of 
withdrawal in the MWS treatment (20.0% withdrawal) than the CAWS treatment (8.6% 
withdrawal). At four months post-treatment there was a smaler diference in the rates of 
withdrawal, with 13.7% of the remaining MWS participants withdrawing from the study, and 
9.4% of the remaining CAWS participants withdrawing from the study.  The majority of 
participants who did not continue in the study did not respond to emails at the prescribed folow-
ups, although three participants asked to withdraw from the study at four weeks post-treatment, 
and one participant asked to withdraw at four months post-treatment. 
Treatments. The CAWS treatment folowed the wory scheduling procedures from 
Borkovec et al. (1983). Upon meeting with a therapist, the therapist described how wory can 
become associated with many environments and how the contingency between wory and 
diferent environmental stimuli need to be weakened in order to decrease the frequency of wory 
and anxiety. Participants in the CAWS treatment were asked to self-restrict their wory to a 30-
minute period every day for the folowing four weeks. Participants were asked to atend to what 
is occuring in their immediate environment or their own physiology (e.g., their breathing) 
whenever they notice that they are beginning to wory during the day. They were also instructed 
that whenever they notice that the distraction is efective in aleviating wories, anxiety, or 
distress, that they should reward themselves either overtly or covertly. For their 30-minute 
wory period, participants were asked to set aside a 30-minute period in the early evening during 
which time they alow themselves to wory as much as they can. They were instructed to wory  
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Figure 1. Progress of participants through the study. 
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as intensely as they can, so that the wory becomes associated with the specific location. 
Participants were neither encouraged or discouraged from atempting to problem solve at this 
time. 
The MWS treatment was based on the wory postponement experiment and detached 
mindfulness techniques as described by Wels (2009). Upon meeting with the therapist, the 
therapist described how the beliefs that wory is uncontrolable and dangerous leads to wory and 
anxiety, and that the participant must develop a sense of control over his or her wory. Like the 
CAWS treatment, participants were asked to self-restrict their wory to a 30-minute period every 
day for the folowing four weeks. Unlike the CAWS treatment, which asked participants to turn 
their atention outwards when wory occurs outside of the wory period, in the MWS treatment 
participants were asked to non-judgmentaly observe their thoughts and wories whenever the 
participants began to wory during the day. For their 30-minute wory period, participants were 
asked to set aside a 30-minute period in the early evening during which time they alow 
themselves to wory as much as they can. They were instructed to wory as intensely as they 
can, so that they would be able to see that worying is not dangerous to their body or mind. 
Participants were neither encouraged or discouraged from atempting to problem solve at this 
time. 
Almost al of the discussion of the theory and application of the techniques was scripted 
for the therapists to decrease the influence of between-therapist variation. Please see Appendix 
K for the treatment scripts and associated handouts. The therapists were permited to explain the 
techniques in their own terms, but were instructed to adhere to the original scripts as closely as 
possible.  For the CAWS, the average time that a therapist was meeting with a client was 
approximately 11 minutes (ranging from 7 minutes to 20 minutes). For the MWS, the average 
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time that a therapist was meeting with a client was approximately 10 minutes (ranging from 6 
minutes to 20 minutes). These times were comparable to the average times physicians talk to 
their patients (an average of 10.7 minutes; Gotschalk & Flocke, 2005). 
Therapists. The therapists for this study were six Clinical Psychology Ph.D. students 
who had completed courses in CBT, clinical interviewing, ethics, and assessment, and had 
completed at least 400 hours of supervised practice. None of the therapists had prior experience 
with using the wory scheduling techniques.  The therapists were trained in the therapeutic 
techniques by the researcher and primary supervisor through a one-day workshop, and were 
provided with additional reading materials to become familiar with both the theory and 
application of each technique. Throughout the course of the study, they were formaly 
supervised by the primary supervisor of this study, and were able to clarify any issues with the 
researcher. 
Treatment adherence. To ensure that the therapists explained only the therapeutic 
technique that the participant was assigned to, and did not discuss the other treatment, al 
treatment sessions were audiotaped. The researcher and primary supervisor reviewed the first 
five tapes of each treatment from each therapist to provide corective feedback and ensure 
excelent participant care. To assess adherence, three tapes from each therapy for each therapist 
were randomly selected to be reviewed by an independent rater. The rater was an advanced 
honours undergraduate student in psychology who was not familiar with the study hypotheses. 
The rater was given checklists of techniques permited and not permited with each technique 
and assessed how closely each therapist adhered to the permited techniques (see Appendix L). 
Compensation.  One draw for a $50 pre-paid VISA card occurred every four months, 
with a total of three draws occuring during the course of the study. Every time a participant 
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atended a session at Lakehead University or completed questionnaires online, he or she was 
given one entry into the next draw. Each draw was independent of al other draws. As wel, 
when a participant completed the four-week folow-up, he or she was given a $10 gift card for 
Tim Horton’s. Further, when a participant completed the four-month folow-up, he or she was 
given $20. Finaly, any participant who would have had to pay for parking at Lakehead 
University to complete a portion of the study had his or her parking fees paid. 
Statistical Analyses 
The data were first examined to check the accuracy of data entry, missing values, 
outliers, and fit to multivariate assumptions. Any possible departures from linerality and 
homoscedasticity were examined. Scores on the problematic response styles questionnaires were 
also examined. 
After the data screening was complete, the main analyses were conducted. Multivariate 
analyses of variances (MANOVAs) were conducted prior to conducting any univariate analyses. 
To test Hypothesis 1, that the treatments would lead to larger decreases in GAD symptoms, 
wory severity, health anxiety, and negative afect than the DT condition, repeated measures 
analyses of variances (ANOVAs) were used to examine if the treatments were superior to the 
delayed treatment control from baseline to four-week folow-up. The PSWQ, WAQ, SHAI, and 
PANAS-NA were the dependent measures. 
To test Hypothesis 2, that the treatments would lead to larger decreases in medication use 
and health care utilization than the delayed treatment control, Pearson chi-square tests and 
repeated measures ANOVAs were conducted to examine if the treatments were superior to the 
DT condition from baseline to four-week folow-up. The first two PMUS items and the number 
of visits to primary care physician as measured by the RGHAS were the dependent measures. 
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To test Hypothesis 3, that the treatments would lead to larger increases in motivation for 
more intensive therapy and in the expectancy that the wory can be treated than the delayed 
treatment control, repeated measures ANOVAs were conducted to examine if the treatments 
were superior to the DT condition from baseline to four-week folow-up. The MRTS and the 
ACES were the dependent measures. 
To test Hypothesis 4, that the MWS would lead to larger decreases in GAD symptoms 
and wory severity than the CAWS after four weeks and four months repeated measures 
ANOVAs were conducted using baseline and four-week post-treatment scores, and four-week 
and four-month post-treatment scores on the WAQ and PSWQ. 
To test Hypothesis 5, that the MWS would lead to larger decreases on measures of the 
proposed cognitive factors than the CAWS after four weeks and four months repeated measures 
ANOVAs were conducted using baseline and four-week post-treatment scores, and four-week 
and four-month post-treatment scores on the MCQ-30, MWQ, CAQ, and BFNE. 
To test Hypothesis 6, that the CAWS would lead to larger increases in positive afect than 
the MWS after four weeks and four months a series of repeated measures ANOVAs comparing 
the treatments was conducted using baseline and four-week post-treatment scores, and four-week 
and four-month post-treatment scores on the PANAS-PA scale. 
To test Hypothesis 7, that changes in negative beliefs about wory and meta-wory, but 
not changes in cognitive avoidance, negative evaluation sensitivity, positive beliefs about wory, 
or other metacognitive beliefs, would be related to changes in GAD symptoms and wory 
severity, change scores on the MWQ, MCQ-30, CAQ, and BFNE were calculated using baseline 
and four-week folow-up scores, and baseline and four-month folow-up scores. Change scores 
on the WAQ and PSWQ were also calculated using baseline and four-week folow-up scores, 
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and baseline and four-month folow-up scores. A series of regression equations was used to 
examine which change scores of the MCQ-30, MWQ, CAQ, and BFNE were related to changes 
in WAQ and PSWQ scores. 
For al analyses, except for the analyses done to test Hypothesis 7, the ANOVAs or chi-
square tests were first conducted using data from participants who returned for the given folow-
ups, and any participants who did not return were excluded from the analyses (termed completer 
analyses). This was folowed by conducting intent-to-treat analyses. For intent-to-treat analyses, 
if a participant did not return for a folow-up, the last score they supplied was moved forward to 
the folow-up they missed. For example, if a participant missed the four-week and four-month 
folow-ups, their baseline scores would be moved to forward to both the four-week and four-
month folow-ups, assuming no change in scores. Intent-to-treat analyses are conducted to 
decrease the efect of participants who did not improve dropping out of the study, while 
participants who benefited from the treatments staying in the study. Therefore, intent-to-treat 
analyses generaly result in less significant findings and lower efect sizes. 
To examine efect sizes, partial eta squared (η2) were computed where appropriate, and 
interpreted as according to Cohen (1988) where .01 is a smal efect, .09 is a medium efect, and 
.25 is a large efect. Post hoc t-tests or Pearson chi-square tests were conducted when 
appropriate for simple efects. To address the potential of a high Type I eror rate, a range of 
options were considered, from applying a stringent Bonferoni type adjustment, to assigning 
diferent alpha levels to diferent tests. In order to strike a balance between potential Type I 
eror and being too conservative, alpha was set to .025 for al analyses. In addition, for 
interpretation of the findings, the focus was placed on efect sizes rather than significance level. 
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Results 
Data Screening 
Prior to data analyses, the raw data for al variables were examined for erors and 
possible outliers. For missing data, if less than 20% of the data from a given scale was missing, 
the missing scores were replaced using the average item score that was calculated from the 
remaining items that were completed. Therefore, if a scale had less than five items, no missing 
scores were replaced, while if a scale was between 10 and 14 items long, two missing scores 
could be replaced. For the RGHAS, because it is designed as a checklist and scored yes (i.e., a 
score of 1) or no (i.e., a score of 0), any missing item was replaced with a 0. While many 
participants missed a few items at each measurement point, only one participant, at the four-
month folow-up, was missing a large enough percentage of data to warant having al of their 
scores removed from the analyses at that measurement point. The total number of missing scores 
replaced was 128 at baseline, 90 at four weeks post-treatment, and 65 at four months post-
treatment. This equals an average of 1.12 missing items per participant at baseline (i.e., less than 
1% of al items), 0.93 missing items per participant at four weeks (i.e., less than 1% of al items), 
and 0.76 missing items per participant at four months post-treatment (i.e., less than 1% of al 
items). 
Folowing recommendations by Tabachnick and Fidel, (2007), any subscale or total 
scale scores exceeding three standard deviations above and below the mean of that subscale or 
total scale was replaced. Scores that were three standard deviations above the mean were 
changed to be one value higher than the highest score that was not an outlier. Scores that were 
three standard deviations below the mean were changed to be one value lower than the lowest 
score that was not an outlier. Only two outliers were replaced in total. 
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 Skewness and kurtosis were examined for al measures. Al scales were within 
acceptable limits and did not require transformation (Tabachnick & Fidel, 2007). Similarly, 
folowing Tabachnick and Fidel (2007), multicolinearity and singularity were not found with 
the scales used in this study. Upon examining the measures of positive impression management, 
negative impression management, and random responding, it was found that between seven and 
17 participants scored above the empirical cut-of of the PIM across the diferent measurement 
points. For the NIM and INF scales, less than four participants scored above the empirical cut-
ofs at any measurement point. Al of the scores on the PIM, NIM, and INF were no more than 
seven points above the cut-ofs, and based on the participants’ other self-reported symptoms, 
none of the scores suggested extremely biased or careless responding, and the decision was made 
to not remove the participants from the analyses. 
Participant Characteristics at Baseline 
 The main demographic characteristics of the sample at baseline, as wel as the mean 
scores on the primary outcome measures, are presented in Table 1. There were no significant 
diferences between the groups at baseline, including no significant diferences in terms of 
ethnicity, marital status, employment, or education, ps > .115. The entire sample had an age 
range of 18 to 75 (M = 38.67, SD = 15.26), was 84.2% White/Caucasian, was predominantly 
single (32.5%) or maried (40.4%), was employed (68.4%), and had a colege diploma (26.3%) 
or some university education (56.2%), although only 35.3% were curently students. 
Therapist Efects and Treatment Adherence 
Due to issues with availability and scheduling, the number of participants that each 
therapist met with varied greatly, from a low of 12 participants to a high of 34 participants. 
While most therapists met with nearly equal numbers of participants from each therapy, there 
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Table 1 
Characteristics of the Sample at Baseline 
Variable CAW 
(n = 41) 
MWS 
(n = 37) 
DT 
(n = 36) 
p-value 
Age 40.02 38.00 37.81 .779 
Sex (% female)  70.7%  72.2%  83.3% .389 
Curently a student   36.6%  30.3%  44.1% .611 
GAD   58.5%  64.9%  75.0% .312 
Number of  
 curent diagnoses 
  
 1.54  1.62  1.56 .961 
WAQ 52.29 51.00 50.56 .836 
PSWQ  57.83 59.24 58.50 .830 
SHAI  18.68 17.83 17.61 .850 
PANAS-PA 29.90 28.70 29.43 .815 
PANAS-NA 28.12 28.78 27.37 .749 
Curently using  
 medication 
 
  
 34.1%  32.4%  27.8% .828 
RGHAS total  3.61  3.95  2.81 .099 
RGHAS primary  
 care item 
 
 1.93  1.55  0.44 .212 
MRTS 21.66 25.22 22.06 .064 
ACES 72.88 74.51 75.17 .712 
Note. GAD = Met criteria for generalized anxiety disorder; WAQ = Wory and Anxiety 
Questionnaire; PSWQ = Penn State Wory Questionnaire; SHAI = Short Health Anxiety 
Inventory; PANAS-PA = Positive and Negative Afect Schedule – Positive afect subscale; 
PANAS-NA = Positive and Negative Afect Schedule – Negative afect subscale; RGHAS = 
Revised Geting Help for Anxiety Scale; MRTS = Motivation for Receiving Treatment Scale; 
ACES = Anxiety Change Expectancy Scale. 
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was variation, with a therapist seeing up to eight more participants in one therapy than the other 
therapy. However, ANOVAs were used to examine diferences in the baseline scores of the 
WAQ, PSWQ, SHAI, PANAS-NA, PANAS-PA, RGHAS total, number of visits to primary care, 
MRTS, ACES, RCES, and RHCS found no main efect of therapist, ps > .097. Similarly, 
ANOVAs found no main efect of therapist on these measures at four weeks post-treatment, ps > 
.121, or four months post-treatment, ps > .105. However, there was a significant main efect of 
therapist on the PANAS-PA, F (5, 80) = 2.96, p = .017 at four months post-treatment. This was 
due to the participants of one therapist scoring the lowest on the PANAS-PA. Because this was 
the only measure showing a significant main efect of therapist, the efect of therapists on 
outcome was deemed to be negligible. 
When reviewed by an independent researcher, the therapists had a high treatment 
adherence. Three recordings of each therapy for each therapist were chosen at random for the 
adherence checks. This equates to 18 recordings from each therapy, or 31.0% of CAW 
treatments, and 32.7% of MWS treatments. For the CAWS, there was an average adherence of 
98.9%, which ranged from 95% to 100%. For the MWS, there was an average adherence of 
96.1%, which ranged from 90% to 100%. 
Treatment Credibility, Expectancy, and Implementation 
 In addition to having high adherence rates, the treatments were also perceived to be 
highly credible. Immediately folowing therapy, the CAWS had a mean credibility rating of 
19.64 (SD = 5.21), and the MWS had a mean credibility rating of 18.31 (SD = 5.06), F (1, 111) = 
1.89, p = .172. At four-week post-treatment the credibility remained high, with the CAWS 
having a mean credibility of 18.17 (SD = 5.48), and the MWS having a mean credibility of 16.61 
(SD = 5.84), F (1, 95) = 1.83, p = .179. These levels were maintained at four months post-
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treatment, with the CAWS having a mean credibility of 18.67 (SD = 6.10), and the MWS having 
a mean credibility of 17.03 (SD = 5.99), F (1, 84) = 1.56, p = .215. 
 The participants also reported that they expected the treatment would decrease their 
anxiety and wory at baseline. The CAWS had a mean expectancy score of 34.14 (SD = 27.27), 
while the MWS had a mean expectancy score of 34.91 (SD = 31.32), F (1, 111) = 0.02, p = .889. 
After four weeks, participants generaly reported that the treatments had been efective in 
decreasing their symptoms, with the CAWS having a mean expectancy score of 29.06 (SD = 
35.42), and the MWS having a mean expectancy score of 27.27 (SD = 28.64), F (1, 95) = 0.07, p 
= .789. This continued at four months post-treatment, with the CAWS having a mean 
expectancy score of 42.50 (SD = 33.17), and the MWS having a mean expectancy score of 38.95 
(SD = 34.47), F (1, 84) = 0.23, p = .629. 
 The amount that participants reported using the treatments at folow-ups also did not 
significantly difer between treatments. Scores on the RHCS items at four weeks post-treatment, 
Fs < 1.30, ps > .250, and four months post-treatment, Fs < 1.30, ps > .250, were not significantly 
diferent between the CAWS and MWS treatments. 
Comparison of Treatments to Waitlist 
 Completer analyses. For al analyses comparing the treatments to DT, a grouping 
variable combining participants who completed the CAWS and participants who completed the 
MWS was created. Before examining changes on the primary outcome measures between the 
treatments and DT, changes in the percentage of participants meeting criteria for GAD were 
examined. As previously mentioned, it was determined a priori that significant diferences were 
not anticipated, so significance tests were not conducted. For the DT participants, the percentage 
meeting criteria for GAD decreased from 74.3% at baseline to 55.9% at four-week folow-up. 
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For the participants who received treatment, the percentage meeting criteria for GAD decreased 
from 62.1% at baseline to 6.6% at four-week folow-up. Further, the average number of curent 
diagnoses decreased from 1.51 (SD = 1.27) at baseline to 1.21 (SD = 1.25) at four-week folow-
up for DT participants, while going from 1.53 (SD = 1.46) at baseline to 0.25 (SD = 0.65) at 
four-week folow-up for participants who received treatment. 
 Prior to univariate analyses, a 2-between (treatment, DT) × 2-within (baseline, four-week 
folow-up) MANOVA with the folowing dependent measures was conducted: the WAQ, the 
PSWQ, the SHAI, the PANAS-NA, the change in amount of medication being used, the 
RGHAS, the MRTS, and the ACES. Since the omnibus F value of Wilk’s criterion was 
significant, F (20, 38) = 332.59, p < .001, the univariate analyses were conducted. 
 To test Hypothesis 1, that treatment would lead to larger decreases on the WAQ, PSWQ, 
SHAI, and PANAS-NA than the DT condition, 2-between (treatment, DT) × 2-within (baseline, 
four-week folow-up) ANOVAs were conducted. For the WAQ, there was a significant main 
efect of measurement point (change from baseline to four-week folow-up), F (1, 99) = 77.01, p 
< .001, partial η2 = .44, a significant main efect of condition (treatment vs. DT), F (1, 99) = 
6.95, p = .010, partial η2 = .06, and a significant condition × measurement point interaction, F (1, 
99) = 24.22, p < .001, partial η2 = .20. While the treatment (M = 51.58, SD = 13.64) and DT 
conditions (M = 50.43, SD = 13.07) did not difer at baseline, t (99) = 0.41, p = .684, the WAQ 
scores of the treated participants (M = 29.03, SD = 15.71) were significantly lower than the 
WAQ scores of DT participants (M = 44.09, SD = 16.99) at four-week folow-up, t (99) = -4.45, 
p < .001. 
 For scores on the PSWQ, there was a significant main efect of measurement point, F (1, 
99) = 38.87, p < .001, partial η2 = .28, and a significant condition × measurement point 
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interaction, F (1, 99) = 18.71, p < .001, partial η2 = .16. There was no main efect of condition, 
F (1, 99) = 3.08, p = .082, partial η2 = .03. While the treatment (M = 58.52, SD = 10.62) and DT 
conditions (M = 58.17, SD = 10.14) did not difer at baseline, t (99) = 0.16, p = .875, the PSWQ 
scores of the treated participants (M = 49.03, SD = 11.13) were significantly lower than the 
PSWQ scores of DT participants (M = 56.46, SD = 9.72) at four-week folow-up, t (99) = -3.33, 
p = .001. 
 There was also a significant main efect of measurement point, F (1, 98) = 16.54, p < 
.001, partial η2 = .14, on the SHAI. However, there was no main efect of condition, F (1, 98) = 
0.002, p = .969, partial η2 < .001, or condition × measurement point interaction, F (1, 98) = 2.87, 
p = .093, partial η2 = .03. While the SHAI scores decreased from baseline to four-week folow-
up, there was no diference between participants who received treatment and participants in the 
DT condition. 
 Regarding the PANAS-NA, there was a significant main efect of measurement point, F 
(1, 99) = 26.48, p < .001, partial η2 = .21, and a significant condition × measurement point 
interaction, F (1, 99) = 15.36, p < .001, partial η2 = .13. There was no main efect of condition, 
F (1, 99) = 2.08, p = .152, partial η2 = .02. While the treatment (M = 28.32, SD = 7.59) and DT 
conditions (M = 27.37, SD = 8.42) did not difer at baseline, t (99) = 0.57, p = .567, the PANAS-
NA scores of the treated participants (M = 21.35, SD = 7.26) were significantly lower than the 
PSWQ scores of DT participants (M = 26.43, SD = 8.37) at four-week folow-up, t (99) = -3.17, 
p = .002. 
To test the first part of Hypothesis 2, that the treatments would lead to larger decreases in 
the percentage of participants using medication for wory and anxiety than the delayed treatment 
control, a Pearson’s chi-square was conducted on the percentage of participants using medication 
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item of the PMUS at four-week folow-up. To test the remaining elements of Hypothesis 2, that 
the treatments would lead to greater decreases in amounts of medication being used and 
decreased number of visits to primary care than the delayed treatment control, a 2-between 
(treatment, DT) × 2-within (baseline, four-week folow-up) ANOVA was conducted for the 
change in medication use item of the PMUS, and an independent samples t-test was conducted 
on the number of visits to a primary care physician item of the RGHAS at four-week folow-up. 
There was no significant diference between the participants reporting that they used medication 
at four-week folow-up, χ2 (1, n = 101) = 1.55, p = .214. Of the participants in DT, 22.9% 
reported using a medication, while 34.8% of the participants who were treated reported using a 
medication at four-week folow-up. For the amount of medication, there was a significant main 
efect of measurement point, F (1, 57) = 5.39, p = .025, partial η2 = .09, but no main efect of 
condition, F (1, 57) = 1.01, p = .320, partial η2 = .02, or condition × measurement point 
interaction, F (1, 57) = 0.02, p = .881, partial η2 < .01. Treatment had no efect on medication 
use. 
Because the RGHAS visits to primary care item is a frequency item, an ANOVA could 
not be used because the RGHAS at baseline measures the number of times in the past month, 
while the RGHAS at four-week folow-up measures the number of times in the past week. 
Treatment had no efect on the number of visits to primary care at four-week folow-up, t (99) = 
1.49, p = .139, with treated participants (M = 0.33, SD = 0.69) and DT participants (M = 0.14, SD 
= .43) both reporting few visits to primary care at four-week folow-up. 
To test Hypothesis 3, that treatment would lead to larger increases on the MRTS and 
ACES than the DT condition, 2-between (treatment, DT) × 2-within (baseline, four-week folow-
up) ANOVAs were conducted.  On the MRTS, there was a significant main efect of 
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measurement point, F (1, 98) = 9.62, p = .003, partial η2 = .09. However, there was no main 
efect of condition, F (1, 98) = 0.51, p = .479, partial η2 = .01, or condition × measurement point 
interaction, F (1, 98) = 1.64, p = .203, partial η2 = .02. There was no diference in MRTS scores 
between participants who received treatment and participants in the DT condition, and the 
average scores of participants decreased from baseline (M treated participants = 23.70, SD = 
7.45; M DT participants = 21.86, SD = 6.65) to four-week folow-up (M treated participants = 
21.12, SD = 7.30; M DT participants = 20.83, SD = 7.83). 
For the ACES, on the other hand, there was a significant main efect of measurement 
point, F (1, 99) = 8.08, p = .005, partial η2 = .07, and a significant condition × measurement 
point interaction, F (1, 99) = 9.66, p = .002, partial η2 = .09. There was no main efect of 
condition, F (1, 99) = 0.22, p = .640, partial η2 = .002. While the treatment (M = 73.79, SD = 
11.74) and DT conditions (M = 75.43, SD = 12.84) did not difer at baseline, t (99) = -0.65, p = 
.519, the ACES scores of the treated participants (M = 78.92, SD = 9.81) were higher than the 
ACES scores of DT participants (M = 75.20, SD = 11.99) at four-week folow-up, though not 
significantly so, t (99) = 1.68, p = .096. 
 Intent-to-treat analyses. As intent-to-treat analyses generaly result in less significant 
findings and lower efect sizes, only the completer analyses that had resulted in a significant 
main efect of condition or a significant interaction efect were examined using the intent-to-treat 
analyses. The variables selected included the WAQ, PSWQ, PANAS-NA, and ACES. 
Therefore, these analyses further tested elements of Hypothesis 1 (that treatment would decrease 
scores on the WAQ, PSWQ, and PANAS-NA greater than delayed treatment) and Hypothesis 3 
(that treatment would increase scores on the ACES greater than delayed treatment). 
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 For scores on the WAQ, there was a significant main efect of measurement point, F (1, 
111) = 60.24, p < .001, partial η2 = .35, and a significant condition × measurement point 
interaction, F (1, 111) = 16.05, p < .001, partial η2 = .13. However, the main efect of condition 
was not significant, F (1, 111) = 4.43, p = .038, partial η2 = .04. While the treatment (M = 51.61, 
SD = 13.48) and DT conditions (M = 50.56, SD = 12.90) did not difer at baseline, t (111) = 0.39, 
p = .695, the WAQ scores of the treated participants (M = 32.29, SD = 17.26) were significantly 
lower than the WAQ scores of DT participants (M = 44.39, SD = 16.84) at four-week folow-up, 
t (111) = -3.50, p = .001 (see Figure 2). 
 The findings of the PSWQ mirored those of the WAQ, as there was a significant main 
efect of measurement point, F (1, 111) = 32.04, p < .001, partial η2 = .22, and a significant 
condition × measurement point interaction, F (1, 111) = 13.94, p < .001, partial η2 = .11. There 
was no main efect of condition, F (1, 111) = 2.95, p = .089, partial η2 = .03. While the 
treatment (M = 58.42, SD = 10.23) and DT conditions (M = 58.50, SD = 10.18) did not difer at 
baseline, t (111) = -0.04, p = .967, the PSWQ scores of the treated participants (M = 50.29, SD = 
11.13) were significantly lower than the PSWQ scores of DT participants (M = 56.83, SD = 9.84) 
at four-week folow-up, t (111) = -3.02, p = .003 (see Figure 3). 
On the PANAS-NA, in line with the completer analyses results, there was a significant 
main efect of measurement point, F (1, 110) = 21.79, p < .001, partial η2 = .16, and a significant 
condition × measurement point interaction, F (1, 110) = 11.53, p = .001, partial η2 = .09, but no 
main efect of condition, F (1, 110) = 1.09, p = .299, partial η2 = .01. While the treatment (M = 
28.39, SD = 7.61) and DT conditions (M = 27.37, SD = 8.42) did not differ at baseline, t (110) = 
0.63, p = .527, the PANAS-NA scores of the treated participants (M = 22.42, SD = 7.79) were 
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significantly lower than the PSWQ scores of DT participants (M = 26.43, SD = 8.37) at four-
week folow-up, t (110) = -2.47, p = .015 (see Figure 4). 
Lastly, on the ACES, there was a significant main efect of measurement point, F (1, 
111) = 6.80, p = .010, partial η2 = .06, and a significant condition × measurement point 
interaction, F (1, 111) = 8.32, p = .005, partial η2 = .07. There was no main efect of condition, 
F (1, 110) = 0.11, p = .743, partial η2 = .001. As found with the completer analyses, while the 
treatment (M = 73.61, SD = 12.56) and DT conditions (M = 75.17, SD = 12.76) did not difer at 
baseline, t (111) = -0.61, p = .543, the ACES scores of the treated participants (M = 78.01, SD = 
11.27) were higher than the ACES scores of DT participants (M = 74.94, SD = 11.92) at four-
week folow-up, though not significantly so, t (111) = 1.32, p = .188. 
Comparison of CAWS to MWS 
Completer analyses. 
Baseline to four weeks post-treatment. The baseline data for comparing the CAWS and 
MWS included data colected at the first appointment of the participants who were randomized 
to either CAWS or MWS for their first appointment, and the data colected at four-week folow-
up for participants who were randomly assigned to DT, since the DT participants received 
treatment at the first folow-up. Before examining changes on the primary outcome measures 
between the CAWS and MWS, changes in the percentage of participants meeting criteria for 
GAD were examined. Again, it had been determined a priori that significant diferences were 
not anticipated, so significance tests were not conducted. For the CAWS participants, the 
percentage meeting criteria for GAD decreased from 54.4% at baseline to 4.2% at four-week 
post-treatment. For the MWS participants, the percentage meeting criteria for GAD decreased 
from 65.5% at baseline to 12.8% at four-week post-treatment. Further, the average number of 
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curent diagnoses decreased from 1.39 (SD = 1.39) at baseline to 0.21 (SD = 0.65) at four-week 
post-treatment for CAWS participants, while going from 1.55 (SD = 1.36) at baseline to 0.49 (SD 
= 0.88) at four-week post-treatment for MWS participants. 
 Prior to univariate analyses, a 2-between (CAWS, MWS) × 2-within (baseline, four-week 
post-treatment) MANOVA with the folowing dependent measures was conducted: the WAQ, 
the PSWQ, the PANAS-PA, the MCQ-30 subscales, the MWQ, the CAQ, and the BFNE. Since 
the omnibus F value of Wilk’s criterion was significant, F (2, 70) = 355.03, p < .001, the 
univariate analyses were conducted. For analyses where no significant diference was found 
between the treatments, the mean scores (and standard deviations) presented are for al 
participants who received treatment. 
To test Hypothesis 4, that the MWS treatment would lead to larger decreases on the 
WAQ and PSWQ than the CAWS condition after four weeks, 2-between (CAWS, MWS) × 2-
within (baseline, four-week post-treatment) ANOVAs were conducted. For the WAQ, there was 
a significant main efect of measurement point, F (1, 95) = 135.43, p < .001, partial η2 = .58. 
However, there was no main efect of condition, F (1, 95) = 0.001, p = .975, partial η2 < .01, 
and no condition × measurement point interaction, F (1, 95) = 0.99, p = .321, partial η2 = .01. 
While the treatments were not significantly diferent, the WAQ scores of participants 
significantly decreased from baseline (M = 48.91, SD = 15.34) to four-week post-treatment (M = 
28.41, SD = 16.35), t (96) = 11.78, p < .001. 
The same results were found on the PSWQ. There was a significant main efect of 
measurement point, F (1, 95) = 86.73, p < .001, partial η2 = .48, but there was no main efect of 
condition, F (1, 95) = 0.08, p = .778, partial η2 = .001, and no condition × measurement point 
interaction, F (1, 95) = 0.27, p = .605, partial η2 = .003. While the treatments were not 
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significantly diferent, the PSWQ scores of participants significantly decreased from baseline (M 
= 57.72, SD = 10.34) to four-week post-treatment (M = 48.72, SD = 10.86), t (96) = 9.44, p < 
.001. 
To test Hypothesis 5, that the MWS would lead to larger decreases on the MCQ-30, 
MWQ, CAQ, and BFNE than the CAWS after four weeks, 2-between (CAWS, MWS) × 2-
within (baseline, four-week post-treatment) ANOVAs were conducted. On the positive beliefs 
of wory subscale of the MCQ-30, there was no main efect of measurement point, F (1, 94) = 
0.49, p = .487, partial η2 = .005, no main efect of condition, F (1, 94) = 0.62, p = .434, partial η2 
= .007, and no condition × measurement point interaction, F (1, 94) = 0.007, p = .934, partial η2 
< .001. The positive beliefs of wory scores did not significantly change from baseline (M = 
10.56, SD = 4.45) to four-week post-treatment (M = 10.30, SD = 4.63). 
The treatments did decrease the negative beliefs about wory. On the negative beliefs of 
wory subscale of the MCQ-30, there was a significant main efect of measurement point, F (1, 
94) = 82.30, p < .001, partial η2 = .47. However, there was no main efect of condition, F (1, 94) 
= 0.40, p = .527, partial η2 = .004, and no condition × measurement point interaction, F (1, 94) = 
1.07, p = .304, partial η2 = .01. The negative beliefs of wory scores significantly decreased 
from baseline (M = 15.52, SD = 4.45) to four-week post-treatment (M = 11.95, SD = 4.34), t (95) 
= 9.19, p < .001, although the treatments were not significantly diferent. 
The treatments also decreased scores on the need to control thoughts subscale of the 
MCQ-30, as there was a significant main efect of measurement point, F (1, 94) = 18.62, p < 
.001, partial η2 = .16. There was no main efect of condition, F (1, 94) = 1.11, p = .295, partial 
η2 = .01, and no condition × measurement point interaction, F (1, 94) = 1.23, p = .270, partial η2 
= .01. Again, although the treatments were not significantly diferent, the need to control 
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thoughts scores significantly decreased from baseline (M = 11.22, SD = 3.48) to four-week post-
treatment (M = 9.97, SD = 3.38), t (95) = 4.42, p < .001. 
A diferent patern of results were produced on the MCQ-30 lack of cognitive confidence 
subscale, as there was a significant main efect of condition, F (1, 94) = 5.74, p = .019, partial η2 
= .06. However, there was no main efect of measurement point, F (1, 94) = 1.21, p = .274, 
partial η2 = .01, and no condition × measurement point interaction, F (1, 94) = 2.47, p = .119, 
partial η2 = .03. Although the treatments did not significantly decrease the lack of cognitive 
confidence, CAWS participants (M = 12.84, SD = 4.85) reported a significantly higher lack of 
cognitive confidence at baseline than the MWS participants (M = 10.50, SD = 4.69), t (109) = 
2.58, p = .011. At four-week post-treatment, no significant diference was found between the 
CAWS participants (M = 11.91, SD = 4.87) and the MWS participants (M = 10.27, SD = 4.46), t 
(95) = 1.71, p = .091. 
Regarding the MCQ-30 cognitive self-consciousness scale, there was a significant main 
efect of measurement point, F (1, 94) = 13.03, p < .001, partial η2 = .12, but there was no main 
efect of condition, F (1, 94) = 0.07, p = .788, partial η2 = .001, and no condition × measurement 
point interaction, F (1, 95) = 2.71, p = .103, partial η2 = .03. While the treatments were not 
significantly diferent, the cognitive self-consciousness scores of participants significantly 
decreased from baseline (M = 16.01, SD = 4.23) to four-week post-treatment (M = 14.67, SD = 
4.66), t (95) = 3.73, p < .001. 
Moving on to the MWQ, there was a significant main efect of measurement point, F (1, 
95) = 57.93, p < .001, partial η2 = .38. However, there was no main efect of condition, F (1, 95) 
= 0.46, p = .501, partial η2 = .005, and no condition × measurement point interaction, F (1, 95) = 
0.68, p = .413, partial η2 = .007. The MWQ scores of participants significantly decreased from 
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baseline (M = 15.86, SD = 5.00) to four-week post-treatment (M = 12.43, SD = 4.38), t (96) = 
7.73, p < .001, although the treatments did not significantly difer. 
The same patern of results was found on the CAQ. There was a significant main efect 
of measurement point, F (1, 92) = 17.29, p < .001, partial η2 = .16, but there was no main efect 
of condition, F (1, 92) = 1.78, p = .186, partial η2 = .02, and no condition × measurement point 
interaction, F (1, 92) = 0.17, p = .677, partial η2 = .002. The treatments did not significantly 
difer. The CAQ scores of participants significantly decreased from baseline (M = 66.11, SD = 
20.22) to four-week post-treatment (M = 58.07, SD = 17.51), t (93) = 4.23, p < .001. 
There was a significant main efect of measurement point, F (1, 95) = 24.17, p < .001, 
partial η2 = .20, on the BFNE as wel. However, there was no main efect of condition, F (1, 95) 
= 1.27, p = .262, partial η2 = .01, and no condition × measurement point interaction, F (1, 95) = 
1.41, p = .237, partial η2 = .01. While the treatments did not significantly difer, the BFNE 
scores of participants significantly decreased from baseline (M = 43.81, SD = 10.46) to four-
week post-treatment (M = 40.32, SD = 9.93), t (96) = 5.04, p < .001. 
To test Hypothesis 6, that the CAWS would lead to larger increases on the PANAS-PA 
than the MWS after four weeks, a 2-between (CAWS, MWS) × 2-within (baseline, four-week 
post-treatment) ANOVA were conducted. The PANAS-PA scores provided a unique set of 
findings. There was a significant main efect of measurement point, F (1, 94) = 7.72, p = .007, 
partial η2 = .08, and a significant main efect of condition, F (1, 94) = 6.09, p = .015, partial η2 = 
.06, but no condition × measurement point interaction, F (1, 94) = 0.28, p = .594, partial η2 = 
.003. The PANAS-PA scores significantly increased from baseline (M = 28.89, SD = 8.11) to 
four-week post-treatment (M = 30.74, SD = 7.41) for participants, t (95) = 2.75, p = .007. While 
there was a significant main efect of condition, the PANAS-PA scores of the CAWS 
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participants (M = 30.14, SD = 9.11) were not significantly diferent from the PANAS-PA scores 
of the MWS participants (M = 27.53, SD = 7.55) at baseline, t (111) = 1.65, p = .101.  The 
PANAS-PA scores of the CAWS participants (M = 30.14, SD = 9.11) also did not significantly 
difer from the scores of the MWS participants (M = 27.53, SD = 7.55) at four-week post-
treatment, t (94) = 2.09, p = .039. 
Four weeks to four months post-treatment. Changes in the percentage of participants 
meeting criteria for GAD from four-week post-treatment to four-month post-treatment were 
examined prior to conducting analyses on the dimensional measures. For the CAWS 
participants, the percentage meeting criteria for GAD increased from 4.2% at four-week post-
treatment to 11.4% at four-month post-treatment. For the MWS participants, the percentage 
meeting criteria for GAD increased from 7.7% at four-week post-treatment to 12.8% at four-
month post-treatment. Further, the average number of curent diagnoses increased from 0.21 
(SD = 0.65) at four-week post-treatment to 0.46 (SD = 0.89) at four-month post-treatment for 
CAWS participants, while going from 0.49 (SD = 0.88) at four-week post-treatment to 0.46 (SD 
= 1.10) at four-month post-treatment for MWS participants.  
 As previously done, a 2-between (CAWS, MWS) × 2-within (four-week post-treatment, 
four-month post-treatment) MANOVA with the folowing dependent measures was conducted 
prior to univariate analyses: the WAQ, the PSWQ, the PANAS-PA, the MCQ-30 subscales, the 
MWQ, the CAQ, and the BFNE. Since the omnibus F value of Wilk’s criterion was significant, 
F (22, 59) = 270.62, p < .001, the univariate analyses were conducted. For analyses where no 
significant diference was found between the treatments, the mean scores (and standard 
deviations) are presented for al participants. 
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To further test Hypothesis 4, that the MWS treatment would lead to larger decreases on 
the WAQ and PSWQ than the CAWS condition after four months, 2-between (CAWS, MWS) × 
2-within (four-week post-treatment, four-month post-treatment) ANOVAs were conducted. For 
the WAQ, there was no main efect of measurement point, F (1, 84) = 1.31, p = .255, partial η2 = 
.01, no main efect of condition, F (1, 84) = 1.02, p = .314, partial η2 = .01, and no condition × 
measurement point interaction, F (1, 84) = 0.27, p = .603, partial η2 = .003. The treatments were 
not significantly diferent, and the WAQ scores of participants did not significantly change from 
four-week post-treatment (M = 28.85, SD = 16.46) to four-month post-treatment (M = 30.70, SD 
= 17.26). 
There were also no significant efects found on the PSWQ. There was no main efect of 
measurement point, F (1, 84) = 1.01, p = .318, partial η2 = .01, no main efect of condition, F (1, 
84) = 1.17, p = .283, partial η2 = .01, and no condition × measurement point interaction, F (1, 84) 
= 0.08, p = .781, partial η2 = .001. The PSWQ scores of participants did not significantly change 
from four-week post-treatment (M = 49.00, SD = 11.24) to four-month post-treatment (M = 
47.87, SD = 11.71), and there was no diference between treatments. 
To test the second half of Hypothesis 5, that the MWS would lead to larger decreases on 
the MCQ-30, MWQ, CAQ, and BFNE than the CAWS after four months, 2-between (CAWS, 
MWS) × 2-within (four-week post-treatment, four-month post-treatment) ANOVAs were 
conducted. On the positive beliefs of wory subscale of the MCQ-30, there was no main efect 
of measurement point, F (1, 84) = 2.10, p = .151, partial η2 = .02, no main efect of condition, F 
(1, 84) = 0.15, p = .700, partial η2 = .002, and no condition × measurement point interaction, F 
(1, 84) = 0.12, p = .728, partial η2 = .001. Positive beliefs of wory scores did not significantly 
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change from four-week post-treatment (M = 10.71, SD = 4.73) to four-month post-treatment (M 
= 10.26, SD = 3.94). 
Scores on the negative beliefs subscale of the MCQ-30 also did not change between four-
week post-treatment and four-month post-treatment. On the negative beliefs of wory subscale, 
there was no main efect of measurement point, F (1, 84) = 2.03, p = .157, partial η2 = .02, no 
main efect of condition, F (1, 84) = 0.21, p = .648, partial η2 = .002, and no condition × 
measurement point interaction, F (1, 84) = 0.03, p = .863, partial η2 < .001. In addition to no 
diference between the CAWS and MWS, the negative beliefs of wory scores of the MCQ-30 
did not significantly difer from four-week post-treatment (M = 12.08, SD = 4.37) to four-month 
post-treatment (M = 11.53, SD = 4.18). 
On the need to control thoughts subscale of the MCQ-30, there was no main efect of 
measurement point, F (1, 84) = 0.04, p = .847, partial η2 < .001, and no main efect of condition, 
F (1, 84) = 0.12, p = .729, partial η2 = .001. There was also no condition × measurement point 
interaction, F (1, 84) = 1.83, p = .180, partial η2 = .02. The need to control thoughts scores did 
not significantly difer from four-week post-treatment (M = 10.09, SD = 3.37) to four-month 
post-treatment (M = 10.10, SD = 3.24). 
This patern of results continued with the MCQ-30 lack of cognitive confidence subscale. 
There was no main efect of measurement point, F (1, 84) = 0.05, p = .828, partial η2 = .001, no 
main efect of condition, F (1, 84) = 1.88, p = .174, partial η2 = .02, and no condition × 
measurement point interaction, F (1, 84) = 0.25, p = .621, partial η2 = .003. The lack of 
cognitive confidence scores did not significantly change from four-week post-treatment (M = 
11.23, SD = 4.61) to four-month post-treatment (M = 11.34, SD = 4.89). 
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For the MCQ-30 cognitive self-consciousness scale, there was a significant main efect of 
measurement point, F (1, 84) = 6.54, p = .012, partial η2 = .07. However, there was no main 
efect of condition, F (1, 84) = 0.67, p = .415, partial η2 = .008, and no condition × measurement 
point interaction, F (1, 84) = 0.01, p = .917, partial η2 < .01. While the treatments were not 
significantly diferent, the cognitive self-consciousness scores of participants significantly 
decreased from four-week post-treatment (M = 14.79, SD = 4.59) to four-month post-treatment 
(M = 13.87, SD = 4.45), t (85) = 2.60, p = .011. 
Moving on to the MWQ, the patern of non-significant findings returned. There was a no 
main efect of measurement point, F (1, 84) = 0.55, p = .460, partial η2 = .01, no main efect of 
condition, F (1, 84) = 0.001, p = .979, partial η2 < .001, and no condition × measurement point 
interaction, F (1, 84) = 0.02, p = .880, partial η2 < .001. From four-week post-treatment (M = 
12.58, SD = 4.36) to four-month post-treatment (M = 12.21, SD = 4.69) the MWQ scores did not 
significantly change, and no diference between treatments was found. 
The same patern of results was found on the CAQ. There was no main efect of 
measurement point, F (1, 82) = 0.01, p = .919, partial η2 < .001. There was also no main efect 
of condition, F (1, 82) = 1.48, p = .227, partial η2 = .02, and no condition × measurement point 
interaction, F (1, 82) = 0.10, p = .749, partial η2 = .001. The CAQ scores of participants did not 
significantly difer from four-week post-treatment (M = 58.24, SD = 17.01) to four-month post-
treatment (M = 58.36, SD = 19.08). 
The scores on the BFNE produced the only significant main efect of condition, F (1, 83) 
= 5.59, p = .020, partial η2 = .06, in this set of analyses. Again however, there was no main 
efect of measurement point, F (1, 83) = 0.22, p = .640, partial η2 = .01, and no condition × 
measurement point interaction, F (1, 83) = 0.29, p = .594, partial η2 = .003. The BFNE scores of 
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participants did not significantly change from four-week post-treatment (M = 40.91, SD = 10.12) 
to four-month post-treatment (M = 40.48, SD = 12.01). In addition, although there was a main 
efect of condition, the BFNE scores of CAWS participants (M = 38.94, SD = 9.33) and MWS 
participants (M = 41.98, SD = 10.47) did not significantly difer at four-week post-treatment, t 
(95) = -1.51, p = .135, nor did the BFNE scores of CAWS participants (M = 37.94, SD = 11.94) 
and MWS participants (M = 43.63, SD = 11.48) significantly difer at four-month post-treatment, 
t (83) = -2.22, p = .029. 
To test the second part of Hypothesis 6, that the CAWS would lead to larger increases on 
the PANAS-PA than the MWS after four months, a 2-between (CAWS, MWS) × 2-within (four-
week post-treatment), four-month post-treatment ANOVA were conducted.  There was no main 
efect of measurement point, F (1, 83) = 0.02, p = .886, partial η2 < .01, no main efect of 
condition, F (1, 83) = 4.27, p = .042, partial η2 = .05, and no condition × measurement point 
interaction, F (1, 83) = 0.45 p = .502, partial η2 = .005, on the PANAS-PA. The PANAS-PA 
scores did not significantly change from four-week post-treatment (M = 31.04, SD = 7.19) to 
four-month post-treatment (M = 30.99, SD = 8.47). 
Intent-to-treat analyses. As previously discussed, because intent-to-treat analyses tend 
to result in less significant findings and lower efect sizes, the only intent-to-treat analyses that 
were conducted focused on the completer analyses that had resulted in a significant main efect 
of measurement point or significant main efect of condition. For the baseline to four-week post-
treatment analyses the variables selected included the WAQ, the PSWQ, al of the MCQ-30 
subscales except for the positive beliefs about wory subscale, the WAQ, the CAQ, the BFNE, 
and the PANAS-PA. For the four-week to four-month post-treatment analyses the variables 
selected included the MCQ-30 cognitive self-consciousness subscale and the BFNE. Therefore, 
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these analyses further tested elements of Hypothesis 4 (that the MWS would decrease scores on 
the WAQ and PSWQ greater than the CAWS), Hypothesis 5 (that the MWS would decrease 
scores on the MCQ-30 subscales, the WAQ, the CAQ, and the BFNE greater than the CAWS), 
and Hypothesis 6 (that the CAWS would increase scores on the PANAS-PA greater than the 
MWS). 
Baseline to four weeks post-treatment. On the WAQ, there was a significant main efect 
of measurement point, F (1, 111) = 16.07, p < .001, partial η2 = .51. However, as found in the 
completer analyses, there was no main efect of condition, F (1, 111) = 0.09, p = .760, partial η2 
= .001, and no condition × measurement point interaction, F (1, 111) = 2.65, p = .106, partial η2 
= .02. While the treatments were not significantly diferent, the WAQ scores of participants 
significantly decreased from baseline (M = 49.33, SD = 14.95) to four-week post-treatment (M = 
31.73, SD = 17.82), t (112) = 10.74, p < .001 (see Figure 5). 
The intent-to-treat results also mirored the completer results for the PSWQ. There was a 
significant main efect of measurement point, F (1, 111) = 78.40, p < .001, partial η2 = .41, but 
there was no main efect of condition, F (1, 111) = 0.82, p = .368, partial η2 = .007, and no 
condition × measurement point interaction, F (1, 111) = 1.61, p = .284, partial η2 = .01. While 
the treatments were not significantly diferent, the PSWQ scores of participants significantly 
decreased from baseline (M = 57.87, SD = 10.05) to four-week post-treatment (M = 50.14, SD = 
11.08), t (112) = 8.88, p < .001 (see Figure 6). 
The same patern was also found for the negative beliefs about wory subscale. On the 
negative beliefs of wory subscale of the MCQ-30, there was a significant main efect of 
measurement point, F (1, 110) = 75.44, p < .001, partial η2 = .41. However, there was no main 
efect of condition, F (1, 110) = 0.16, p = .688, partial η2 = .001, and no condition × 
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measurement point interaction, F (1, 110) = 2.39, p = .125, partial η2 = .02. Although the 
treatments were not significantly diferent, the negative beliefs of wory scores significantly 
decreased from baseline (M = 15.39, SD = 4.35) to four-week post-treatment (M = 12.33, SD = 
4.35), t (111) = 8.66, p < .001 (see Figure 7). 
The treatments also decreased scores on the need to control thoughts subscale of the 
MCQ-30, as there was a significant main efect of measurement point, F (1, 110) = 18.93, p < 
.001, partial η2 = .15. There was no main efect of condition, F (1, 110) = 0.41, p = .525, partial 
η2 = .004, and no condition × measurement point interaction, F (1, 110) = 1.91, p = .170, partial 
η2 = .02. As was found in the completer analyses, although the treatments were not significantly 
diferent, the need to control thoughts scores significantly decreased from baseline (M = 11.37, 
SD = 3.69) to four-week post-treatment (M = 10.29, SD = 3.68), t (111) = 4.35, p < .001 (see 
Figure 7). 
Although the completer analyses found a significant main efect of condition on the 
MCQ-30 lack of confidence subscale, with the intent-to-treat analyses there was no main efect 
of condition, F (1, 109) = 4.71, p = .032, partial η2 = .04. There was also no main efect of 
measurement point, F (1, 109) = 1.42 p = .236, partial η2 = .01, and no condition × measurement 
point interaction, F (1, 109) = 2.68, p = .105, partial η2 = .02. The treatments did not 
significantly decrease the lack of cognitive confidence from baseline (M = 11.70, SD = 4.89) to 
four-week post-treatment (M = 11.34, SD = 4.81). 
Regarding the MCQ-30 cognitive self-consciousness scale, there was a significant main 
efect of measurement point, F (1, 110) = 13.68, p < .001, partial η2 = .11, but there was no main 
efect of condition, F (1, 110) = 0.02, p = .877, partial η2 < .001, and no condition × 
measurement point interaction, F (1, 110) = 3.51, p = .064, partial η2 = .03, as was found with  
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the completer analyses. While the treatments were not significantly diferent, the cognitive self-
consciousness scores of participants significantly decreased from baseline (M = 15.92, SD = 
4.48) to four-week post-treatment (M = 14.77, SD = 4.83), t (95) = 3.69, p < .001 (see Figure 7). 
For the MWQ, as was found with the completer analyses, there was a significant main 
efect of measurement point, F (1, 111) = 54.82, p < .001, partial η2 = .33. However, there was 
no main efect of condition, F (1, 111) = 0.05, p = .828, partial η2 < .001, and no condition × 
measurement point interaction, F (1, 111) = 1.65, p = .202, partial η2 = .01. The MWQ scores of 
participants significantly decreased from baseline (M = 15.88, SD = 4.88) to four-week post-
treatment (M = 12.94, SD = 4.52), t (112) = 7.42, p < .001, although the treatments did not 
significantly difer (see Figure 8). 
The CAQ intent-to-treat analyses results also mirored the CAQ completer analyses 
results. There was a significant main efect of measurement point, F (1, 108) = 17.22, p < .001, 
partial η2 = .14, but there was no main efect of condition, F (1, 108) = 0.25, p = .620, partial η2 
= .002, and no condition × measurement point interaction, F (1, 108) = 0.47, p = .491, partial η2 
= .004. The treatments did not significantly difer. The CAQ scores of participants significantly 
decreased from baseline (M = 66.64, SD = 20.18) to four-week post-treatment (M = 59.77, SD = 
18.31), t (109) = 4.17, p < .001 (see Figure 9). 
On the BFNE there was a significant main efect of measurement point, F (1, 111) = 
24.36, p < .001, partial η2 = .18. Aligning with the completer analyses, there was no main efect 
of condition, F (1, 111) = 0.84, p = .363, partial η2 = .007, and no condition × measurement point 
interaction, F (1, 111) = 2.24, p = .137, partial η2 = .02. While the treatments did not difer, the 
BFNE scores of participants significantly decreased from baseline (M = 43.65, SD = 10.50) to 
four-week post-treatment (M = 40.65, SD = 10.07), t (112) = 4.95, p < .001 (see Figure 10). 
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The results of the intent-to-treat analyses of PANAS-PA scores provided a diferent set of 
findings than the completer analyses of PANAS-PA scores. While the completer analyses found 
a significant main efect of measurement point and significant main efect of condition, the 
intent-to-treat analyses produced only a significant main efect of measurement point, F (1, 110) 
= 7.48, p = .007, partial η2 = .06. There was no main efect of condition, F (1, 110) = 2.83, p = 
.096, partial η2 = .02, and no condition × measurement point interaction, F (1, 110) = 0.12, p = 
.733, partial η2 = .001. The PANAS-PA scores significantly increased from baseline (M = 28.89, 
SD = 8.48) to four-week post-treatment (M = 30.48, SD = 7.82), t (111) = 2.73, p = .007, though 
there was no diference between the CAWS participants and the MWS participants. 
Four weeks to four months post-treatment. On the cognitive self-consciousness scale of 
the MCQ-30 the intent-to-treat analyses led to the same findings as the completer analyses. 
There was a significant main efect of measurement point, F (1, 111) = 6.56, p = .012, partial η2 
= .06, but there was no main efect of condition, F (1, 111) = 0.83, p = .365, partial η2 = .007, 
and no condition × measurement point interaction, F (1, 111) = 0.11, p = .739, partial η2 = .001. 
While the treatments were not significantly diferent, the cognitive self-consciousness scores of 
participants significantly decreased from four-week post-treatment (M = 14.78, SD = 4.81) to 
four-month post-treatment (M = 14.04, SD = 4.72), t (111) = 2.58, p = .011. 
In contrast to the completer analyses, the intent-to-treat analyses of the BFNE scores led 
to no significant findings. There was no main efect of measurement point, F (1, 110) = 0.27, p 
= .604, partial η2 = .002, no main efect of condition, F (1, 110) = 2.25, p = .136, partial η2 = .02, 
and no condition × measurement point interaction, F (1, 110) = 0.34, p = .563, partial η2 = .003. 
In addition to there being no diference between the treatments, the BFNE scores of participants 
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did not significantly change from four-week post-treatment (M = 40.67, SD = 10.11) to four-
month post-treatment (M = 40.35, SD = 11.57). 
Comparison of Proposed Cognitive Factors 
To test Hypothesis 7, that change scores of the negative beliefs about wory subscale of 
the MCQ-30 and change scores of the MWQ, but not change scores of the CAQ, BFNE, or other 
subscales of the MCQ-30, would be related to change scores on the WAQ and PSWQ, a series of 
multiple regression equations were conducted. These analyses were conducted using the 
completer analyses data for participants who received treatment and returned for the folow-ups. 
The first set of change scores were calculated by subtracting each participant’s four-week post-
treatment scores on the WAQ, PSWQ, MCQ-30 subscales, MWQ, CAQ, and BFNE from their 
own baseline scores. The second set of change scores were calculated by subtracting each 
participant’s four-month post-treatment scores on the WAQ, PSWQ, MCQ-30 subscales, MWQ, 
CAQ, and BFNE from their own four-week post-treatment scores. 
Changes in GAD symptoms. Table 2 reports the results of the regression equations 
using the WAQ as the dependent variable. The variables included in the two analyses accounted 
for between 43% and 64% of the variance in WAQ scores, ps < .001. In both the baseline to 
four-week post-treatment analysis and the four-week to four-month post-treatment analyses the 
negative belief about wory subscale of the MCQ-30 significantly related to changes on the 
WAQ, ps < .01. For the four-week to four-month post-treatment analysis, changes on the MWQ 
were also related to changes on the WAQ, p < .001. No other variables were significantly related 
to changes in WAQ scores. 
Changes in worry severity. Table 3 reports the results of the regression equations using 
the PSWQ as the dependent variable. The variables included in the two analyses accounted for 
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Table 2 
Summary of Regression Analyses for Examining Variables Related to Change in GAD Symptoms 
Variable R Adjusted R2 R2 Change t pr 
Pane11: Baseline to four-week post-treatment .65 .37 .43**   
MWQ     0.87   .09 
MCQ-30 negative beliefs about worry      2.85*   .29* 
MCQ-30 positive beliefs    -0.58  -.06 
MCQ-30 need to control thoughts    -0.07  -.01 
MCQ-30 lack of cognitive confidence     0.32   .03 
MCQ-30 cognitive self-consciousness     1.21   .13 
CAQ     1.65   .18 
BFNE     0.26   .03 
Pane12: Four-week to four-month post-treatment .80 .60 .64**   
MWQ       4.92**   .49** 
MCQ-30 negative beliefs about worry      3.00*   .33* 
MCQ-30 positive beliefs    -0.47  -.05 
MCQ-30 need to control thoughts     0.32   .04 
MCQ-30 lack of cognitive confidence    -0.06  -.01 
MCQ-30 cognitive self-consciousness     0.87   .10 
CAQ     0.80   .09 
BFNE    -0.21  -.02 
Note. MWQ = Meta-Wory Questionnaire; MCQ-30 = Metacognitions Questionnaire-30; CAQ = 
Cognitive Avoidance Questionnaire; BFNE = Brief Fear of Negative Evaluation scale; pr = 
Partial corelation. 
* p < .01. **p < .001. 
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Table 3 
Summary of Regression Analyses for Examining Variables Related to Change in Worry Severity 
Variable R Adjusted R2 R2 Change t pr 
Pane11: Baseline to four-week post-treatment .68 .41 .46**   
MWQ     0.61   .07 
MCQ-30 negative beliefs about worry      2.72*   .28* 
MCQ-30 positive beliefs     2.01   .21 
MCQ-30 need to control thoughts    -0.29  -.03 
MCQ-30 lack of cognitive confidence     0.65   .07 
MCQ-30 cognitive self-consciousness    -1.24  -.13 
CAQ      2.70*   .28* 
BFNE     0.95   .10 
Pane12: Four-week to four-month post-treatment .79 .58 .62**   
MWQ      3.26*   .35* 
MCQ-30 negative beliefs about worry       3.74**   .40** 
MCQ-30 positive beliefs     1.50   .17 
MCQ-30 need to control thoughts     0.28   .03 
MCQ-30 lack of cognitive confidence     -0.86  -.10 
MCQ-30 cognitive self-consciousness     -0.74  -.09 
CAQ     0.97   .11 
BFNE     1.15   .13 
Note. MWQ = Meta-Wory Questionnaire; MCQ-30 = Metacognitions Questionnaire-30; CAQ = 
Cognitive Avoidance Questionnaire; BFNE = Brief Fear of Negative Evaluation scale; pr = 
Partial corelation. 
* p < .01. **p < .001. 
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between 46% and 62% of the variance in PSWQ scores, ps < .001. As was found with the WAQ 
analyses, in both the baseline to four-week post-treatment and the four-week to four-month post-
treatment analyses the negative belief about wory subscale of the MCQ-30 significantly related 
to changes on the PSWQ, ps < .01. As wel, for the baseline to four-week post-treatment 
analysis, changes on the CAQ were also related to changes on the PSWQ, p < .01. Changes on 
the MWQ were also related to changes on the PSWQ in the four-week to four-month post-
treatment analysis, p < .01. No other variables were significantly related to changes in PSWQ 
scores. 
Discussion 
The present study contrasted two ultra-brief treatments for GAD symptoms and wory 
severity with a delayed treatment control condition, and investigated which proposed cognitive 
factors were related to changes in GAD symptoms and wory severity. The treatments were 
eficacious in decreasing GAD symptoms, wory severity, and negative afect, with medium to 
large efect sizes, when compared to a four-week delayed treatment control.  Of the participants 
who returned for four-week folow-up, participants who were treated also met criteria for fewer 
disorders and had a lower percentage meeting criteria for GAD than participants who did not 
receive treatment. However, the treatments had litle to no efect on health anxiety, medication 
use, visits to primary care, motivation for additional therapy, or the belief that anxiety could be 
treated. Therefore, while the results provided substantial support for Hypothesis 1, which 
focused on the primary outcome measures, Hypothesis 2 and Hypothesis 3, which focused on the 
secondary indicators of mental health, were not supported. 
 In addition to significantly decreasing GAD symptoms and wory severity, the treatments 
also led to significant decreases, with predominately medium to large efect sizes, in negative 
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beliefs about wory, the belief that one should control their thoughts at al times, the belief that 
one should be aware and conscious of their thoughts constantly, the frequency of meta-wory, 
cognitive avoidance, and fear of negative evaluation. Positive affect also increased in both 
treatments from baseline to four-week post-treatment. The scores on these measures were also 
maintained from four-week post-treatment to four-month post-treatment. Similarly, low 
percentages of participants who were treated and returned for folow-ups met criteria for GAD, 
despite the majority of the sample meeting criteria for GAD at baseline. However, no 
substantive diferences between the CAWS and MWS treatments were noted on any of the 
measures examined. Therefore, while Hypothesis 4, Hypothesis 5, and Hypothesis 6, which 
predicted diferences between the treatments, were not supported, this was due to both treatments 
being eficacious. 
Although these hypotheses were not supported, Hypothesis 7 was largely supported. As 
predicted, negative beliefs about wory and the frequency of meta-worry were strongly related to 
changes in GAD symptoms and wory severity. However, cognitive avoidance was also related 
to changes in wory severity from baseline to four-week post-treatment, which was not 
hypothesized. The other proposed cognitive factors that were examined in this study were not 
related to changes in GAD symptoms or wory severity, as was predicted. The theoretical and 
treatment implications of the findings from this study are next explored in turn. 
Theoretical Implications 
 Overal, the results of this study provide some support for the Metacognitive Model of 
GAD as proposed by Wels (2009). Negative beliefs about wory and meta-wories underlie the 
Metacognitive Model. As expected, negative beliefs about wory were related to changes in 
GAD symptoms and wory severity from baseline to four-week post-treatment, and from four-
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week post-treatment to four-month post-treatment. Similarly, Sica et al. (2007) previously found 
that negative beliefs about wory at baseline predicted chronic wory four months later, even 
when controling for baseline chronic wory, obsessional thoughts, and the other metacognitive 
beliefs. Further, the treatments led to large efect size decreases in negative beliefs about wory, 
coinciding with the large efect size decreases in GAD symptoms and wory severity. Multiple 
research teams have consistently indicated that negative beliefs about wory are closely related to 
GAD symptoms (Cartwright-Haton & Wels, 1997; Hirsch et al., 2013; Penney et al., 2013; 
Ruscio, 2002; Ruscio & Borkovec, 2004) and wory severity (Beloch et al., 2007; de Bruin et 
al., 2007; Penney et al., 2013; Wels & Cartwright-Haton, 2004), and negative beliefs about 
wory are often more strongly related to GAD symptoms than other proposed cognitive factors. 
Believing that wory is uncontrolable and believing that worying is dangerous to one’s mind 
and body appears to increase both the amount of wories a person experiences, classified as both 
Type 1 and Type 2 wories in the metacognitive model of GAD, and the physiological symptoms 
of GAD. 
 Changes in the frequency of Type 2 wory, also known as meta-wory, were also related 
to changes in GAD symptoms and wory severity from four-week post-treatment to four-month 
post-treatment. This finding converges with previous research showing that meta-wory plays a 
significant role in GAD symptoms and chronic wory (Wels, 2005; Wels & Carter 1999, 2001). 
Interestingly, the frequency of meta-wory was found to be related to changes in GAD symptoms 
when examining changes from four-week post-treatment to four-month post-treatment, when 
there was litle change in GAD symptoms, wory severity, or meta-wory frequency overal. 
Yet, when the frequency of meta-worry, GAD symptoms, and wory severity al had large efect 
size decreases from baseline to four-week post-treatment, the change in frequency of meta-wory 
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was not found to be related to changes in GAD symptoms or wory severity. Negative beliefs 
about wory, on the other hand, were related to changes in GAD symptoms and wory severity 
during periods of both large and smal changes in GAD symptoms and wory severity.  
Recently, Wels (2005) reported that the frequency of meta-wory mediated the 
relationship between negative beliefs about wory and GAD symptoms. Wels (2005) argued 
that the frequency of meta-wory plays a more proximal role in GAD symptoms than negative 
beliefs about wory. In the present study, although meta-wory frequency was more strongly 
related to GAD symptoms than negative beliefs about wory from four-week post-treatment to 
four-month post-treatment, the frequency of meta-wory was unrelated to changes in GAD 
symptoms from baseline to four-week post-treatment. These findings suggest that negative 
beliefs about wory may be a more proximal factor in GAD symptoms than the frequency of 
meta-wory. It may be possible that while the negative beliefs about wory have both a state- 
and trait-like association with GAD symptoms and wory severity (i.e., changes in negative 
beliefs about wory may influence the expression of GAD symptoms and wory severity in both 
the short-term and long-term), the frequency of meta-wory has a predominately trait-like 
association with GAD symptoms and wory severity (i.e., changes in the frequency of meta-
wory influence the expression of GAD symptoms and wory severity only in the long-term). 
However, given that this study was not optimaly designed to test how changes in the proposed 
cognitive factors temporaly mediated changes in GAD symptoms and wory severity, further 
research in this area is needed. Researchers may wish to explore this possibility and further 
examine which of the proposed cognitive factors have a more proximal relationship with GAD 
symptoms using longitudinal studies of untreated individuals with GAD. 
ULTRA-BRIEF TREATMENTS FOR GAD   115 
 
The present study also provides some support for the Metacognitive Model by ilustrating 
that other metacognitive beliefs and fear of negative evaluations are not strongly related to GAD 
symptoms or wory severity. While some studies discussed earlier (Beloch et al., 2007; Davis & 
Valentier, 2000; Penney et al., 2013) have produced inconsistent results relating the belief that 
thoughts must be controled, lack of cognitive confidence, and cognitive self-consciousness, the 
present study found that these beliefs were not related to changes in GAD symptoms or wory 
severity. This converges with other research finding that these beliefs do not play a substantive 
role in GAD symptoms or wory severity (Cartwright-Haton & Wels, 1997; de Bruin et al., 
2007; Sica et al., 2007). However, additional studies comparing factors from across models of 
GAD are needed, and this study alone cannot provide strong support for one model over the 
other. As wel, while Kotov et al. (2007) found that fear of negative evaluations were uniquely 
related to GAD, fear of negative evaluations was not related to changes in GAD symptoms or 
wory severity in the present study. However, two studies are not enough to draw firm 
conclusions regarding this potential relationship. Other researchers may wish to further examine 
this potential relationship, particularly with a clinical sample. 
While this study ofers some support for the Metacognitive Model, it also ofers support 
for the Cognitive Avoidance Model (Sibrava & Borkovec, 2006). The CAWS treatment was as 
eficacious as the MWS treatment across al outcome measures. This finding equaly supports 
the Cognitive Avoidance Model and the Metacognitive Model. Focusing the treatment on meta-
wory and negative beliefs about wory is not necessary to decrease GAD symptoms. The 
CAWS targeted cognitive avoidance, and used distraction and behavioural strategies for reducing 
wory. This indicates, not surprisingly, that decreasing wory is an eficacious way to decrease 
GAD symptoms. However, given the limitations of the study, it is unclear what precise changes 
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to proposed cognitive factors, and which exact treatment techniques, directly led to changes in 
GAD symptoms. Further research wil be necessary to examine if treatments based on the 
Cognitive Avoidance Model and Metacognitive Model operate primarily through the proposed 
cognitive factors from their associated model, or if these treatments from diferent theoretical 
perspectives are eficacious due to decreases in the same proposed cognitive factors. 
Changes in cognitive avoidance from baseline to four-week post-treatment were related 
to changes in wory severity, but not GAD symptoms. This finding ofers partial support to the 
Cognitive Avoidance Model. It is important to note that the Cognitive Avoidance Model may be 
considered to be a model of wory, and the role that chronic wory plays in GAD. Therefore, it 
could be argued that Cognitive Avoidance Model equates GAD to high levels of chronic wory. 
As previously discussed research has shown that GAD can be distinguished from chronic wory 
(Hirsch et al., 2013; Ruscio, 2002; Ruscio & Borkovec, 2004) and the two are not equivalent. 
Therefore, the finding that cognitive avoidance was related changes in wory severity supports 
the Cognitive Avoidance Model, but the finding that cognitive avoidance was not related to 
GAD symptoms indicates that while cognitive avoidance may be a key factor of chronic wory, 
but not necessarily GAD symptoms. Overal, however, the finding that cognitive avoidance was 
related to wory severity does support the Cognitive Avoidance Model. 
This study provided some tentative clues regarding how the use of cognitive avoidance 
may increase or decrease how much a person is worying. Because cognitive avoidance was not 
related to changes in wory severity from four-week post-treatment to four-month post-treatment, 
it may display the opposite relationship to wory severity of that discussed with meta-wory 
above. That is, cognitive avoidance may have state-like, short-term influences on wory 
severity. As a person engages in more or less cognitive avoidance he or she may wory more or 
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less over the folowing days and weeks. However, on longer time scales, other factors such as 
meta-wory and negative beliefs about wory may exhibit greater influence on how much an 
individual wories. Again, additional research, including longitudinal research with untreated 
samples, is needed to examine this possibility. 
One of the proposed cognitive factors that the Cognitive Avoidance Model focuses on is 
positive beliefs about wory. The findings from the present study do not support that positive 
beliefs about wory are a significant contributor to GAD symptoms or wory severity. Positive 
beliefs about wory were not related to changes in GAD symptoms or wory severity from 
baseline to four-week post-treatment, or from four-week post-treatment to four-month post-
treatment. In addition, treatment did not lead to decreases in positive beliefs about wory, 
despite decreases in GAD symptoms and wory severity.  It is possible that positive beliefs about 
wory may function at low levels of wory, and may diferentiate people who rarely wory from 
people who wory some of the time.  Positive beliefs about wory may also play a role across 
anxiety disorders (Ladouceur et al., 1999), and may not have a unique relationship to chronic 
wory or GAD (Penney et al., 2013). Alternatively, positive beliefs about wory may be largely 
based on cultural norms and family beliefs, and have litle influence on day-to-day behaviour. 
However, some studies have found positive beliefs about wory to be an important factor in 
GAD and wory severity (Borkovec & Roemer, 1995; Freeston et al., 1994; Holowka et al. 2000; 
Ladouceur et al., 1998), so additional research is needed. 
While this study did not aim to address the other theoretical models of GAD such as the 
Emotional Dysregulation Model (Mennin et al., 2004) or Acceptance-based Model (Roermer & 
Orsilo, 2005), it did examine elements of the Intolerance of Uncertainty Model (Dugas & 
Koerner, 2005) that are shared in common with the Cognitive Avoidance Model. Two key 
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components of the Intolerance of Uncertainty Model include the use of wory as a cognitive 
avoidance technique, and positive beliefs about wory. As discussed, the role of cognitive 
avoidance in wory severity has received support from this study. However, as discussed above, 
the findings from this study do not indicate that positive beliefs about wory play a special role in 
GAD, and therefore these findings do not support the importance of positive beliefs about wory 
in the Intolerance of Uncertainty Model. Again, however, this one study is not enough to make 
definitive statements about the role of positive beliefs about wory in GAD, and further studies 
are needed. 
Treatment Implications 
 While this study did not find diferences between the CAWS and MWS treatments, the 
results stil have significant value for the treatment of GAD. First, this study demonstrated that 
ultra-brief treatments for GAD are feasible. The treatments in this study were explained to 
participants in approximately 10 to 11 minutes on average.  The therapists reported that the 
treatments were easy to explain, and they rarely had to move away from the script to explain the 
basic concepts of the treatments to the participants. Participants also reported that the treatments 
were credible, and believed that the treatments would reduce their symptoms. This indicates that 
the scripts could be used in primary care, making it easy to implement these therapies in primary 
care facilities. 
The treatments also did not require extensive training time for the therapists. However, 
the therapists used in this study al had previously delivered CBT, and had extensive 
backgrounds in CBT. Additional instruction may be necessary if this treatment were to be used 
by professionals with limited backgrounds in CBT. However, because participants generaly 
easily understood the scripts used in this study, it appears likely that the scripts could be used in 
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primary care without dificulty. Implementation and dissemination research is needed to verify 
this hypothesis. As wel, because this study aimed to have high ecological validity, and did not 
restrict participants from seeking other therapists or using medication, this indicates that the 
therapies may be efectively implemented outside of academic research without a loss of 
eficacy. Research examining the dissemination and implementation of these treatments in 
primary care facilities and private clinics is necessary to fuly test this hypothesis, but the curent 
findings support taking this next step. 
 These easy to implement treatments led to significant improvements in GAD symptoms, 
worry severity, and negative afect. The medium to large efect size decreases found in this 
study on these primary outcome measures, in addition to the smal efect size increase found on 
positive afect, indicate that these treatments can lead to substantial improvement for individuals 
with excessive wory. The treatments also led to substantialy fewer participants meeting criteria 
for GAD and other disorders. Although the percent meeting criteria for GAD and other disorders 
increased slightly from the four-week folow-up to the four-month folow-up, it is not uncommon 
to find that a few participants in GAD outcome studies are unable to maintain their gains across 
multiple folow-ups (Borkovec et al., 2002; Ladouceur et al., 2000; Wels et al., 2010).  ` This 
study was only the second study to implement this type of treatment with participants who were 
seeking treatment. Previous research on the CAWS primarily used adolescent and young adult 
samples that were not seeking treatment (Borkovec et al., 1983; Brosschot & van der Doef, 2006; 
McGowan & Behar, 2013), though Verkuil et al. (2011) provided the CAWS prior to adults 
engaging in a standard CBT. The efect sizes found in the curent study were similar to the 
efect sizes found by McGown and Behar (2013). This leads to two conclusions: 1) delivering 
the CAWS treatment in less than 20 minutes does not appear to decrease the strength of the 
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treatments, and 2) the CAWS treatment may be as eficacious as a stand-alone treatment in 
treatment seeking samples as it is with student samples. 
 The results also indicate that the MWS treatment is no more eficacious than the CAWS 
treatment. Based on previous research showing that metacognitive therapy was superior to 
standard CBT and intolerance of uncertainty therapy (Nordahl, 2009; van der Heiden et al., 
2012), it was predicted that the MWS would be superior to the CAWS on a number of measures. 
The lack of significant findings may be for a number of reasons. First, the common component 
to both the MWS and CAWS, the 30-minute wory scheduling, may be the key factor in both 
treatments. Forcing oneself to wory at only a specific time and specific place, as intensely as 
possible, may be al that is needed to elicit change in GAD symptoms and wory severity. The 
diferences between the treatments in terms of rationale (i.e., behaviouristic perspective versus 
metacognitive perspective) and strategies to use outside of the 30-minute period when worying 
appears (i.e., distraction versus detached mindfulness) may play smal roles in eliciting change. 
Alternatively, these perspectives and strategies may each be eficacious and useful, with litle 
diference between them in terms of how eficacious they are. With only two studies previously 
comparing models of therapy for GAD against each other, it is unclear whether the superiority of 
metacognitive therapy found in these studies were representative of the superiority of 
metacognitive therapy in general, or if they were rare findings. In this study, an ultra-brief form 
of metacognitive therapy was not superior to an ultra-brief form of standard CBT. 
 It had also been hypothesized that the CAWS would be superior to the MWS in 
increasing positive afect. This was hypothesized due to the self-reinforcing component that was 
added to the CAWS script, based on previous research indicating that individuals with GAD 
symptoms have normal self-reinforcing skils (Penney & Mazmanian, 2010a; 2010c). The self-
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reinforcing component was added to the CAWS script since McGowan and Behar (2013) found 
no changes in positive afect due to the CAWS treatment after two weeks. However, in the 
present study, both the CAWS and the MWS led to increases in positive afect after four weeks, 
though the efect size was smal. The finding that positive afect increased in the present study 
but not in the McGowan and Behar (2013) study may be primarily due to the two week 
diference in the length of folow-ups between the studies. It does not appear that the self-
reinforcing component of the CAWS script added substantialy to the treatment. 
 While the MWS and CAWS were eficacious in decreasing GAD symptoms, wory 
severity, negative afect, and the proposed cognitive factors in GAD, the treatments had no 
significant efects on health anxiety, medication use, or visits to primary care. Due to the limited 
time frame of the study, and the few visits that participants made to primary care, it is not 
surprising that treatment had litle influence on these variables. However, treatment was 
expected to decrease health anxiety. If health anxiety had been decreased due to treatment, it 
could have been postulated that visits to primary care may be reduced in the long-term.  
 Treatment also had no efect on motivation to receive a ful-course (i.e., 12 weeks) of 
therapy. In fact, participants reported slightly lower motivation for a ful-course of therapy when 
they returned at four-week folow-up than they did at baseline. While Verkuil et al. (2011) found 
that providing the CAWS prior to a standard CBT led to significant improvements at post-
treatment, it does not appear that this was due to the CAWS enhancing motivation for treatment. 
However, there are multiple possible reasons for the lack of enhanced motivation. First, the 
measure of motivation, the MRTS, was developed for this study, and additional research wil be 
necessary to determine if the measure is adequately measuring motivation for treatment. As 
wel, it is possible that if participants are experiencing large benefits from the CAWS or MWS, 
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they may feel that they do not need to receive additional treatment. Alternatively, if participants 
experienced litle benefit from treatment, they may feel that commiting to a 12-week therapy 
could be a waste of time. The research has shown, however, that clarifying motivation for 
treatment, particularly through the use of motivational interviewing, can lead to improved 
outcomes in GAD treatment (Westra, Arkowitz, & Dozois, 2009). Because the research has 
shown that motivational interviewing or pre-treatment of wory can improve outcomes for 
individuals receiving treatment for GAD, future researchers may wish to compare motivational 
interviewing with an ultra-brief treatment to determine if either lead to beter post-treatment 
outcomes. 
The finding that the MWS and CAWS did not decrease health anxiety or increase 
motivation for treatment also supports a conclusion reached by McGowan and Behar (2013): the 
CAWS and MWS treatments specificaly target wory and GAD. McGowan and Behar (2013) 
reached this conclusion because the CAWS treatment had litle efect on depression symptoms. 
In the present study, although the treatments also decreased negative afect and led to smal 
increases in positive afect, the treatments predominately decreased symptoms of GAD and 
wory severity. Therefore, if the CAWS or MWS treatments were implemented in primary care, 
they may not be useful as a general, transdiagnostic approach. While the CAWS or MWS may 
decrease some comorbid symptoms by decreasing negative afect, alternative treatments would 
likely stil be necessary for participants with depression, health anxiety, a lack of motivation, or 
other anxiety symptoms. 
 A final note is needed on the treatments used in this study. At the outset of this study, 
one of the reasons for predicting that the MWS would be more eficacious than the CAWS was 
due to the diferent techniques that were used outside the wory period in each treatment. While 
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the MWS treatment used detached mindfulness, the CAWS treatment focused on distraction. It 
was assumed that by engaging in detached mindfulness when wories arose MWS participants 
would experience greater decreases in negative beliefs about wory, and therefore greater 
decreases in GAD symptoms and wory severity, than CAWS participants using distraction when 
wories arose. There are a number of possibilities for why the use of detached mindfulness was 
not more eficacious than distraction, but three of the possibilities are discussed here. 
First, detached mindfulness is a complex idea that is not easily grasped by members of 
the general public. Some of the participants who received the MWS treatment mentioned when 
they returned at four-week post-treatment that they did not use the detached mindfulness, and 
some reported using a combination of thought stopping and distraction. As wel, when 
reviewing the audiotapes with therapists during the initial stages of the study, it was clear that 
participants occasionaly did not fuly grasp the concept of detached mindfulness. It may be that 
a longer treatment session, where detached mindfulness is first explored with the guidance of a 
therapist, is necessary before individuals are able to use this technique on their own. Although 
Sugiura (2004) previously examined how the use of detached mindfulness interacted with wory, 
Sugiura (2004) was measuring a trait-like form of detached mindfulness. The curent study was 
the first to atempt to teach detached mindfulness without incorporating it as part of a larger 
therapy protocol. Future studies may wish to look at how easy it is to teach detached 
mindfulness and examine who can benefit the most from developing a detached atitude towards 
worying. 
A second possibility for why detached mindfulness did not appear to be superior to 
distraction may be due to the strength of distraction as a therapeutic technique.  The general 
public often regards distraction as a means to avoid working through emotional issues, and some 
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clinicians equate distraction to thought and emotion suppression. Wels (2009) even argues that 
the use of distraction maintains GAD as part of the Metacognitive Model. Yet, research has 
shown many benefits to distraction. For example, in depressed patients, the use of distraction 
and habitual distraction predicts beter mood outcomes folowing a negative mood induction than 
rumination or mindful self-focus (Hufziger & Kuehner, 2009), and habitual distraction from 
depressed mood also predicts greater receptivity to treatment and stronger therapeutic aliances 
during treatment (Teismann, Michalak, Wilutzki, & Schulte, 2012). Further, in anxiety, using 
distraction during exposure trials in the treatment of phobia leads to improved outcomes 
(Johnstone & Page, 2004), and engaging in distraction after giving a speech has been found to be 
beneficial for individuals with social anxiety (Kocovski, MacKenzie, & Rector, 2011). Wels 
and Davies (1994) also previously found that meta-wory and wory severity were not related to 
the use of distraction. Further, Coles and Heimberg (2005) and Fehm and Hoyer (2004) also 
found that wory severity negatively corelated with the use of distraction. However, distraction 
may also be used as a safety behaviour for some individuals (Wels et al., 1995), therefore the 
use of distraction should be determined on a case-by-case basis. Indeed, folow-ups may be 
necessary when implementing the CAWS or MWS treatments to determine if the treatment is 
functioning to maintain the excessive wory at its baseline level, or if the treatment is targeting 
underlying dysfunctional beliefs and leading to true change in symptoms. 
Of course, a final potential reason why detached mindfulness did not appear to be 
particularly useful in decreasing symptoms of GAD may be due to detached mindfulness not 
being a strong therapeutic technique. While Wels (2009) has reported that this technique works 
very wel with clients, and has used detached mindfulness in his mindfulness-based treatment 
outcome studies, there has been no independent examination of the eficacy of this technique as a 
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standalone treatment.  Indeed, further research that conducts component analyses of the MWS 
and CAWS treatments (i.e., comparing the eficacy of wory scheduling, detached mindfulness, 
and distraction as standalone treatments) is needed to fuly examine the utility of the techniques 
used within these treatments. 
 Overal, the results of this study indicate that the CAWS and MWS treatments could 
potentialy be useful in primary care. Given the high rate of GAD in primary care (Bélanger et 
al., 2005; Goldberg & Lecrubier, 1995; Katon et al., 1990), and long waitlists for mental health 
services (Barua et al., 2011), new and cost-efective approaches are needed to treat GAD and 
excessive wory. There has been a cal for more CBT in primary care (Demertzis & Craske, 
2006), and equipping primary care workers with the skils to treat wory could also help to 
increase the recognition of GAD in front line care. With minimal investment into teaching the 
CAWS and MWS techniques to primary care workers, these techniques could potentialy lead to 
substantial reductions in GAD symptoms and wory severity for patients with excessive wory. 
As previous brief and preventative treatments for GAD have had equivocal results (Higgins, 
2006; Higgins & Hecker, 2008; Nordahl, 2009; Seligman et al., 1999; Shoenberger, 2008), 
bringing the CAWS and MWS treatments to primary care workers could be innovative, 
eficacious, and cost-efective approaches to treating GAD and excessive wory which certainly 
warants future examination. 
Strengths and Weaknesses 
 Although the present study had some limitations, it also had some significant strengths. 
First, while the sample was low in ethnic diversity, the sample came primarily from the 
community.  As wel, GAD research, and psychology research as a whole, commonly recruits 
participants from undergraduate psychology (e.g., Borkovec et al., 1983; Dugas et al., 1995; 
ULTRA-BRIEF TREATMENTS FOR GAD   126 
 
McGowan & Behar, 2013; Wels & Cartwright-Haton, 2004). The large community component 
in this study alows the findings from this study to be generalized to a much greater degree than 
similar studies. 
 By recruiting from the general community and university population, the sample in this 
study was not anticipated to represent a clinical population. Indeed, many in this sample were 
curently employed or students, and may not have sought out treatment for their wory through 
typical medical channels. However, the majority of participants in this sample met diagnostic 
criteria for GAD, and numerous participants had comorbid disorders. While this sample may not 
represent a clinical sample found at a specialty mental health clinic, it may represent the range of 
individuals with excessive wory found in primary care. The sample size was also much larger 
than typicaly reported in GAD treatment research. 
 Some may point to the extensive use of self-report questionnaires as being problematic 
for this study, and that a couple of measures had low Cronbach’s alphas. Others may also point 
to the need for additional measures coming from other theoretical perspectives, such as measures 
of intolerance of uncertainty or emotional avoidance. The lack of a larger and more detailed 
diagnostic measure, completed by an independent diagnostic interviewer, may also be pointed to 
as a significant limitation of the study. However, given the internal nature of wories, and the 
fact that only self-report measures have been developed to tap constructs such as negative beliefs 
about wory and cognitive avoidance, the reliance on self-report measures was justified for this 
study. Time constraints and the potential for participant fatigue also limited the number of 
measures that could be included. Further, while measures from diferent theoretical perspectives 
were not included, this study was one of only a handful of studies that have contrasted diferent 
theoretical models of GAD. Resource constraints, the length of the study, the large sample size, 
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and the multiple folow-up appointments also made the involvement of independent diagnostic 
interviewers regretably unfeasible. 
 The fact that some participants completed the folow-ups at home or other locations may 
also be considered a limitation. By completing the folow-ups at home, diagnostic interviews 
could not be completed with these participants, and the integrity of how the questionnaires were 
completed could not be ascertained. However, by permiting participants to complete the 
questionnaires at home, this study had a low atrition rate, and three-quarters of participants 
completed the entire study. The lack of highly restrictive criteria, such as alowing participants 
to see other therapists and change medications during the study, may also be seen as a limitation 
to some researchers. However, in doing so, this study had good ecological validity, and the 
results give a beter indication of likely outcomes should the CAWS or MWS be implemented in 
the community. 
 It may also be argued that the therapists used in this study were not representative of the 
practitioners that would potentialy be implementing these ultra-brief treatments in primary care. 
Indeed, the therapists used in this study had extensive background training in CBT, which most 
practitioners in primary care are unlikely to have. However, none of the therapists in this study 
had prior exposure to the treatments used in this study, and rarely brought up material that was 
not already included in the treatment scripts. This indicates that with only minor training, the 
scripts used in this study could be implemented by primary care practitioners. Of course, until 
the dissemination of these treatments into primary care is atempted, it is not possible to know 
for certain how much training would be required. 
 Diferences in rates of atrition between the CAWS and MWS may also be pointed out as 
a significant limitation. With 20.0% of participants in the MWS treatment withdrawing at four-
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week post-treatment, versus 8.6% of participants in the CAWS treatment withdrawing at four-
week post-treatment, it could be argued that this diference influenced the results, and indicates 
that the MWS was less eficacious than the CAWS. However, conducting the intent-to-treat 
analyses, and focusing the discussion on the findings that came from the intent-to-treat results, 
mitigates the potential that the diferences in withdrawals significantly influenced the 
conclusions drawn from this study. 
Future Directions 
 As already mentioned, numerous studies can build of the findings presented in this 
study. The potential studies already presented include an examination of the predictors of 
symptom change in longitudinal studies of people with GAD, a study of changes on measures of 
the proposed cognitive factors in standard CBT based on the Cognitive Avoidance Model and 
Metacognitive Model, and research into the dissemination and implementation of CAWS and 
MWS in primary care. Additional potential studies already stated include testing whether ultra-
brief treatments or motivational interviewing prior to standard therapy lead to a greater reduction 
in symptoms at post-treatment, and analyses of the eficacy of wory scheduling, detached 
mindfulness, and distraction as standalone treatments for excessive wory and GAD symptoms. 
Since this study by itself is not enough to definitively support one model of GAD over another, 
additional studies that contrast the diferent models of GAD would be required to reach more 
definitive conclusions. However, these are but a few of the many potential folow-up studies. 
 One potential study folowing from this research would be an examination of how patient 
characteristics interact with the type of ultra-brief treatment. For example, do individuals with 
previous exposure to mindfulness experience greater symptom reduction when using the MWS, 
are the elderly beter at implementing the CAWS than the MWS, and are people with more 
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regular routines and schedules able to use the treatments beter than individuals with changing 
life and work schedules, are al potential research questions. Researchers may also consider 
examining alternative forms of delivery for the CAWS and MWS, such as the use of handouts or 
pre-recorded videos. 
 The CAWS or MWS may also be examined as preventative treatments in the future, 
using a strictly preventative research design. This would include restricting the potential 
participants to only individuals with subclinical levels of GAD. Using multiple long-term 
folow-ups and a large sample, this could be a very useful study, particularly if adolescents or 
young adults were recruited as participants. Alternatively, the CAWS or MWS could also be 
tested as relapse-prevention strategies, and taught to participants after they have received 
standard CBT. Researchers may also wish to compare ultra-brief therapies with standard 
treatment across a range of measures beyond efectiveness, potentialy including such things as 
therapeutic aliance, perceived credibility, ease of dissemination, and cognitive factors. 
 Finaly, an area with the greatest potential for future research is in the development of 
additional ultra-brief therapies for other anxiety and mood disorders. Given that ultra-brief 
therapies have been found to be eficacious for GAD symptoms in the present study, and found 
to be eficacious for alcohol abuse and pathological gambling in previous studies (Carlbring et 
al., 2010; Moyer et al., 2002; Vasilaki et al., 2006), researchers may wish to consider developing 
ultra-brief therapies for depression, social anxiety, panic disorder, and other emotional disorders. 
This would also help researchers and therapists think deeply about which elements of standard 
therapy are the most eficacious, and should be implemented early in treatment. A movement 
towards ultra-brief therapies could also greatly reduce costs in primary care, help people with 
emotional disorders receive empirical treatment without siting on a wait-list for several months, 
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and could potentialy form the first step in stepped-care approaches to the treatment of emotional 
disorders. 
Conclusions 
GAD is commonly found in primary care, however the standard treatments for GAD 
include either medication, with negative side efects, or receiving standard CBT at a speciality 
mental health clinic after being placed on a waitlist for many months. By examining two ultra-
brief treatments for GAD based on the Cognitive Avoidance Model and Metacognitive Model, 
this study revealed that GAD symptoms and excessive wory could be treated in less than 20 
minutes. While the treatments did not difer, compared to a waitlist control, the CAWS and 
MWS led to substantial reductions in GAD symptoms, wory severity, and negative afect. The 
ultra-brief treatments also led to large decreases in negative metacognitions, meta-wory, 
cognitive avoidance, and fear of negative evaluation, while also increasing positive afect. With 
future research, these ultra-brief treatments would appear to be wel suited for application in 
primary care setings. 
Further, by contrasting these two models and treatments of GAD, the results also 
provided support for both the Cognitive Avoidance Model and the Metacognitive Model. 
Finding that both treatments decreased GAD symptoms, wory severity, and the proposed 
cognitive factors provide support for both models of GAD. Changes in negative beliefs about 
wory and the frequency of meta-wories significantly were significantly related to changes in 
GAD symptoms and wory severity, providing further support for the Metacognitive Model. In 
addition, the finding that changes in cognitive avoidance were related to changes in wory 
severity as a result of treatment provided support for the Cognitive Avoidance Model, while also 
ULTRA-BRIEF TREATMENTS FOR GAD   131 
 
further indicating that the Cognitive Avoidance model could be considered a model of wory, 
rather than a model of GAD specificaly. 
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Script for the Recruitment of  
Introduction to Psychology Students 
 
My name is Alex Penney, and I am a PhD student in Psychological Science working 
being supervised by Dr. Dwight Mazmanian. I am curently conducting a study on ultra-brief 
treatments for wory and anxiety. I am examining the efectiveness of 2 diferent treatments. 
The treatments take only 20 minutes. Participants wil be randomly alocated to receive one of 
the treatments immediately or after a 4 week delay. We also ask participants to complete a 
number of questionnaires regarding wory, mood, and anxiety, which takes approximately an 
hour and a half prior to receiving the treatment. Finaly, we also ask people to return 4 weeks 
and 4 months after treatment for folow-up questionnaires. If you believe that you are worying 
too much, or if you feel anxious or stressed most days, please contact me to participate in the 
study. 
 If you are interested in being a participant in this study, please email me at 
worystudy@lakeheadu.ca or cal 343-8943. As wel, if you have of any friends or relatives who 
you think wory too much, and if they might be interested in receiving the treatment, please give 
them my contact information. 
 Your participation to this study is entirely voluntary, and your instructor wil not be made 
aware of who chooses to participate in this study. 
 Thank you for your time. 
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Information for Local Newspaper Ads 
Are you worying too much? Do you feel anxious or stressed most days? 
Psychologists and researchers at Lakehead University are examining the efectiveness of two 
ultra-brief treatments for wory or anxiety. Anyone 18 years or older can participate. The 
treatment is free, easy to use, and does not involve medication. 
Contact Alexander Penney at 343-8943 or worystudy@lakeheadu.ca to find out more. 
 
 
 
  
Figure A1. Newspaper advertisement 
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Figure A2. Recruitment poster version 1 
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Figure A3. Recruitment poster version 2 
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Figure A4. Recruitment poster version 3 
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Appendix B 
Self-Report Questionnaires at Baseline 
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 Background Information Questionnaire 
We would appreciate your responses to the folowing questions. 
 
1) Biological Sex:   Male      Female 
 
2) Age:  _________ 
 
3) Ethnicity:    Caucasian/White    Middle Eastern  
    African-Canadian/Black   East Indian  
    Native-Canadian/Aboriginal  Hispanic/Latino 
    Asian      Other  
 
4) What is your marital status? 
    Single     Dating  
Maried/common law   Divorced/separated   
 Widowed  
 
5) Are you pregnant?  Yes     No 
 
6) Do you have any children?  
 Yes     No 
Number of biological children _________ 
Number of step-children     _________ 
Number of adopted children  _________ 
 
7) Are you curently employed? 
    Ful Time     Part Time  
    Retired     No  
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8) Are you curently a student?   
Yes – Ful Time    Yes – Part Time 
No  
 
9) What is the highest level of education that you have achieved? 
    Doctoral degree    Colege diploma  
    Master’s degree   Some colege  
    Undergraduate degree  High school diploma 
    Some university   Some high school 
 
10) How many alcohol-containing beverages (1 shot of hard liquor = 1 botle of beer = 1 cooler 
= 1 glass of wine) have you consumed in the last week?    _________ 
 
11) How often do you drink alcohol-containing beverages in a normal month? 
Never     Once or twice        Once or twice     Three or four    Almost  
  a month     a week      times a week   every day 
 
  0            1                   2               3              4 
 
12) What percentage of the day did you spend worying on a typical day during the past week 
(0-100%):  ________ 
 
13) How many times did you wory on a typical day during the past week? 
Never     Once or twice        Three to five     Six to ten    Al day/  
  a day    times a day     times a day  continuously 
 
  0            1                   2               3              4 
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WAQ 
1. What things do you wory about most often? 
a) __________________________________ d) _________________________________ 
b) __________________________________ e) _________________________________ 
c) __________________________________ f) _________________________________ 
 
For the folowing items, please circle the coresponding number (0-8). 
 
2. Do your wories seem excessive or exaggerated? 
   Not at al                       Moderately                      Totaly 
   excessive                       excessive                       excessive 
 
      0       1       2       3       4       5       6       7       8 
3. Over the past six months, how many days have you been bothered by excessive wory? 
                                  1 day                       
    Never                         out of 2                       Everyday 
 
      0       1       2       3       4       5       6       7       8 
4. Do you have dificulty controling your wories? For example, when you start worying about 
something, do you have dificulty stopping? 
     No                          Moderate                       Extreme 
   dificulty                       dificulty                       dificulty 
 
      0       1       2       3       4       5       6       7       8 
5. Over the past six months, to what extent have you been disturbed by the folowing 
sensations when you were woried or anxious? Rate each sensation by circling a number (0-8). 
a) Restlessness or feeling keyed up or on edge. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
b) Being easily fatigued. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
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For the folowing items, please circle the coresponding number (0-8). 
 
c) Dificulty concentrating or mind going blank. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
d) Iritability. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
e) Muscle tension. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
f) Sleep disturbance (dificulty faling or staying asleep, or restless unsatisfying sleep). 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
6. To what extent does wory or anxiety interfere with your life? For example, your work, social 
activities, family life, etc.? 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
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MWQ 
This questionnaire assesses thoughts and ideas about worying. Listed below are some thoughts 
that you may have about worying when you notice yourself worying. Indicate how often each 
thought occurs by circling the appropriate number, using the scale below. 
 
 Never     Sometimes      Often   Almost always 
  1                 2                 3                 4 
 
WHEN I AM WORRYING I THINK: 
 
1. I am going crazy with worying. 
 
  1                 2                 3                 4 
 
2. My worying wil escalate and I’l cease to function. 
 
  1                 2                 3                 4 
 
3. I’m making myself il with wory. 
 
  1                 2                 3                 4 
 
4. I’m abnormal for worying. 
 
  1                 2                 3                 4 
 
5. My mind can’t take the worying. 
 
  1                 2                 3                 4 
 
6. I’m losing out in life because of worying. 
 
  1                 2                 3                 4 
 
7. My body can’t take the worying. 
 
  1                 2                 3                 4 
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PIM 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        true           true 
  1                 2                 3                 4 
 
1. Sometimes I let litle things bother me too much. 
 
  1                 2                 3                 4 
 
2. Sometimes I’l avoid someone I realy don’t like. 
 
  1                 2                 3                 4 
 
3. I sometimes complain too much. 
 
  1                 2                 3                 4 
 
4. Sometimes I’m too impatient. 
 
  1                 2                 3                 4 
 
5. I don’t take criticism very wel. 
 
  1                 2                 3                 4 
 
6. Sometimes I put things of until the last minute. 
 
  1                 2                 3                 4 
 
7. I sometimes make promises I can’t keep. 
 
  1                 2                 3                 4 
 
8. There have been times when I could have been more thoughtful than I was. 
 
  1                 2                 3                 4 
 
9. I rarely get in a bad mood. 
 
  1                 2                 3                 4 
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PSWQ 
Circle the number that describes how typical or characteristic each item is of you, using the 
folowing scale: 
 
  Not at al Typical         Somewhat Typical          Very Typical 
1              2              3              4              5 
 
1. If I don’t have enough time to do everything, I don’t wory about it. 
 
1              2              3              4              5 
 
2. My wories overwhelm me. 
 
1              2              3              4              5 
 
3. I don’t tend to wory about things. 
 
1              2              3              4              5 
 
4. Many situations make me wory. 
 
1              2              3              4              5 
 
5. I know I shouldn’t wory about things, but I just can’t help it. 
 
1              2              3              4              5 
 
6. When I’m under pressure, I wory a lot. 
 
1              2              3              4              5 
 
7. I am always worying about something. 
 
1              2              3              4              5 
 
8. I find it easy to dismiss worisome thoughts. 
 
1              2              3              4              5 
 
9. As soon as I finish one task, I start to wory about everything else I have to do. 
 
1              2              3              4              5 
 
10. I never wory about anything. 
 
1              2              3              4              5 
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  Not at al Typical         Somewhat Typical          Very Typical 
1              2              3              4              5 
 
11. When there is nothing more I can do about a concern, I don’t wory about it anymore. 
 
1              2              3              4              5 
 
12. I’ve been a worier al my life. 
 
1              2              3              4              5 
 
13. I notice that I have been worying about things. 
 
1              2              3              4              5 
 
14. Once I start worying, I can’t stop. 
 
1              2              3              4              5 
 
15. I wory al the time. 
 
1              2              3              4              5 
 
16. I wory about projects until they are al done. 
 
1              2              3              4              5 
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CAQ 
People react diferently to certain types of thoughts. Using the folowing scale, please indicate to 
what extent each of the folowing statements is typical of the way that you respond to certain 
thoughts. Please circle the appropriate number (1 to 5). 
 
   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
1. There are things that I would rather not think about. 
 
1              2              3              4              5 
 
2. I avoid certain situations that lead me to pay atention to things I don't want to think about. 
 
1              2              3              4              5 
 
3. I replace threatening mental images with things I say to myself in my mind. 
 
1              2              3              4              5 
 
4. I think about things that concern me as if they were occuring to someone else. 
 
1              2              3              4              5 
 
5. I have thoughts that I try to avoid. 
 
1              2              3              4              5 
 
6. I try not to think about the most upseting aspects of some situations so as not to be too afraid. 
 
1              2              3              4              5 
 
7. I sometimes avoid objects that can trigger upseting thoughts. 
 
1              2              3              4              5 
 
8. I distract myself to avoid thinking about certain disturbing subjects. 
 
1              2              3              4              5 
 
9. I avoid people who make me think about things that I do not want to think about. 
 
1              2              3              4              5 
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   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
10. I often do things to distract myself from my thoughts. 
 
1              2              3              4              5 
 
11. I think about trivial details so as not to think about important subjects that wory me. 
 
1              2              3              4              5 
 
12. Sometimes I throw myself into an activity so as not to think about certain things. 
 
1              2              3              4              5 
 
13. To avoid thinking about subjects that upset me, I force myself to think about something else. 
 
1              2              3              4              5 
 
14. There are things I try not to think about. 
 
1              2              3              4              5 
 
15. I keep saying things to myself in my head to avoid visualizing scenarios (a series of mental 
images) that frighten me. 
 
1              2              3              4              5 
 
16. Sometimes I avoid places that make me think about things I would prefer not to think about. 
 
1              2              3              4              5 
 
17. I think about past events so as not to think about future events that make me feel insecure. 
 
1              2              3              4              5 
 
18. I avoid actions that remind me of things I do not want to think about. 
 
1              2              3              4              5 
 
19. When I have mental images that are upseting, I say things to myself in my head to replace 
the images. 
 
1              2              3              4              5 
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   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
20. I think about many litle things so as not to think about more important maters. 
 
1              2              3              4              5 
 
21. Sometimes I keep myself occupied just to prevent thoughts from popping up in my mind. 
 
1              2              3              4              5 
 
22. I avoid situations that involve people who make me think about unpleasant things. 
 
1              2              3              4              5 
 
23. Rather than having images of upseting events form in my mind, I try to describe the events 
using an internal monologue (things that I say to myself in my head). 
 
1              2              3              4              5 
 
24. I push away the mental images related to a threatening situation by trying to describe the 
situation using an internal monologue. 
 
1              2              3              4              5 
 
25. I think about things that are worying other people rather than thinking about my own 
wories. 
 
1              2              3              4              5 
 
ULTRA-BRIEF TREATMENTS FOR GAD   185 
 
RGHAS_______________________________________________________________________ 
Listed below are various methods that people use to get help for an anxiety problem. Check al of the 
methods that you have used in the past month. If you check an item, please indicate the number of times 
you have used this method in the past month. If none apply, leave it blank.  
 
___ I have read a book or multiple books on how to solve or manage my anxiety  
 Number of occasions: ______ 
 
___ I have searched the internet for resources on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have watched tapes or videos on my own on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have exercised on my own or as part of a group (e.g., yoga, Tai Chi, walking, biking, weight lifting, 
swimming, etc.) to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have discussed on one or more occasions how to solve or manage my anxiety with a friend, family 
member, pastor, or work coleague in order to get advice on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have been involved with a "chat-group" or other internet service to help me solve or manage my 
anxiety 
 Number of occasions: ______ 
 
___ I have gone on one or more occasions to a self-help or support group to help me solve or manage my 
anxiety 
 Number of occasions: ______ 
 
___ I have atended a class/seminar or have atended multiple classes/seminars (e.g., stress management, 
relaxation, meditation, etc.) to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have discussed how to solve or manage my anxiety with my family physician or other primary care 
provider (i.e., registered nurse, etc.) 
 Number of occasions: ______ 
 
___ I have seen one or more professional counselors or therapists on one or more occasions to help me 
how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have been hospitalized for to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ Other (please describe): _______________________________________________ 
 Number of occasions: ______ 
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BFNE 
Read each of the folowing statements carefuly and indicate how characteristic it is of you 
according to the folowing scale. 
 
    Not at al       Slightly   Moderately  Very   Extremely 
   characteristic   characteristic  characteristic    characteristic characteristic 
     of me   of me     of me  of me    of me 
1              2              3              4              5 
 
1. I wory about what other people wil think of me even when I know it doesn’t make any 
diference. 
 
1              2              3              4              5 
 
2. I am unconcerned even if I know people are forming an unfavourable impression of me. 
 
1              2              3              4              5 
 
3. I am frequently afraid of other people noticing my shortcomings. 
 
1              2              3              4              5 
 
4. I rarely wory about what kind of impression I am making on someone. 
 
1              2              3              4              5 
 
5. I am afraid that others wil not approve of me. 
 
1              2              3              4              5 
 
6. I am afraid that other people wil find fault with me. 
 
1              2              3              4              5 
 
7. Other people’s opinions of me do not bother me. 
 
1              2              3              4              5 
 
8. When I am talking to someone, I wory about what they may be thinking of me. 
 
1              2              3              4              5 
 
9. I am usualy woried about what kind of impression I make. 
 
1              2              3              4              5 
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    Not at al       Slightly   Moderately  Very   Extremely 
   characteristic   characteristic  characteristic    characteristic characteristic 
     of me   of me     of me  of me    of me 
1              2              3              4              5 
 
10. If I know someone is judging me, it has litle efect on me. 
 
1              2              3              4              5 
 
11. Sometimes I think I am too concerned with what other people think of me. 
 
1              2              3              4              5 
 
12. I often wory that I wil say or do the wrong things. 
 
1              2              3              4              5 
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INF 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        True           True 
  1                 2                 3                 4 
 
1. My favourite poet is Raymond Kertezc. 
 
  1                 2                 3                 4 
 
2. Sometimes I get ads in the mail that I don’t realy want. 
 
  1                 2                 3                 4 
 
3. My favourite sports event on television is the high jump. 
 
  1                 2                 3                 4 
 
4. Most people would rather win than lose. 
 
  1                 2                 3                 4 
 
5. My favourite hobbies are archery and stamp-colecting. 
 
  1                 2                 3                 4 
 
6. I don’t like to have to buy things that are overpriced. 
 
  1                 2                 3                 4 
 
7. Most people look forward to a trip to the dentist. 
 
  1                 2                 3                 4 
 
8. In my free time I might read, watch TV, or just relax. 
 
  1                 2                 3                 4 
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MCQ-30 
This questionnaire is concerned with beliefs people have about their thinking. Listed below are a 
number of beliefs that people have expressed. Please read each item and say how much you 
generaly agree with it by circling the appropriate number. Please respond to al the items, there 
are no right or wrong answers. 
 
 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
1. Worying helps me to avoid problems in the future 
 
  1                 2                 3                 4 
 
2. My worying is dangerous for me 
 
  1                 2                 3                 4 
 
3. I think a lot about my thoughts 
 
  1                 2                 3                 4 
 
4. I could make myself sick with worying 
 
  1                 2                 3                 4 
 
5. I am aware of the way my mind works when I am thinking through a problem 
 
  1                 2                 3                 4 
 
6. If I did not control a worying thought, and then it happened, it would be my fault 
 
  1                 2                 3                 4 
 
7. I need to wory in order to remain organized 
 
  1                 2                 3                 4 
 
8. I have litle confidence in my memory for words and names 
 
  1                 2                 3                 4 
 
9. My worying thoughts persist, no mater how I try to stop them 
 
  1                 2                 3                 4 
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 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
 
10. Worying helps me to get things sorted out in my mind 
 
  1                 2                 3                 4 
 
11. I cannot ignore my worying thoughts 
 
  1                 2                 3                 4 
 
12. I monitor my thoughts 
 
  1                 2                 3                 4 
 
13. I should be in control of my thoughts al of the time 
 
  1                 2                 3                 4 
 
14. My memory can mislead me at times 
 
  1                 2                 3                 4 
 
15. My worying could make me go mad 
 
  1                 2                 3                 4 
 
16. I am constantly aware of my thinking 
 
  1                 2                 3                 4 
 
17. I have a poor memory 
 
  1                 2                 3                 4 
 
18. I pay close atention to the way my mind works 
 
  1                 2                 3                 4 
 
19. Worying helps me cope 
 
  1                 2                 3                 4 
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 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
20. Not being able to control my thoughts is a sign of weakness 
 
  1                 2                 3                 4 
 
21. When I start worying, I cannot stop 
 
  1                 2                 3                 4 
 
22. I wil be punished for not controling certain thoughts 
 
  1                 2                 3                 4 
 
23. Worying helps me to solve problems 
 
  1                 2                 3                 4 
 
24. I have litle confidence in my memory for places 
 
  1                 2                 3                 4 
 
25. It is bad to think certain thoughts 
 
  1                 2                 3                 4 
 
26. I do not trust my memory 
 
  1                 2                 3                 4 
 
27. If I could not control my thoughts, I would not be able to function 
 
  1                 2                 3                 4 
 
28. I need to wory, in order to work wel 
 
  1                 2                 3                 4 
 
29. I have litle confidence in my memory for actions 
 
  1                 2                 3                 4 
 
30. I constantly examine my thoughts 
  1                 2                 3                 4 
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MRTS 
Please select the likelihood that you would engage in the folowing treatments, if they were made 
available to you: 
 
  Not very likely       Not sure     Very likely 
1         2         3         4         5          6         7 
 
1. I would atend a 12-week group psychotherapy/counseling program: 
 
1         2         3         4         5         6         7 
 
2. I would atend a 12-week individual psychotherapy/counseling program: 
 
1         2         3         4         5         6         7 
 
3. I would atend a 12-week support group (i.e., Mental Health Peer Support Group): 
 
1         2         3         4         5         6         7 
 
4. I would atend a 12-week psychotherapy/counseling seminar (i.e., classes) program: 
 
1         2         3         4         5         6         7 
 
5. I would use a 12-week self-help manual: 
 
1         2         3         4         5         6         7 
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PANAS 
This scale consists of a number of words that describe diferent feelings and emotions. Read 
each item and then choose the appropriate answer by circling the number under the word. 
Indicate to what extent you have felt this way during the past few weeks. Use the folowing 
scale to record your answers. 
 
  Very slightly   A          Quite 
  or not at al        litle        Moderately         a bit       Extremely 
1              2              3              4              5 
 
1. Interested 
 
1              2              3              4              5 
 
2. Iritable 
 
1              2              3              4              5 
 
3. Distressed 
 
1              2              3              4              5 
 
4. Alert 
 
1              2              3              4              5 
 
5. Excited 
 
1              2              3              4              5 
 
6. Ashamed 
 
1              2              3              4              5 
 
7. Upset 
 
1              2              3              4              5 
 
8. Inspired 
 
1              2              3              4              5 
 
9. Strong 
 
1              2              3              4              5 
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  Very slightly   A          Quite 
  or not at al        litle        Moderately         a bit       Extremely 
1              2              3              4              5 
 
10. Nervous 
 
1              2              3              4              5 
 
11. Guilty 
 
1              2              3              4              5 
 
12. Determined 
 
1              2              3              4              5 
 
13. Scared 
 
1              2              3              4              5 
 
14. Atentive 
 
1              2              3              4              5 
 
15. Hostile 
 
1              2              3              4              5 
 
16. Jitery 
 
1              2              3              4              5 
 
17. Enthusiastic 
 
1              2              3              4              5 
 
18. Active 
 
1              2              3              4              5 
 
19. Proud 
 
1              2              3              4              5 
 
20. Afraid 
1              2              3              4              5 
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PMUS 
 
1. Are you currently taking any medications to treat anxiety or wory?  Yes   No  
 
2. Compared to 4 weeks ago, how has your medication use changed: 
 
Greatly decreased      No change in        Greatly increased 
the frequency/     the frequency/     the frequency/ 
dose/amount         dose/amount      dose/amount 
 
-3  -2  -1  0  +1  +2  +3 
 
3. Please list any medications you are curently taking to treat anxiety, wory, depression, or 
other emotional issue: 
 
Medication A:_____________________________ Dose per week:________________________ 
 
Medication B:_____________________________ Dose per week:________________________ 
 
Medication C:_____________________________ Dose per week:________________________ 
 
Medication D:_____________________________ Dose per week:________________________ 
 
Medication E:_____________________________ Dose per week:________________________ 
 
Medication F:_____________________________ Dose per week:________________________ 
 
Medication G:_____________________________ Dose per week:________________________ 
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NIM 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        True           True 
  1                 2                 3                 4 
 
1. Sometimes I cannot remember who I am. 
 
  1                 2                 3                 4 
 
2. I have visions in which I see myself forced to commit crimes. 
 
  1                 2                 3                 4 
 
3. Since the day I was born, I was destined to be unhappy. 
 
  1                 2                 3                 4 
 
4. I think I have three or four completely diferent personalities inside of me. 
 
  1                 2                 3                 4 
 
5. People don’t understand how much I sufer. 
 
  1                 2                 3                 4 
 
6. Every once in a while I totaly lose my memory. 
 
  1                 2                 3                 4 
 
7. Sometimes my vision is only in black and white. 
 
  1                 2                 3                 4 
 
8. I don’t have any good memories from my childhood. 
 
  1                 2                 3                 4 
 
9. I have severe psychological problems that began very suddenly 
 
  1                 2                 3                 4 
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SHAI 
Each question is this section consists of a group of four statements. Please read each group of 
statements carefuly and then select the one which best describes your feelings, over the past six 
months. Identify the statement by circling the leter next to the statement. It may be that more 
than one statement applies, in which case, please circle any that are applicable. 
 
1.  (a) I do not wory about my health. 
(b) I occasionaly wory about my health. 
(c) I spend much of my time worying about my health. 
(d) I spend most of my time worying about my health. 
 
2. (a) I notice aches/pains less than most other people (of my age). 
(b) I notice aches/pains as much as most other people (of my age). 
(c) I notice aches/pains more than most other people (of my age). 
(d) I am aware of aches/pains in my body al the time. 
 
3.  (a) As a rule I am not aware of bodily sensations or changes. 
(b) Sometimes I am aware of bodily sensations or changes. 
(c) I am often aware of bodily sensations or changes. 
(d) I am constantly aware of bodily sensations or changes. 
 
4.  (a) Resisting thoughts of ilness is never a problem. 
(b) Most of the time I can resist thoughts of ilness. 
(c) I try to resist thoughts of ilness but am often unable to do so. 
(d) Thoughts of ilness are so strong that I no longer even try to resist them. 
 
5.  (a) As a rule I am not afraid that I have a serious ilness. 
(b) I am sometimes afraid that I have a serious ilness. 
(c) I am often afraid that I have a serious ilness. 
(d) I am always afraid that I have a serious ilness. 
 
6.  (a) I do not have images (mental pictures) of myself being il. 
(b) I occasionaly have images of myself being il. 
(c) I frequently have images of myself being il. 
(d) I constantly have images of myself being il. 
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7.  (a) I do not have any dificulty taking my mind of thoughts about my health. 
(b) I sometimes have dificulty taking my mind of thoughts about my health. 
(c) I often have dificulty in taking my mind of thoughts about my health. 
(d) Nothing can take my mind of thoughts about my health. 
 
8.  (a) I am lastingly relieved if my doctor tels me there is nothing wrong. 
(b) I am initialy relieved but the wories sometimes return later. 
(c) I am initialy relieved but the wories always return later. 
(d) I am not relieved if my doctor tels me there is nothing wrong. 
 
9.  (a) If I hear about an ilness I never think I have it myself. 
(b) If I hear about an ilness I sometimes think I have it myself. 
(c) If I hear about an ilness I often think I have it myself. 
(d) If I hear about an ilness I always think I have it myself. 
 
10. (a) If I have a bodily sensation or change I rarely wonder what it means. 
(b) If I have a bodily sensation or change I often wonder what it means. 
(c) If I have a bodily sensation or change I always wonder what it means. 
(d) If I have a bodily sensation or change I must know what it means. 
 
11.  (a) I usualy feel at very low risk for developing a serious ilness. 
(b) I usualy feel at fairly low risk for developing a serious ilness. 
(c) I usualy feel at moderate risk for developing a serious ilness. 
(d) I usualy feel at high risk for developing a serious ilness. 
 
12.  (a) I never think I have a serious ilness. 
(b) I sometimes think I have a serious ilness. 
(c) I often think I have a serious ilness. 
(d) I usualy think that I am seriously il. 
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13.  (a) If I notice an unexplained bodily sensation I don't find it dificult to think about other 
things. 
(b) If I notice an unexplained bodily sensation I sometimes find it dificult to think about 
other things. 
(c) If I notice an unexplained bodily sensation I often find it dificult to think about other 
things. 
(d) If I notice an unexplained bodily sensation I always find it dificult to think about 
other things. 
 
14.  (a) My family/friends would say I do not wory enough about my health. 
(b) My family/friends would say I have a normal atitude to my health. 
(c) My family/friends would say I wory too much about my health. 
(d) My family/friends would say I am a hypochondriac. 
 
For the folowing questions, please think about what it might be like if you had a serious ilness 
of a type which particularly concerns you (such as heart disease, cancer, multiple sclerosis and so 
on). Obviously it may not be possible to know for definite what it would be like; please give 
your best estimate of what you think might happen, basing your estimate on what you know 
about yourself and serious ilness in general. 
 
15.  (a) If I had a serious ilness I would stil be able to enjoy things in my life quite a lot. 
(b) If I had a serious ilness I would stil be able to enjoy things in my life a litle. 
(c) If I had a serious ilness I would be almost completely unable to enjoy things in my 
life. 
(d) If I had a serious ilness I would be completely unable to enjoy life at al. 
 
16.  (a) If I developed a serious ilness there is a good chance that modern medicine would be 
able to cure me. 
(b) If I developed a serious ilness there is a moderate chance that modern medicine 
would be able to cure me. 
(c) If I developed a serious ilness there is a very smal chance that modern medicine 
would be able to cure me. 
(d) If I developed a serious ilness there is no chance that modern medicine would be able 
to cure me. 
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17.  (a) A serious ilness would ruin some aspects of my life. 
(b) A serious ilness would ruin many aspects of my life. 
(c) A serious ilness would ruin almost every aspect of my life. 
(d) A serious ilness would ruin every aspect of my life. 
 
18.  (a) If I had a serious ilnes I would not feel that I had lost my dignity. 
(b) If I had a serious ilness I would feel that I had lost a litle of my dignity. 
(c) If I had a serious ilness I would feel that I had lost quite a lot of my dignity. 
(d) If I had a serious ilness I would feel that I had totaly lost my dignity. 
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ACES 
Listed below are a number of statements concerning beliefs about change. Please read each item 
carefuly, and circle one of the five options that best reflect how you feel about the statement 
right now. 
 
Strongly Disagree   Disagree   Undecided      Agree      Strongly Agree 
1              2              3              4              5 
 
1. I feel pessimistic that my anxiety problems could ever change for the beter. 
 
1              2              3              4              5 
 
2. Even though I try, nothing seems to help with my anxiety. 
 
1              2              3              4              5 
 
3. It would be extremely dificult or impossible to solve my problems with anxiety. 
 
1              2              3              4              5 
 
4. I have had some positive experiences with being able to control my anxiety through talking 
positively to myself. 
 
1              2              3              4              5 
 
5. My problems with anxiety are too severe to benefit from treatment. 
 
1              2              3              4              5 
 
6. Self-help methods may help others control their anxiety but they won’t work for me. 
 
1              2              3              4              5 
 
7. I don’t believe I wil ever feel truly relaxed and not woried. 
 
1              2              3              4              5 
 
8. Facing my fears has never helped me to reduce my anxiety. 
 
1              2              3              4              5 
 
9. When I force myself to do something that scares me, often it’s not as bad as I thought. 
 
1              2              3              4              5 
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Strongly Disagree   Disagree   Undecided      Agree      Strongly Agree 
1              2              3              4              5 
 
10. I have had some success in reducing my anxiety. 
 
1              2              3              4              5 
 
11. There is very litle anyone could do to help me solve my anxiety problems. 
 
1              2              3              4              5 
 
12. Even when I try to talk positively to myself, it doesn’t help my anxiety. 
 
1              2              3              4              5 
 
13. Positive thinking is helpful to me in managing my anxiety. 
 
1              2              3              4              5 
 
14. There is no solution to my anxiety problems. 
 
1              2              3              4              5 
 
15. I am optimistic that my anxiety can change for the beter. 
 
1              2              3              4              5 
 
16. I have found that I can reduce my anxiety by teling myself to relax or by using relaxation 
exercises. 
 
1              2              3              4              5 
 
17. I’l never be able to control my anxiety and wory. 
 
1              2              3              4              5 
 
18. I believe it’s quite possible for me to feel less woried and more relaxed. 
 
1              2              3              4              5 
 
19. If I work hard, I can have a positive impact on my problems with anxiety. 
 
1              2              3              4              5 
 
20. There are factors contributing to my anxiety that I can learn to control. 
1              2              3              4              5 
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OCI-R 
The folowing statements refer to experiences that many people have in their everyday lives. 
Circle the number that best describes how much that experience has distressed or bothered you 
during the past month. The numbers refer to the folowing verbal labels: 
 
    Not at al       A litle   Moderately  A lot   Extremely 
0              1              2              3              4 
 
1. I have saved up so many things that they get in the way. 
 
0              1              2              3              4 
 
2. I check things more often than necessary.  
 
0              1              2              3              4 
 
3. I get upset if objects are not aranged properly.  
 
0              1              2              3              4 
 
4. I feel compeled to count while I am doing things.  
 
0              1              2              3              4 
 
5. I find it dificult to touch an object when I know it has been touched by strangers or certain 
people.  
 
0              1              2              3              4 
 
6. I find it dificult to control my own thoughts.  
 
0              1              2              3              4 
 
7. I colect things I don’t need.  
 
0              1              2              3              4 
 
8. I repeatedly check doors, windows, drawers, etc.  
 
0              1              2              3              4 
 
9. I get upset if others change the way I have aranged things.  
 
0              1              2              3              4 
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    Not at al       A litle   Moderately  A lot   Extremely 
0              1              2              3              4 
 
10. I feel I have to repeat certain numbers.  
 
0              1              2              3              4 
 
11. I sometimes have to wash or clean myself simply because I feel contaminated.  
 
0              1              2              3              4 
 
12. I am upset by unpleasant thoughts that come into my mind against my wil.  
 
0              1              2              3              4 
 
13. I avoid throwing things away because I am afraid I might need them later.  
 
0              1              2              3              4 
 
14. I repeatedly check gas and water taps and light switches after turning them of.  
 
0              1              2              3              4 
 
15. I need things to be aranged in a particular order.  
 
0              1              2              3              4 
 
16. I feel that there are good and bad numbers.  
 
0              1              2              3              4 
 
17. I wash my hands more often and longer than necessary.  
 
0              1              2              3              4 
 
18. I frequently get nasty thoughts and have dificulty in geting rid of them. 
 
0              1              2              3              4 
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SCMS 
Please read each of the folowing statements and rate how wel each statement describes you, 
using the folowing scale: 
 
    Very  Somewhat/mostly  A litle  A litle     Somewhat/mostly   Very 
 undescriptive   undescriptive   undescriptive   descriptive  descriptive     descriptive 
    of me      of me       of me        of me   of me         of me 
      0            1            2            3            4            5 
 
1. When I work toward something, it gets al my atention. 
 
      0            1            2            3            4            5 
 
2. The goals I achieve do not mean much to me. 
 
      0            1            2            3            4            5 
 
3. I become very aware of what I am doing when I am working towards a goal. 
 
      0            1             2            3            4            5 
 
4. I get myself through hard things by planning to enjoy myself afterwards. 
 
      0            1            2            3            4            5 
 
5. I know I can track my behaviour when working toward a goal. 
 
      0            1            2            3            4             5 
 
6. When I set important goals for myself, I usualy do not achieve them. 
 
      0            1            2            3            4            5 
 
7. When I do something right, I take time to enjoy the feeling. 
 
      0            1            2            3            4            5 
 
8. I pay close atention to my thoughts when I am working on something hard. 
 
      0            1            2            3            4            5 
 
9. I silently praise myself even when others do not praise me. 
 
      0            1            2            3            4            5 
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    Very  Somewhat/mostly  A litle  A litle     Somewhat/mostly   Very 
 undescriptive   undescriptive   undescriptive   descriptive  descriptive      descriptive 
    of me      of me       of me        of me   of me         of me 
      0            1            2            3            4             5 
 
10. I do not seem capable of making clear plans for most problems that come up in my life. 
 
      0            1            2            3            4            5 
 
11. I make sure to track my progress regularly when I am working on a goal. 
 
      0            1            2            3            4            5 
 
12. The standards I set for myself are unclear and make it hard for me to judge how I am doing 
on a task. 
 
      0            1            2            3            4            5 
 
13. I congratulate myself when I make some progress. 
 
      0            1            2            3            4            5 
 
14. I keep focused on tasks I need to do even if I do not like them. 
 
      0            1            2            3            4            5 
 
15. I have learned that it is useless to make plans. 
 
      0            1            2            3             4            5 
 
16. I give myself something special when I make some progress. 
 
      0            1            2            3            4            5 
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IDAS 
 
Below is a list of feelings, sensations, problems, and experiences that people sometimes have. Read each 
item to determine how wel it describes your recent feelings and experiences. Then select the option that 
best describes how much you have felt or experienced things this way during the past two weeks, 
including today. Use this scale when answering: 
___________________________________________________________________________ 
 1 2 3 4 5 
 Not at al A little bit Moderately Quite a bit Extremely 
__________________________________________________________________________ 
 
_____  1. I was proud of myself 
_____  2. I felt exhausted 
_____  3. I felt depressed 
_____  4. I felt inadequate 
_____  5. I slept less than usual 
_____  6. I felt fidgety, restless 
_____  7. I had thoughts of suicide 
_____  8. I slept more than usual 
_____  9. I hurt myself purposely 
_____ 10. I slept very poorly 
_____ 11. I blamed myself for things 
_____ 12. I had trouble faling asleep 
_____ 13. I felt discouraged about things 
_____ 14. I thought about my own death 
_____ 15. I thought about hurting myself 
_____ 16. I did not have much of an 
appetite 
_____ 17. I felt like eating less than usual 
_____ 18. I thought a lot about food 
_____ 19. I did not feel much like eating 
_____ 20. I ate when I wasn’t hungry 
_____ 21. I felt optimistic 
_____ 22. I ate more than usual 
_____ 23. I felt that I had accomplished a lot 
_____ 24. I looked forward to things with 
enjoyment 
_____ 25. I was furious 
_____ 26. I felt hopeful about the future 
_____ 27. I felt that I had a lot to look forward to 
_____ 28. I felt like breaking things 
_____ 29. I had disturbing thoughts of 
something bad that happened to me 
_____ 30. Litle things made me mad 
_____ 31. I felt enraged 
_____ 32. I had nightmares that reminded me 
of something bad that happened 
_____ 33. I lost my temper and yeled at people 
_____ 34. I felt like I had a lot of interesting 
things to do 
_____ 35. I felt like I had a lot of energy 
___________________________________________________________________________ 
 1 2 3 4 5 
 Not at al A little bit Moderately Quite a bit Extremely 
__________________________________________________________________________ 
 
 
_____ 36. I had memories of something 
scary that happened 
_____ 37. I felt self-conscious knowing that 
others were watching me 
_____ 38. I felt a pain in my chest 
_____ 39. I was worried about 
embarrassing myself socialy 
_____ 40. I felt dizzy or light headed 
_____ 41. I cut or burned myself on 
purpose  
_____ 42. I had litle interest in my usual 
hobbies or activities  
_____ 43. I thought that the world would be 
beter of without me 
_____ 44. I felt much worse in the morning 
than later in the day 
_____ 45. I felt drowsy, sleepy 
_____ 46. I woke up early and could not 
get back to sleep 
_____ 47. I had trouble concentrating 
_____ 48. I had trouble making up my 
mind 
_____ 49. I talked more slowly than usual 
_____ 50. I had trouble waking up in the 
morning 
 
 
 
_____ 51. I found myself worrying al the time 
_____ 52. I woke up frequently during the night 
_____ 53. It took a lot of efort for me to get 
going 
_____ 54. I woke up much earlier than usual 
_____ 55. I was trembling or shaking 
_____ 56. I became anxious in a crowded 
public seting 
_____ 57. I felt faint 
_____ 58. I found it dificult to make eye contact 
with people 
_____ 59. My heart was racing or pounding 
_____ 60. I got upset thinking about something 
bad that happened 
_____ 61. I found it dificult to talk with people I 
did not know wel 
_____ 62. I had a very dry mouth 
_____ 63. I was short of breath 
_____ 64. I felt like I was choking
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RCES________________________________________________________________________ 
We would like you to indicate below how much you believe, right now, that the treatment that 
was described to you wil help to reduce your anxiety. 
 
1. At this point, how logical does the therapy ofered to you seem? 
 
Not logical at al    Somewhat Logical     Very Logical 
1         2         3         4         5         6         7         8         9 
 
2. At this point, how successful do you think this treatment wil be in reducing your wory? 
 
Not at al useful    Somewhat Useful      Very Useful 
1         2         3         4         5         6         7         8         9 
 
3. How confident would you be in recommending this treatment to a friend who has similar 
problems? 
 
Not at al confident    Somewhat Confident        Very Confident 
1         2         3         4         5         6         7         8         9 
 
4. Over the next few weeks, how much worsening or improvement in your wory and anxiety 
symptoms do you think wil occur? 
 
Symptoms        No symptom        Symptoms 
becoming worse      change        improving 
-100%    -80%    -60%    -40%    -20%    0%   20%   40%   60%   80%   100% 
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RHCS  
 
On how many days in the next week do you plan to do the wory scheduling?  
 
0 days     1 day     2 days     3 days     4 days     5 days     6 days     7 days 
 
 
In the next week: 
How much actual time do you plan to spend doing the wory scheduling? 
 
    None       A litle     Some      Quite a   A whole 
                   bit       lot 
0              1              2              3              4 
 
 
In the next week: 
How much efort do you plan to put into the wory scheduling? 
 
    None       A litle     Some      Quite a   A whole 
                   bit       lot 
0              1              2              3              4 
 
 
How dificult to start or complete in the next week does the wory scheduling sound? 
 
    Not at       A litle   Somewhat       Quite    Extremely 
   al dificult      dificult        dificult      dificult    dificult 
0              1              2              3              4 
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Appendix D 
List of Counseling Services Available in Thunder Bay 
ULTRA-BRIEF TREATMENTS FOR GAD   216 
 
 
ULTRA-BRIEF TREATMENTS FOR GAD   217 
 
 
 
 
 
 
 
 
Appendix E 
Consent Form 
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Appendix F 
Contact Information Form 
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Appendix G 
Brief Cover Leter for Folow-ups  
and Debriefing Form 
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Appendix H 
The “Psychology Works” Fact Sheets: Generalized Anxiety Disorder 
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“Psychology Works” Facts Sheet: Generalized Anxiety Disorder 
 
What is generalized anxiety disorder (GAD)? 
If you have Generalized Anxiety Disorder you wil experience chronic, excessive, and 
uncontrolable wory, be on edge, be easily fatigued, have difficulty concentrating, feel iritable, 
experience muscle tension, and have problems sleeping. 
 
GAD is one of the most common anxiety disorders. Studies show that at least one out of every 
20 individuals wil sufer from GAD at some time in their life. It can be mild or it can contribute 
to unemployment and serious family and social problems. 
 
GAD can lead to other problems such as fear of meeting people (social phobia), severe panic 
atacks (panic disorder), and depression. If left untreated, those with GAD are at greater risk of 
developing medical problems such as heart disease, diabetes, and cancer. 
 
Proven psychological approaches to treat GAD 
There are a number of proven psychological therapies for GAD. They wil help you gain control 
over your wories, decrease your anxiety, and improve your quality of life. The therapies that 
have been shown to be most helpful are: 
• cognitive re-evaluation to help you corect thinking paterns which cause and increase 
wory; 
• problem-solving training to help you learn beter ways to solve everyday problems; 
• exposure to help you confront and control rather than avoid and be controled by fears; 
and 
• progressive relaxation to decrease your physical symptoms of anxiety such as rapid 
breathing and sore muscles. 
 
Research shows that psychological treatments are efective in treating GAD 
Psychological therapy is very efective in the treatment of GAD. In a recent Canadian study, 
77% of those receiving short-term psychotherapy (16 sessions of cognitive re-evaluation, 
problem-solving training, and exposure) remained GAD-free one year after treatment. 
The fact that you get beter and stay beter after psychological therapy is certainly an important 
consideration for those seeking help for anxiety-related problems. 
 
Where do I go for more information? 
For more information visit the folowing websites: 
• The Anxiety Disorders Association of Canada at htp:/www.anxietycanada.ca. 
• AnxietyBC at htp:/www.anxietybc.com. 
 
You can consult with a registered psychologist to find out if psychological interventions might 
be of help to you. For the names and coordinators of provincial and teritorial associations of 
psychology, please visit www.cpa.ca/public/whatisapsychologist/PTassociations/. The 
Canadian Register of Health Service Providers in Psychology also has a listing service and can 
be reached through htp:/www.crhspp.ca. 
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Appendix I 
Self-Report Questionnaires at Four-Week Folow-up 
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Background Information Questionnaire 
We would appreciate your responses to the folowing questions. 
 
1) Biological Sex:   Male      Female 
 
2) Age:  _________ 
 
3) Ethnicity:    Caucasian/White    Middle Eastern  
    African-Canadian/Black   East Indian  
    Native-Canadian/Aboriginal  Hispanic/Latino 
    Asian      Other  
 
4) What is your marital status? 
    Single     Dating  
Maried/common law   Divorced/separated   
 Widowed  
 
5) Are you pregnant?  Yes     No 
 
6) Do you have any children?  
 Yes     No 
Number of biological children _________ 
Number of step-children     _________ 
Number of adopted children  _________ 
 
7) Are you curently employed?  
    Ful Time     Part Time  
    Retired     No  
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8) Are you curently a student?   
Yes – Ful Time    Yes – Part Time 
No  
 
9) What is the highest level of education that you have achieved? 
    Doctoral degree    Colege diploma  
    Master’s degree   Some colege  
    Undergraduate degree  High school diploma 
    Some university   Some high school 
 
10) How many alcohol-containing beverages (1 shot of hard liquor = 1 botle of beer = 1 cooler 
= 1 glass of wine) have you consumed in the last week?    _________ 
 
11) How often do you drink alcohol-containing beverages in a normal month? 
Never     Once or twice        Once or twice     Three or four    Almost  
  a month     a week      times a week   every day 
 
  0            1                   2               3              4 
 
12) What percentage of the day did you spend worying on a typical day during the past week 
(0-100%):  ________ 
 
13) How many times did you wory on a typical day during the past week? 
Never     Once or twice        Three to five     Six to ten    Al day/  
  a day    times a day     times a day  continuously 
 
  0            1                   2               3              4 
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WAQ 
1. What things do you wory about most often? 
a) __________________________________ d) _________________________________ 
b) __________________________________ e) _________________________________ 
c) __________________________________ f) _________________________________ 
 
For the folowing items, please circle the coresponding number (0-8). 
 
2. Over the past week, have your wories seemed excessive or exaggerated? 
   Not at al                       Moderately                      Totaly 
   excessive                       excessive                       excessive 
 
      0       1       2       3       4       5       6       7       8 
3. Over the past week, how many days have you been bothered by excessive wory? 
                                  1 day                        
    Never                         out of 2                       Everyday 
 
      0       1       2       3       4       5       6       7       8 
4. Over the past week, did you have dificulty controling your wories? For example, when you 
start worying about something, did you have dificulty stopping? 
     No                          Moderate                       Extreme 
   dificulty                        dificulty                       dificulty 
 
      0       1       2       3       4       5       6       7       8 
5. Over the past week, to what extent have you been disturbed by the folowing sensations 
when you were woried or anxious? Rate each sensation by circling a number (0-8). 
a) Restlessness or feeling keyed up or on edge. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
b) Being easily fatigued. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
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For the folowing items, please circle the coresponding number (0-8). 
 
c) Dificulty concentrating or mind going blank. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
d) Iritability. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
e) Muscle tension. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
f) Sleep disturbance (dificulty faling or staying asleep, or restless unsatisfying sleep). 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
6. Over the past week, to what extent did wory or anxiety interfere with your life? For 
example, your work, social activities, family life, etc.? 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
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MWQ 
This questionnaire assesses thoughts and ideas about worying. Listed below are some thoughts 
that you may have about worying when you notice yourself worying. Indicate how often each 
thought occured over the past week by circling the appropriate number, using the scale below. 
 
 Never     Sometimes      Often   Almost always 
  1                 2                 3                 4 
 
WHEN I AM WORRYING I THINK: 
 
1. I am going crazy with worying. 
 
  1                 2                 3                 4 
 
2. My worying wil escalate and I’l cease to function. 
 
  1                 2                 3                 4 
 
3. I’m making myself il with wory. 
 
  1                 2                 3                 4 
 
4. I’m abnormal for worying. 
 
  1                 2                 3                 4 
 
5. My mind can’t take the worying. 
 
  1                 2                 3                 4 
 
6. I’m losing out in life because of worying. 
 
  1                 2                 3                 4 
 
7. My body can’t take the worying. 
 
  1                 2                 3                 4 
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PIM 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        true           true 
  1                 2                 3                 4 
 
1. Sometimes I let litle things bother me too much. 
 
  1                 2                 3                 4 
 
2. Sometimes I’l avoid someone I realy don’t like. 
 
  1                 2                 3                 4 
 
3. I sometimes complain too much. 
 
  1                 2                 3                 4 
 
4. Sometimes I’m too impatient. 
 
  1                 2                 3                 4 
 
5. I don’t take criticism very wel. 
 
  1                 2                 3                 4 
 
6. Sometimes I put things of until the last minute. 
 
  1                 2                 3                 4 
 
7. I sometimes make promises I can’t keep. 
 
  1                 2                 3                 4 
 
8. There have been times when I could have been more thoughtful than I was. 
 
  1                 2                 3                 4 
 
9. I rarely get in a bad mood. 
 
  1                 2                 3                 4 
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PSWQ 
Circle the number that describes how typical or characteristic each item is of you over the past 
week, using the folowing scale: 
 
  Not at al Typical         Somewhat Typical          Very Typical 
1              2              3              4              5 
 
1. If I don’t have enough time to do everything, I don’t wory about it. 
 
1              2              3              4              5 
 
2. My wories overwhelm me. 
 
1              2              3              4              5 
 
3. I don’t tend to wory about things. 
 
1              2              3              4              5 
 
4. Many situations make me wory. 
 
1              2              3              4              5 
 
5. I know I shouldn’t wory about things, but I just can’t help it. 
 
1              2              3              4              5 
 
6. When I’m under pressure, I wory a lot. 
 
1              2              3              4              5 
 
7. I am always worying about something. 
 
1              2              3              4              5 
 
8. I find it easy to dismiss worisome thoughts. 
 
1              2              3              4              5 
 
9. As soon as I finish one task, I start to wory about everything else I have to do. 
 
1              2              3              4              5 
 
10. I never wory about anything. 
 
1              2              3              4              5 
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  Not at al Typical         Somewhat Typical          Very Typical 
1              2              3              4              5 
 
11. When there is nothing more I can do about a concern, I don’t wory about it anymore. 
 
1              2              3              4              5 
 
12. I notice that I have been worying about things. 
 
1              2              3              4              5 
 
13. Once I start worying, I can’t stop. 
 
1              2              3              4              5 
 
14. I wory al the time. 
 
1              2              3              4              5 
 
15. I wory about projects until they are al done. 
 
1              2              3              4              5 
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CAQ 
People react diferently to certain types of thoughts. Using the folowing scale, please indicate to 
what extent each of the folowing statements is typical of the way that you respond to certain 
thoughts over the past week. Please circle the appropriate number (1 to 5). 
 
   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
1. There are things that I would rather not think about. 
 
1              2              3              4              5 
 
2. I avoid certain situations that lead me to pay atention to things I don't want to think about. 
 
1              2              3              4              5 
 
3. I replace threatening mental images with things I say to myself in my mind. 
 
1              2              3              4              5 
 
4. I think about things that concern me as if they were occuring to someone else. 
 
1              2              3              4              5 
 
5. I have thoughts that I try to avoid. 
 
1              2              3              4              5 
 
6. I try not to think about the most upseting aspects of some situations so as not to be too afraid. 
 
1              2              3              4              5 
 
7. I sometimes avoid objects that can trigger upseting thoughts. 
 
1              2              3              4              5 
 
8. I distract myself to avoid thinking about certain disturbing subjects. 
 
1              2              3              4              5 
 
9. I avoid people who make me think about things that I do not want to think about. 
 
1              2              3              4              5 
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   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
10. I often do things to distract myself from my thoughts. 
 
1              2              3              4              5 
 
11. I think about trivial details so as not to think about important subjects that wory me. 
 
1              2              3              4              5 
 
12. Sometimes I throw myself into an activity so as not to think about certain things. 
 
1              2              3              4              5 
 
13. To avoid thinking about subjects that upset me, I force myself to think about something else. 
 
1              2              3              4              5 
 
14. There are things I try not to think about. 
 
1              2              3              4              5 
 
15. I keep saying things to myself in my head to avoid visualizing scenarios (a series of mental 
images) that frighten me. 
 
1              2              3              4              5 
 
16. Sometimes I avoid places that make me think about things I would prefer not to think about. 
 
1              2              3              4              5 
 
17. I think about past events so as not to think about future events that make me feel insecure. 
 
1              2              3              4              5 
 
18. I avoid actions that remind me of things I do not want to think about. 
 
1              2              3              4              5 
 
19. When I have mental images that are upseting, I say things to myself in my head to replace 
the images. 
 
1              2              3              4              5 
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   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
20. I think about many litle things so as not to think about more important maters. 
 
1              2              3              4              5 
 
21. Sometimes I keep myself occupied just to prevent thoughts from popping up in my mind. 
 
1              2              3              4              5 
 
22. I avoid situations that involve people who make me think about unpleasant things. 
 
1              2              3              4              5 
 
23. Rather than having images of upseting events form in my mind, I try to describe the events 
using an internal monologue (things that I say to myself in my head). 
 
1              2              3              4              5 
 
24. I push away the mental images related to a threatening situation by trying to describe the 
situation using an internal monologue. 
 
1              2              3              4              5 
 
25. I think about things that are worying other people rather than thinking about my own 
wories. 
 
1              2              3              4              5 
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RGHAS_______________________________________________________________________ 
Listed below are various methods that people use to get help for an anxiety problem. Check al of the 
methods that you have used in the past week. If you check an item, please indicate the number of times 
you have used this method in the past week. If none apply, leave it blank.  
 
___ I have read a book or multiple books on how to solve or manage my anxiety  
 Number of occasions: ______ 
 
___ I have searched the internet for resources on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have watched tapes or videos on my own on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have exercised on my own or as part of a group (e.g. yoga, Tai Chi, walking, biking, weight lifting, 
swimming, etc.) to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have discussed on one or more occasions how to solve or manage my anxiety with a friend, family 
member, pastor, or work coleague in order to get advice on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have been involved with a "chat-group" or other internet service to help me solve or manage my 
anxiety 
 Number of occasions: ______ 
 
___ I have gone on one or more occasions to a self-help or support group to help me solve or manage my 
anxiety 
 Number of occasions: ______ 
 
___ I have atended a class/seminar or have atended multiple classes/seminars (e.g. stress management, 
relaxation, meditation, etc.) to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have discussed how to solve or manage my anxiety with my family physician or other primary care 
provider (i.e., registered nurse, etc.) 
 Number of occasions: ______ 
 
___ I have seen one or more professional counselors or therapists on one or more occasions to help me 
how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have been hospitalized for to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ Other (please describe): _______________________________________________ 
 Number of occasions: ______ 
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BFNE 
Read each of the folowing statements carefuly and indicate how characteristic it is of you over 
the past week according to the folowing scale. 
 
    Not at al       Slightly   Moderately  Very   Extremely 
   characteristic   characteristic  characteristic    characteristic characteristic 
     of me   of me     of me  of me    of me 
1              2              3              4              5 
 
1. I wory about what other people wil think of me even when I know it doesn’t make any 
diference. 
 
1              2              3              4              5 
 
2. I am unconcerned even if I know people are forming an unfavourable impression of me. 
 
1              2              3              4              5 
 
3. I am frequently afraid of other people noticing my shortcomings. 
 
1              2              3              4              5 
 
4. I rarely wory about what kind of impression I am making on someone. 
 
1              2              3              4              5 
 
5. I am afraid that others wil not approve of me. 
 
1              2              3              4              5 
 
6. I am afraid that other people wil find fault with me. 
 
1              2              3              4              5 
 
7. Other people’s opinions of me do not bother me. 
 
1              2              3              4              5 
 
8. When I am talking to someone, I wory about what they may be thinking of me. 
 
1              2              3              4              5 
 
9. I am usualy woried about what kind of impression I make. 
 
1              2              3              4              5 
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    Not at al       Slightly   Moderately  Very   Extremely 
   characteristic   characteristic  characteristic    characteristic characteristic 
     of me   of me     of me  of me    of me 
1              2              3              4              5 
 
10. If I know someone is judging me, it has litle efect on me. 
 
1              2              3              4              5 
 
11. Sometimes I think I am too concerned with what other people think of me. 
 
1              2              3              4              5 
 
12. I often wory that I wil say or do the wrong things. 
 
1              2              3              4              5 
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INF 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        True           True 
  1                 2                 3                 4 
 
1. My favourite poet is Raymond Kertezc. 
 
  1                 2                 3                 4 
 
2. Sometimes I get ads in the mail that I don’t realy want. 
 
  1                 2                 3                 4 
 
3. My favourite sports event on television is the high jump. 
 
  1                 2                 3                 4 
 
4. Most people would rather win than lose. 
 
  1                 2                 3                 4 
 
5. My favourite hobbies are archery and stamp-colecting. 
 
  1                 2                 3                 4 
 
6. I don’t like to have to buy things that are overpriced. 
 
  1                 2                 3                 4 
 
7. Most people look forward to a trip to the dentist. 
 
  1                 2                 3                 4 
 
8. In my free time I might read, watch TV, or just relax. 
 
  1                 2                 3                 4 
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MCQ-30 
This questionnaire is concerned with beliefs people have about their thinking. Listed below are a 
number of beliefs that people have expressed. Please read each item and say how much you 
agree with it in general over the past week by circling the appropriate number. Please respond 
to al the items, there are no right or wrong answers. 
 
 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
1. Worying helps me to avoid problems in the future 
 
  1                 2                 3                 4 
 
2. My worying is dangerous for me 
 
  1                 2                 3                 4 
 
3. I think a lot about my thoughts 
 
  1                 2                 3                 4 
 
4. I could make myself sick with worying 
 
  1                 2                 3                 4 
 
5. I am aware of the way my mind works when I am thinking through a problem 
 
  1                 2                 3                 4 
 
6. If I did not control a worying thought, and then it happened, it would be my fault 
 
  1                 2                 3                 4 
 
7. I need to wory in order to remain organized 
 
  1                 2                 3                 4 
 
8. I have litle confidence in my memory for words and names 
 
  1                 2                 3                 4 
 
9. My worying thoughts persist, no mater how I try to stop them 
 
  1                 2                 3                 4 
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 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
10. Worying helps me to get things sorted out in my mind 
 
  1                 2                 3                 4 
 
11. I cannot ignore my worying thoughts 
 
  1                 2                 3                 4 
 
12. I monitor my thoughts 
 
  1                 2                 3                 4 
 
13. I should be in control of my thoughts al of the time 
 
  1                 2                 3                 4 
 
14. My memory can mislead me at times 
 
  1                 2                 3                 4 
 
15. My worying could make me go mad 
 
  1                 2                 3                 4 
 
16. I am constantly aware of my thinking 
 
  1                 2                 3                 4 
 
17. I have a poor memory 
 
  1                 2                 3                 4 
 
18. I pay close atention to the way my mind works 
 
  1                 2                 3                 4 
 
19. Worying helps me cope 
 
  1                 2                 3                 4 
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 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
20. Not being able to control my thoughts is a sign of weakness 
 
  1                 2                 3                 4 
 
21. When I start worying, I cannot stop 
 
  1                 2                 3                 4 
 
22. I wil be punished for not controling certain thoughts 
 
  1                 2                 3                 4 
 
23. Worying helps me to solve problems 
 
  1                 2                 3                 4 
 
24. I have litle confidence in my memory for places 
 
  1                 2                 3                 4 
 
25. It is bad to think certain thoughts 
 
  1                 2                 3                 4 
 
26. I do not trust my memory 
 
  1                 2                 3                 4 
 
27. If I could not control my thoughts, I would not be able to function 
 
  1                 2                 3                 4 
 
28. I need to wory, in order to work wel 
 
  1                 2                 3                 4 
 
29. I have litle confidence in my memory for actions 
 
  1                 2                 3                 4 
 
30. I constantly examine my thoughts 
  1                 2                 3                 4 
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MRTS 
Please select the likelihood that you would engage in the folowing treatments, if they were made 
available to you: 
 
  Not very likely       Not sure     Very Likely 
1         2         3         4         5         6         7 
 
1. I would atend a 12-week group psychotherapy/counseling program: 
 
1         2         3         4         5          6         7 
 
2. I would atend a 12-week individual psychotherapy/counseling program: 
 
1         2         3         4         5         6         7 
 
3. I would atend a 12-week support group (i.e., Mental Health Peer Support Group): 
 
1         2         3         4         5         6         7 
 
4. I would atend a 12-week psychotherapy/counseling seminar (i.e., classes) program: 
 
1         2         3         4         5         6         7 
 
5. I would use a 12-week self-help manual: 
 
1         2         3         4         5          6         7 
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PANAS 
This scale consists of a number of words that describe diferent feelings and emotions. Read 
each item and then choose the appropriate answer by circling the number under the word. 
Indicate to what extent you have felt this way during the past week. Use the folowing scale to 
record your answers. 
 
  Very slightly   A          Quite 
  or not at al        litle        Moderately         a bit       Extremely 
1              2              3              4              5 
 
1. Interested 
 
1              2              3              4              5 
 
2. Iritable 
 
1              2              3              4              5 
 
3. Distressed 
 
1              2              3              4              5 
 
4. Alert 
 
1              2              3              4              5 
 
5. Excited 
 
1              2              3              4              5 
 
6. Ashamed 
 
1              2              3              4              5 
 
7. Upset 
 
1              2              3              4              5 
 
8. Inspired 
 
1              2              3              4              5 
 
9. Strong 
 
1              2              3              4              5 
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  Very slightly   A          Quite 
  or not at al        litle        Moderately         a bit       Extremely 
1              2              3              4              5 
 
10. Nervous 
 
1              2              3              4              5 
 
11. Guilty 
 
1              2              3              4              5 
 
12. Determined 
 
1              2              3              4              5 
 
13. Scared 
 
1              2              3              4              5 
 
14. Atentive 
 
1              2              3              4              5 
 
15. Hostile 
 
1              2              3              4              5 
 
16. Jitery 
 
1              2              3              4              5 
 
17. Enthusiastic 
 
1              2              3              4              5 
 
18. Active 
 
1              2              3              4              5 
 
19. Proud 
 
1              2              3              4              5 
 
20. Afraid 
1              2              3              4              5 
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PMUS 
 
1. Are you currently taking any medications to treat anxiety or wory?  Yes   No  
 
2. Compared to when you first began the study, how has your medication use changed: 
 
Greatly decreased      No change in        Greatly increased 
the frequency/     the frequency/     the frequency/ 
dose/amount         dose/amount      dose/amount 
 
-3  -2  -1  0  +1  +2  +3 
 
3. Please list any medications you are curently taking to treat anxiety, wory, depression, or 
other emotional issue: 
 
Medication A:_____________________________ Dose per week:________________________ 
 
Medication B:_____________________________ Dose per week:_______________________ 
 
Medication C:_____________________________ Dose per week:________________________ 
 
Medication D:_____________________________ Dose per week:________________________ 
 
Medication E:_____________________________ Dose per week:_______________________ 
 
Medication F:_____________________________ Dose per week:________________________ 
 
Medication G:_____________________________ Dose per week:________________________ 
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NIM 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        True           True 
  1                 2                 3                 4 
 
1. Sometimes I cannot remember who I am. 
 
  1                 2                 3                 4 
 
2. I have visions in which I see myself forced to commit crimes. 
 
  1                 2                 3                 4 
 
3. Since the day I was born, I was destined to be unhappy. 
 
  1                 2                 3                 4 
 
4. I think I have three or four completely diferent personalities inside of me. 
 
  1                 2                 3                 4 
 
5. People don’t understand how much I sufer. 
 
  1                 2                 3                 4 
 
6. Every once in a while I totaly lose my memory. 
 
  1                 2                 3                 4 
 
7. Sometimes my vision is only in black and white. 
 
  1                 2                 3                 4 
 
8. I don’t have any good memories from my childhood. 
 
  1                 2                 3                 4 
 
9. I have severe psychological problems that began very suddenly 
 
  1                 2                 3                 4 
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SHAI 
Each question is this section consists of a group of four statements. Please read each group of 
statements carefuly and then select the one which best describes your feelings, over the past 
week. Identify the statement by circling the leter next to the statement. It may be that more than 
one statement applies, in which case, please circle any that are applicable. 
 
1.  (a) I do not wory about my health. 
(b) I occasionaly wory about my health. 
(c) I spend much of my time worying about my health. 
(d) I spend most of my time worying about my health. 
 
2. (a) I notice aches/pains less than most other people (of my age). 
(b) I notice aches/pains as much as most other people (of my age). 
(c) I notice aches/pains more than most other people (of my age). 
(d) I am aware of aches/pains in my body al the time. 
 
3.  (a) As a rule I am not aware of bodily sensations or changes. 
(b) Sometimes I am aware of bodily sensations or changes. 
(c) I am often aware of bodily sensations or changes. 
(d) I am constantly aware of bodily sensations or changes. 
 
4.  (a) Resisting thoughts of ilness is never a problem. 
(b) Most of the time I can resist thoughts of ilness. 
(c) I try to resist thoughts of ilness but am often unable to do so. 
(d) Thoughts of ilness are so strong that I no longer even try to resist them. 
 
5.  (a) As a rule I am not afraid that I have a serious ilness. 
(b) I am sometimes afraid that I have a serious ilness. 
(c) I am often afraid that I have a serious ilness. 
(d) I am always afraid that I have a serious ilness. 
 
6.  (a) I do not have images (mental pictures) of myself being il. 
(b) I occasionaly have images of myself being il. 
(c) I frequently have images of myself being il. 
(d) I constantly have images of myself being il. 
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7.  (a) I do not have any dificulty taking my mind of thoughts about my health. 
(b) I sometimes have dificulty taking my mind of thoughts about my health. 
(c) I often have dificulty in taking my mind of thoughts about my health. 
(d) Nothing can take my mind of thoughts about my health. 
 
8.  (a) I am lastingly relieved if my doctor tels me there is nothing wrong. 
(b) I am initialy relieved but the wories sometimes return later. 
(c) I am initialy relieved but the wories always return later. 
(d) I am not relieved if my doctor tels me there is nothing wrong. 
 
9.  (a) If I hear about an ilness I never think I have it myself. 
(b) If I hear about an ilness I sometimes think I have it myself. 
(c) If I hear about an ilness I often think I have it myself. 
(d) If I hear about an ilness I always think I have it myself. 
 
10. (a) If I have a bodily sensation or change I rarely wonder what it means. 
(b) If I have a bodily sensation or change I often wonder what it means. 
(c) If I have a bodily sensation or change I always wonder what it means. 
(d) If I have a bodily sensation or change I must know what it means. 
 
11.  (a) I usualy feel at very low risk for developing a serious ilness. 
(b) I usualy feel at fairly low risk for developing a serious ilness. 
(c) I usualy feel at moderate risk for developing a serious ilness. 
(d) I usualy feel at high risk for developing a serious ilness. 
 
12.  (a) I never think I have a serious ilness. 
(b) I sometimes think I have a serious ilness. 
(c) I often think I have a serious ilness. 
(d) I usualy think that I am seriously il. 
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13.  (a) If I notice an unexplained bodily sensation I don't find it dificult to think about other 
things. 
(b) If I notice an unexplained bodily sensation I sometimes find it dificult to think about 
other things. 
(c) If I notice an unexplained bodily sensation I often find it dificult to think about other 
things. 
(d) If I notice an unexplained bodily sensation I always find it dificult to think about 
other things. 
 
14.  (a) My family/friends would say I do not wory enough about my health. 
(b) My family/friends would say I have a normal atitude to my health. 
(c) My family/friends would say I wory too much about my health. 
(d) My family/friends would say I am a hypochondriac. 
 
For the folowing questions, please think about what it might be like if you had a serious ilness 
of a type which particularly concerns you (such as heart disease, cancer, multiple sclerosis and so 
on). Obviously it may not be possible to know for definite what it would be like; please give 
your best estimate of what you think might happen, basing your estimate on what you know 
about yourself and serious ilness in general. 
 
15.  (a) If I had a serious ilness I would stil be able to enjoy things in my life quite a lot. 
(b) If I had a serious ilness I would stil be able to enjoy things in my life a litle. 
(c) If I had a serious ilness I would be almost completely unable to enjoy things in my 
life. 
(d) If I had a serious ilness I would be completely unable to enjoy life at al. 
 
16.  (a) If I developed a serious ilness there is a good chance that modern medicine would be 
able to cure me. 
(b) If I developed a serious ilness there is a moderate chance that modern medicine 
would be able to cure me. 
(c) If I developed a serious ilness there is a very smal chance that modern medicine 
would be able to cure me. 
(d) If I developed a serious ilness there is no chance that modern medicine would be able 
to cure me. 
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17.  (a) A serious ilness would ruin some aspects of my life. 
(b) A serious ilness would ruin many aspects of my life. 
(c) A serious ilness would ruin almost every aspect of my life. 
(d) A serious ilness would ruin every aspect of my life. 
 
18.  (a) If I had a serious ilness I would not feel that I had lost my dignity. 
(b) If I had a serious ilness I would feel that I had lost a litle of my dignity. 
(c) If I had a serious ilness I would feel that I had lost quite a lot of my dignity. 
(d) If I had a serious ilness I would feel that I had totaly lost my dignity. 
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ACES 
Listed below are a number of statements concerning beliefs about change. Please read each item 
carefuly, and circle one of the five options that best reflect how you feel about the statement 
right now. 
 
Strongly Disagree   Disagree   Undecided      Agree      Strongly Agree 
1              2              3              4              5 
 
1. I feel pessimistic that my anxiety problems could ever change for the beter. 
 
1              2              3              4              5 
 
2. Even though I try, nothing seems to help with my anxiety. 
 
1              2              3              4              5 
 
3. It would be extremely dificult or impossible to solve my problems with anxiety. 
 
1              2              3              4              5 
 
4. I have had some positive experiences with being able to control my anxiety through talking 
positively to myself. 
 
1              2              3              4              5 
 
5. My problems with anxiety are too severe to benefit from treatment. 
 
1              2              3              4              5 
 
6. Self-help methods may help others control their anxiety but they won’t work for me. 
 
1              2              3              4              5 
 
7. I don’t believe I wil ever feel truly relaxed and not woried. 
 
1              2              3              4              5 
 
8. Facing my fears has never helped me to reduce my anxiety. 
 
1              2              3              4              5 
 
9. When I force myself to do something that scares me, often it’s not as bad as I thought. 
 
1              2              3              4              5 
 
 
ULTRA-BRIEF TREATMENTS FOR GAD   257 
 
Strongly Disagree   Disagree   Undecided      Agree      Strongly Agree 
1              2              3              4              5 
 
10. I have had some success in reducing my anxiety. 
 
1              2              3              4              5 
 
11. There is very litle anyone could do to help me solve my anxiety problems. 
 
1              2              3              4              5 
 
12. Even when I try to talk positively to myself, it doesn’t help my anxiety. 
 
1              2              3              4              5 
 
13. Positive thinking is helpful to me in managing my anxiety. 
 
1              2              3              4              5 
 
14. There is no solution to my anxiety problems. 
 
1              2              3              4              5 
 
15. I am optimistic that my anxiety can change for the beter. 
 
1              2              3              4              5 
 
16. I have found that I can reduce my anxiety by teling myself to relax or by using relaxation 
exercises. 
 
1              2              3              4              5 
 
17. I’l never be able to control my anxiety and wory. 
 
1              2              3              4              5 
 
18. I believe it’s quite possible for me to feel less woried and more relaxed. 
 
1              2              3              4              5 
 
19. If I work hard, I can have a positive impact on my problems with anxiety. 
 
1              2              3              4              5 
 
20. There are factors contributing to my anxiety that I can learn to control. 
1              2              3              4              5 
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OCI-R 
The folowing statements refer to experiences that many people have in their everyday lives. 
Circle the number that best describes how much that experience has distressed or bothered you 
during the past week. The numbers refer to the folowing verbal labels: 
 
    Not at al       A litle   Moderately  A lot   Extremely 
0              1              2              3              4 
 
1. I have saved up so many things that they get in the way. 
 
0              1              2              3              4 
 
2. I check things more often than necessary.  
 
0              1              2              3              4 
 
3. I get upset if objects are not aranged properly.  
 
0              1              2              3              4 
 
4. I feel compeled to count while I am doing things.  
 
0              1              2              3              4 
 
5. I find it dificult to touch an object when I know it has been touched by strangers or certain 
people.  
 
0              1              2              3              4 
 
6. I find it dificult to control my own thoughts.  
 
0              1              2              3              4 
 
7. I colect things I don’t need.  
 
0              1              2              3              4 
 
8. I repeatedly check doors, windows, drawers, etc.  
 
0              1              2              3              4 
 
9. I get upset if others change the way I have aranged things.  
 
0              1              2              3              4 
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    Not at al       A litle   Moderately  A lot   Extremely 
0              1              2              3              4 
 
10. I feel I have to repeat certain numbers.  
 
0              1              2              3              4 
 
11. I sometimes have to wash or clean myself simply because I feel contaminated.  
 
0              1              2              3              4 
 
12. I am upset by unpleasant thoughts that come into my mind against my wil.  
 
0              1              2              3              4 
 
13. I avoid throwing things away because I am afraid I might need them later.  
 
0              1              2              3              4 
 
14. I repeatedly check gas and water taps and light switches after turning them of.  
 
0              1              2              3              4 
 
15. I need things to be aranged in a particular order.  
 
0              1              2              3              4 
 
16. I feel that there are good and bad numbers.  
 
0              1              2              3              4 
 
17. I wash my hands more often and longer than necessary.  
 
0              1              2              3              4 
 
18. I frequently get nasty thoughts and have dificulty in geting rid of them.  
 
0              1              2              3              4 
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SCMS 
Please read each of the folowing statements and rate how wel each statement describes you 
over the past week, using the folowing scale: 
 
    Very  Somewhat/mostly  A litle  A litle     Somewhat/mostly   Very 
 undescriptive   undescriptive   undescriptive   descriptive  descriptive     descriptive 
    of me      of me       of me        of me   of me         of me 
      0            1            2            3            4            5 
 
1. When I work toward something, it gets al my atention. 
 
      0            1            2            3            4            5 
 
2. The goals I achieve do not mean much to me. 
 
      0            1            2            3            4            5 
 
3. I become very aware of what I am doing when I am working towards a goal. 
 
      0            1             2            3            4            5 
 
4. I get myself through hard things by planning to enjoy myself afterwards. 
 
      0            1            2            3            4            5 
 
5. I know I can track my behaviour when working toward a goal. 
 
      0            1            2            3            4             5 
 
6. When I set important goals for myself, I usualy do not achieve them. 
 
      0            1            2            3            4            5 
 
7. When I do something right, I take time to enjoy the feeling. 
 
      0            1            2            3            4            5 
 
8. I pay close atention to my thoughts when I am working on something hard. 
 
      0            1            2            3            4            5 
 
9. I silently praise myself even when others do not praise me. 
 
      0            1            2            3            4            5 
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    Very  Somewhat/mostly  A litle  A litle     Somewhat/mostly   Very 
 undescriptive   undescriptive   undescriptive   descriptive  descriptive     descriptive 
    of me      of me       of me        of me   of me         of me 
      0            1            2             3            4            5 
 
10. I do not seem capable of making clear plans for most problems that come up in my life. 
 
      0            1            2            3             4            5 
 
11. I make sure to track my progress regularly when I am working on a goal. 
 
      0            1            2            3            4            5 
 
12. The standards I set for myself are unclear and make it hard for me to judge how I am doing 
on a task. 
 
      0            1            2            3            4            5 
 
13. I congratulate myself when I make some progress. 
 
      0            1            2            3            4            5 
 
14. I keep focused on tasks I need to do even if I do not like them. 
 
      0            1            2            3            4            5 
 
15. I have learned that it is useless to make plans. 
 
      0            1            2             3            4            5 
 
16. I give myself something special when I make some progress. 
 
      0            1            2            3            4            5 
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IDAS 
 
Below is a list of feelings, sensations, problems, and experiences that people sometimes have. Read each 
item to determine how wel it describes your recent feelings and experiences. Then select the option that 
best describes how much you have felt or experienced things this way during the past week, including 
today. Use this scale when answering: 
_________________________________________________________________________ 
 1 2 3 4 5 
 Not at al A little bit Moderately Quite a bit Extremely 
_________________________________________________________________________ 
 
_____  1. I was proud of myself 
_____  2. I felt exhausted 
_____  3. I felt depressed 
_____  4. I felt inadequate 
_____  5. I slept less than usual 
_____  6. I felt fidgety, restless 
_____  7. I had thoughts of suicide 
_____  8. I slept more than usual 
_____  9. I hurt myself purposely 
_____ 10. I slept very poorly 
_____ 11. I blamed myself for things 
_____ 12. I had trouble faling asleep 
_____ 13. I felt discouraged about things 
_____ 14. I thought about my own death 
_____ 15. I thought about hurting myself 
_____ 16. I did not have much of an 
appetite 
_____ 17. I felt like eating less than usual 
_____ 18. I thought a lot about food 
_____ 19. I did not feel much like eating 
_____ 20. I ate when I wasn’t hungry 
_____ 21. I felt optimistic 
_____ 22. I ate more than usual 
_____ 23. I felt that I had accomplished a lot 
_____ 24. I looked forward to things with 
enjoyment 
_____ 25. I was furious 
_____ 26. I felt hopeful about the future 
_____ 27. I felt that I had a lot to look forward to 
_____ 28. I felt like breaking things 
_____ 29. I had disturbing thoughts of 
something bad that happened to me 
_____ 30. Litle things made me mad 
_____ 31. I felt enraged 
_____ 32. I had nightmares that reminded me 
of something bad that happened 
_____ 33. I lost my temper and yeled at people 
_____ 34. I felt like I had a lot of interesting 
things to do 
_____ 35. I felt like I had a lot of energy 
_____ 36. I had memories of something scary 
that happened 
________________________________________________________________________ 
 1 2 3 4 5 
 Not at al A little bit Moderately Quite a bit Extremely 
________________________________________________________________________ 
 
 
_____ 37. I felt self-conscious knowing that 
others were watching me 
_____ 38. I felt a pain in my chest 
_____ 39. I was worried about 
embarrassing myself socialy 
_____ 40. I felt dizzy or light headed 
_____ 41. I cut or burned myself on 
purpose  
_____ 42. I had litle interest in my usual 
hobbies or activities  
_____ 43. I thought that the world would be 
beter of without me 
_____ 44. I felt much worse in the morning 
than later in the day 
_____ 45. I felt drowsy, sleepy 
_____ 46. I woke up early and could not 
get back to sleep 
_____ 47. I had trouble concentrating 
_____ 48. I had trouble making up my 
mind 
_____ 49. I talked more slowly than usual 
_____ 50. I had trouble waking up in the 
morning 
 
 
 
 
_____ 51. I found myself worrying al the time 
_____ 52. I woke up frequently during the night 
_____ 53. It took a lot of efort for me to get 
going 
_____ 54. I woke up much earlier than usual 
_____ 55. I was trembling or shaking 
_____ 56. I became anxious in a crowded 
public seting 
_____ 57. I felt faint 
_____ 58. I found it dificult to make eye contact 
with people 
_____ 59. My heart was racing or pounding 
_____ 60. I got upset thinking about something 
bad that happened 
_____ 61. I found it dificult to talk with people I 
did not know wel 
_____ 62. I had a very dry mouth 
_____ 63. I was short of breath 
_____ 64. I felt like I was choking
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RCES________________________________________________________________________ 
We would like you to indicate below how much you believe, right now, that the treatment that 
was described to you has helped to reduce your anxiety. 
 
1. At this point, how logical does the therapy ofered to you seem? 
 
Not logical at al    Somewhat Logical     Very Logical 
1         2         3         4         5         6         7         8         9 
 
2. At this point, how successful do you think this treatment has been in reducing your wory? 
 
Not at al useful    Somewhat Useful      Very Useful 
1         2         3         4         5         6         7         8         9 
 
3. How confident would you be in recommending this treatment to a friend who has similar 
problems? 
 
Not at al confident    Somewhat Confident        Very Confident 
1         2         3         4         5         6         7         8         9 
 
4. Compared to when you first began the study, how much worsening or improvement in your 
wory and anxiety symptoms did you experience? 
 
Symptoms        No symptom        Symptoms 
becoming worse      change        improving 
-100%    -80%    -60%    -40%    -20%    0%   20%   40%   60%   80%   100% 
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RHCS  
 
On how many days in the last week did you use the wory scheduling? 
 
0 days     1 day     2 days     3 days     4 days     5 days     6 days     7 days 
 
 
In the last week: 
How much actual time did you spend doing the wory scheduling? 
 
    None       A litle     Some      Quite a   A whole 
                   bit       lot 
0              1              2              3              4 
 
 
In the last week: 
How much efort did you put into the wory scheduling? 
 
    None       A litle     Some      Quite a   A whole 
                   bit       lot 
0              1              2              3              4 
 
 
How dificult to start or complete in the last week was the wory scheduling? 
 
    Not at       A litle   Somewhat       Quite    Extremely 
   al dificult      dificult        dificult      dificult    dificult 
0              1              2              3              4 
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Appendix J 
Self-Report Questionnaires at Four-Month Post-Treatment 
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Background Information Questionnaire 
We would appreciate your responses to the folowing questions. 
 
1) Biological Sex:   Male      Female 
 
2) Age:  _________ 
 
3) Ethnicity:    Caucasian/White    Middle Eastern  
    African-Canadian/Black   East Indian  
    Native-Canadian/Aboriginal  Hispanic/Latino 
    Asian      Other  
 
4) What is your marital status? 
    Single     Dating 
Maried/common law   Divorced/separated   
 Widowed  
 
5) Are you pregnant?  Yes     No 
 
6) Do you have any children?  
 Yes     No 
Number of biological children _________ 
Number of step-children     _________ 
Number of adopted children  _________ 
 
7) Are you curently employed?  
    Ful Time     Part Time  
    Retired     No  
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8) Are you curently a student?   
Yes – Ful Time    Yes – Part Time 
No  
 
9) What is the highest level of education that you have achieved? 
    Doctoral degree   Colege diploma  
    Master’s degree   Some colege  
    Undergraduate degree  High school diploma 
    Some university   Some high school 
 
10) How many alcohol-containing beverages (1 shot of hard liquor = 1 botle of beer = 1 cooler 
= 1 glass of wine) have you consumed in the last week?    _________ 
 
11) How often do you drink alcohol-containing beverages in a normal month? 
Never     Once or twice        Once or twice     Three or four    Almost  
  a month     a week      times a week   every day 
 
  0            1                   2               3              4 
 
12) What percentage of the day did you spend worying on a typical day during the past week 
(0-100%):  ________ 
 
13) How many times did you wory on a typical day during the past week? 
Never     Once or twice        Three to five     Six to ten    Al day/  
  a day    times a day     times a day  continuously 
 
  0            1                   2               3              4 
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WAQ 
1. What things do you wory about most often? 
a) __________________________________ d) _________________________________ 
b) __________________________________ e) _________________________________ 
c) __________________________________ f) _________________________________ 
 
For the folowing items, please circle the coresponding number (0-8). 
 
2. Over the past month, have your wories seemed excessive or exaggerated? 
   Not at al                       Moderately                      Totaly 
   excessive                       excessive                       excessive 
 
      0       1       2       3       4       5       6       7       8 
3. Over the past month, how many days have you been bothered by excessive wory? 
                                  1 day                        
    Never                         out of 2                       Everyday 
 
      0       1       2       3       4       5       6       7       8 
4. Over the past month, did you have dificulty controling your wories? For example, when 
you start worying about something, did you have dificulty stopping? 
     No                          Moderate                       Extreme 
   dificulty                       dificulty                       dificulty 
 
      0       1       2       3       4       5       6       7       8 
5. Over the past month, to what extent have you been disturbed by the folowing sensations 
when you were woried or anxious? Rate each sensation by circling a number (0-8). 
a) Restlessness or feeling keyed up or on edge. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
b) Being easily fatigued. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
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For the folowing items, please circle the coresponding number (0-8). 
 
c) Dificulty concentrating or mind going blank. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
d) Iritability. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
e) Muscle tension. 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
f) Sleep disturbance (dificulty faling or staying asleep, or restless unsatisfying sleep). 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
6. Over the past month, to what extent did wory or anxiety interfere with your life? For 
example, your work, social activities, family life, etc.? 
               Very 
   Not at al                       Moderately                      Severely 
 
      0       1       2       3       4       5       6       7       8 
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MWQ 
This questionnaire assesses thoughts and ideas about worying. Listed below are some thoughts 
that you may have about worying when you notice yourself worying. Indicate how often each 
thought occured over the past month by circling the appropriate number, using the scale 
below. 
 
 Never     Sometimes      Often   Almost always 
  1                 2                 3                 4 
 
WHEN I AM WORRYING I THINK: 
 
1. I am going crazy with worying. 
 
  1                 2                 3                 4 
 
2. My worying wil escalate and I’l cease to function. 
 
  1                 2                 3                 4 
 
3. I’m making myself il with wory. 
 
  1                 2                 3                 4 
 
4. I’m abnormal for worying. 
 
  1                 2                 3                 4 
 
5. My mind can’t take the worying. 
 
  1                 2                 3                 4 
 
6. I’m losing out in life because of worying. 
 
  1                 2                 3                 4 
 
7. My body can’t take the worying. 
 
  1                 2                 3                 4 
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PIM 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        true           true 
  1                 2                 3                 4 
 
1. Sometimes I let litle things bother me too much. 
 
  1                 2                 3                 4 
 
2. Sometimes I’l avoid someone I realy don’t like. 
 
  1                 2                 3                 4 
 
3. I sometimes complain too much. 
 
  1                 2                 3                 4 
 
4. Sometimes I’m too impatient. 
 
  1                 2                 3                 4 
 
5. I don’t take criticism very wel. 
 
  1                 2                 3                 4 
 
6. Sometimes I put things of until the last minute. 
 
  1                 2                 3                 4 
 
7. I sometimes make promises I can’t keep. 
 
  1                 2                 3                 4 
 
8. There have been times when I could have been more thoughtful than I was. 
 
  1                 2                 3                 4 
 
9. I rarely get in a bad mood. 
 
  1                 2                 3                 4 
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PSWQ 
Circle the number that describes how typical or characteristic each item is of you over the past 
month, using the folowing scale: 
 
  Not at al Typical         Somewhat Typical          Very Typical 
1              2              3              4              5 
 
1. If I don’t have enough time to do everything, I don’t wory about it. 
 
1              2              3              4              5 
 
2. My wories overwhelm me. 
 
1              2              3              4              5 
 
3. I don’t tend to wory about things. 
 
1              2              3              4              5 
 
4. Many situations make me wory. 
 
1              2              3              4              5 
 
5. I know I shouldn’t wory about things, but I just can’t help it. 
 
1              2              3              4              5 
 
6. When I’m under pressure, I wory a lot. 
 
1              2              3              4              5 
 
7. I am always worying about something. 
 
1              2              3              4              5 
 
8. I find it easy to dismiss worisome thoughts. 
 
1              2              3              4              5 
 
9. As soon as I finish one task, I start to wory about everything else I have to do. 
 
1              2              3              4              5 
 
10. I never wory about anything. 
 
1              2              3              4              5 
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  Not at al Typical         Somewhat Typical          Very Typical 
1              2              3              4              5 
 
11. When there is nothing more I can do about a concern, I don’t wory about it anymore. 
 
1              2              3              4              5 
 
12. I notice that I have been worying about things. 
 
1              2              3              4              5 
 
13. Once I start worying, I can’t stop. 
 
1              2              3              4              5 
 
14. I wory al the time. 
 
1              2              3              4              5 
 
15. I wory about projects until they are al done. 
 
1              2              3              4              5 
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CAQ 
People react diferently to certain types of thoughts. Using the folowing scale, please indicate to 
what extent each of the folowing statements is typical of the way that you respond to certain 
thoughts over the past month. Please circle the appropriate number (1 to 5). 
 
   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
1. There are things that I would rather not think about. 
 
1              2              3              4              5 
 
2. I avoid certain situations that lead me to pay atention to things I don't want to think about. 
 
1              2              3              4              5 
 
3. I replace threatening mental images with things I say to myself in my mind. 
 
1              2              3              4              5 
 
4. I think about things that concern me as if they were occuring to someone else. 
 
1              2              3              4              5 
 
5. I have thoughts that I try to avoid. 
 
1              2              3              4              5 
 
6. I try not to think about the most upseting aspects of some situations so as not to be too afraid. 
 
1              2              3              4              5 
 
7. I sometimes avoid objects that can trigger upseting thoughts. 
 
1              2              3              4              5 
 
8. I distract myself to avoid thinking about certain disturbing subjects. 
 
1              2              3              4              5 
 
9. I avoid people who make me think about things that I do not want to think about. 
 
1              2              3              4              5 
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   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
10. I often do things to distract myself from my thoughts. 
 
1              2              3              4              5 
 
11. I think about trivial details so as not to think about important subjects that wory me. 
 
1              2              3              4              5 
 
12. Sometimes I throw myself into an activity so as not to think about certain things. 
 
1              2              3              4              5 
 
13. To avoid thinking about subjects that upset me, I force myself to think about something else. 
 
1              2              3              4              5 
 
14. There are things I try not to think about. 
 
1              2              3              4              5 
 
15. I keep saying things to myself in my head to avoid visualizing scenarios (a series of mental 
images) that frighten me. 
 
1              2              3              4              5 
 
16. Sometimes I avoid places that make me think about things I would prefer not to think about. 
 
1              2              3              4              5 
 
17. I think about past events so as not to think about future events that make me feel insecure. 
 
1              2              3              4              5 
 
18. I avoid actions that remind me of things I do not want to think about. 
 
1              2              3              4              5 
 
19. When I have mental images that are upseting, I say things to myself in my head to replace 
the images. 
 
1              2              3              4              5 
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   Not at al        A litle   Somewhat       Very   Completely 
    typical   typical    typical  typical   typical 
1              2              3              4              5 
 
20. I think about many litle things so as not to think about more important maters. 
 
1              2              3              4              5 
 
21. Sometimes I keep myself occupied just to prevent thoughts from popping up in my mind. 
 
1              2              3              4              5 
 
22. I avoid situations that involve people who make me think about unpleasant things. 
 
1              2              3              4              5 
 
23. Rather than having images of upseting events form in my mind, I try to describe the events 
using an internal monologue (things that I say to myself in my head). 
 
1              2              3              4              5 
 
24. I push away the mental images related to a threatening situation by trying to describe the 
situation using an internal monologue. 
 
1              2              3              4              5 
 
25. I think about things that are worying other people rather than thinking about my own 
wories. 
 
1              2              3              4              5 
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RGHAS_______________________________________________________________________ 
Listed below are various methods that people use to get help for an anxiety problem. Check al of the 
methods that you have used in the past month. If you check an item, please indicate the number of times 
you have used this method in the past month. If none apply, leave it blank.  
 
___ I have read a book or multiple books on how to solve or manage my anxiety  
 Number of occasions: ______ 
 
___ I have searched the internet for resources on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have watched tapes or videos on my own on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have exercised on my own or as part of a group (e.g. yoga, Tai Chi, walking, biking, weight lifting, 
swimming, etc.) to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have discussed on one or more occasions how to solve or manage my anxiety with a friend, family 
member, pastor, or work coleague in order to get advice on how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have been involved with a "chat-group" or other internet service to help me solve or manage my 
anxiety 
 Number of occasions: ______ 
 
___ I have gone on one or more occasions to a self-help or support group to help me solve or manage my 
anxiety 
 Number of occasions: ______ 
 
___ I have atended a class/seminar or have atended multiple classes/seminars (e.g. stress management, 
relaxation, meditation, etc.) to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have discussed how to solve or manage my anxiety with my family physician or other primary care 
provider (i.e., registered nurse, etc.) 
 Number of occasions: ______ 
 
___ I have seen one or more professional counselors or therapists on one or more occasions to help me 
how to solve or manage my anxiety 
 Number of occasions: ______ 
 
___ I have been hospitalized for to help me solve or manage my anxiety 
 Number of occasions: ______ 
 
___ Other (please describe): _______________________________________________ 
 Number of occasions: ______ 
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BFNE 
Read each of the folowing statements carefuly and indicate how characteristic it is of you over 
the past month according to the folowing scale. 
 
    Not at al       Slightly   Moderately  Very   Extremely 
   characteristic   characteristic  characteristic    characteristic characteristic 
     of me   of me     of me  of me    of me 
1              2              3              4              5 
 
1. I wory about what other people wil think of me even when I know it doesn’t make any 
diference. 
 
1              2              3              4              5 
 
2. I am unconcerned even if I know people are forming an unfavourable impression of me. 
 
1              2              3              4              5 
 
3. I am frequently afraid of other people noticing my shortcomings. 
 
1              2              3              4              5 
 
4. I rarely wory about what kind of impression I am making on someone. 
 
1              2              3              4              5 
 
5. I am afraid that others wil not approve of me. 
 
1              2              3              4              5 
 
6. I am afraid that other people wil find fault with me. 
 
1              2              3              4              5 
 
7. Other people’s opinions of me do not bother me. 
 
1              2              3              4              5 
 
8. When I am talking to someone, I wory about what they may be thinking of me. 
 
1              2              3              4              5 
 
9. I am usualy woried about what kind of impression I make. 
 
1              2              3              4              5 
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    Not at al       Slightly   Moderately  Very   Extremely 
   characteristic   characteristic  characteristic    characteristic characteristic 
     of me   of me     of me  of me    of me 
1              2              3              4              5 
 
10. If I know someone is judging me, it has litle efect on me. 
 
1              2              3              4              5 
 
11. Sometimes I think I am too concerned with what other people think of me. 
 
1              2              3              4              5 
 
12. I often wory that I wil say or do the wrong things. 
 
1              2              3              4              5 
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INF 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        True           True 
  1                 2                 3                 4 
 
1. My favourite poet is Raymond Kertezc. 
 
  1                 2                 3                 4 
 
2. Sometimes I get ads in the mail that I don’t realy want. 
 
  1                 2                 3                 4 
 
3. My favourite sports event on television is the high jump. 
 
  1                 2                 3                 4 
 
4. Most people would rather win than lose. 
 
  1                 2                 3                 4 
 
5. My favourite hobbies are archery and stamp-colecting. 
 
  1                 2                 3                 4 
 
6. I don’t like to have to buy things that are overpriced. 
 
  1                 2                 3                 4 
 
7. Most people look forward to a trip to the dentist. 
 
  1                 2                 3                 4 
 
8. In my free time I might read, watch TV, or just relax. 
 
  1                 2                 3                 4 
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MCQ-30 
This questionnaire is concerned with beliefs people have about their thinking. Listed below are a 
number of beliefs that people have expressed. Please read each item and say how much you 
agree with it in general over the past month by circling the appropriate number. Please 
respond to al the items, there are no right or wrong answers. 
 
 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
1. Worying helps me to avoid problems in the future 
 
  1                 2                 3                 4 
 
2. My worying is dangerous for me 
 
  1                 2                 3                 4 
 
3. I think a lot about my thoughts 
 
  1                 2                 3                 4 
 
4. I could make myself sick with worying 
 
  1                 2                 3                 4 
 
5. I am aware of the way my mind works when I am thinking through a problem 
 
  1                 2                 3                 4 
 
6. If I did not control a worying thought, and then it happened, it would be my fault 
 
  1                 2                 3                 4 
 
7. I need to wory in order to remain organized 
 
  1                 2                 3                 4 
 
8. I have litle confidence in my memory for words and names 
 
  1                 2                 3                 4 
 
9. My worying thoughts persist, no mater how I try to stop them 
 
  1                 2                 3                 4 
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 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
10. Worying helps me to get things sorted out in my mind 
 
  1                 2                 3                 4 
 
11. I cannot ignore my worying thoughts 
 
  1                 2                 3                 4 
 
12. I monitor my thoughts 
 
  1                 2                 3                 4 
 
13. I should be in control of my thoughts al of the time 
 
  1                 2                 3                 4 
 
14. My memory can mislead me at times 
 
  1                 2                 3                 4 
 
15. My worying could make me go mad 
 
  1                 2                 3                 4 
 
16. I am constantly aware of my thinking 
 
  1                 2                 3                 4 
 
17. I have a poor memory 
 
  1                 2                 3                 4 
 
18. I pay close atention to the way my mind works 
 
  1                 2                 3                 4 
 
19. Worying helps me cope 
 
  1                 2                 3                 4 
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 Do not       Agree       Agree       Agree 
  agree       slightly      moderately    very much 
  1                 2                 3                 4 
 
20. Not being able to control my thoughts is a sign of weakness 
 
  1                 2                 3                 4 
 
21. When I start worying, I cannot stop 
 
  1                 2                 3                 4 
 
22. I wil be punished for not controling certain thoughts 
 
  1                 2                 3                 4 
 
23. Worying helps me to solve problems 
 
  1                 2                 3                 4 
 
24. I have litle confidence in my memory for places 
 
  1                 2                 3                 4 
 
25. It is bad to think certain thoughts 
 
  1                 2                 3                 4 
 
26. I do not trust my memory 
 
  1                 2                 3                 4 
 
27. If I could not control my thoughts, I would not be able to function 
 
  1                 2                 3                 4 
 
28. I need to wory, in order to work wel 
 
  1                 2                 3                 4 
 
29. I have litle confidence in my memory for actions 
 
  1                 2                 3                 4 
 
30. I constantly examine my thoughts 
  1                 2                 3                 4 
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MRTS 
Please select the likelihood that you would engage in the folowing treatments, if they were made 
available to you: 
 
  Not very likely       Not sure     Very Likely 
1         2         3         4         5         6         7 
 
1. I would atend a 12-week group psychotherapy/counseling program: 
 
1          2         3         4         5         6         7 
 
2. I would atend a 12-week individual psychotherapy/counseling program: 
 
1         2         3         4         5          6         7 
 
3. I would atend a 12-week support group (i.e., Mental Health Peer Support Group): 
 
1         2         3         4         5         6         7 
 
4. I would atend a 12-week psychotherapy/counseling seminar (i.e., classes) program: 
 
1         2         3         4         5         6         7 
 
5. I would use a 12-week self-help manual: 
 
1         2         3         4         5         6         7 
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PANAS 
This scale consists of a number of words that describe diferent feelings and emotions. Read 
each item and then choose the appropriate answer by circling the number under the word. 
Indicate to what extent you have felt this way during the past few weeks. Use the folowing 
scale to record your answers. 
 
  Very slightly   A          Quite 
  or not at al        litle        Moderately         a bit       Extremely 
1              2              3              4              5 
 
1. Interested 
 
1              2              3              4              5 
 
2. Iritable 
 
1              2              3              4              5 
 
3. Distressed 
 
1              2              3              4              5 
 
4. Alert 
 
1              2              3              4              5 
 
5. Excited 
 
1              2              3              4              5 
 
6. Ashamed 
 
1              2              3              4              5 
 
7. Upset 
 
1              2              3              4              5 
 
8. Inspired 
 
1              2              3              4              5 
 
9. Strong 
 
1              2              3              4              5 
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  Very slightly   A          Quite 
  or not at al        litle        Moderately         a bit       Extremely 
1              2              3              4              5 
 
10. Nervous 
 
1              2              3              4              5 
 
11. Guilty 
 
1              2              3              4              5 
 
12. Determined 
 
1              2              3              4              5 
 
13. Scared 
 
1              2              3              4              5 
 
14. Atentive 
 
1              2              3              4              5 
 
15. Hostile 
 
1              2              3              4              5 
 
16. Jitery 
 
1              2              3              4              5 
 
17. Enthusiastic 
 
1              2              3              4              5 
 
18. Active 
 
1              2              3              4              5 
 
19. Proud 
 
1              2              3              4              5 
 
20. Afraid 
1              2              3              4              5 
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PMUS 
 
1. Are you currently taking any medications to treat anxiety or wory?  Yes   No  
 
2. Compared to when you first began the study, how has your medication use changed: 
 
Greatly decreased      No change in        Greatly increased 
the frequency/     the frequency/     the frequency/ 
dose/amount         dose/amount      dose/amount 
 
-3  -2  -1  0  +1  +2  +3 
 
3. Please list any medications you are curently taking to treat anxiety, wory, depression, or 
other emotional issue: 
 
Medication A:_____________________________ Dose per week:________________________ 
 
Medication B:_____________________________ Dose per week:_______________________ 
 
Medication C:_____________________________ Dose per week:________________________ 
 
Medication D:_____________________________ Dose per week:________________________ 
 
Medication E:_____________________________ Dose per week:_______________________ 
 
Medication F:_____________________________ Dose per week:________________________ 
 
Medication G:_____________________________ Dose per week:________________________ 
 
ULTRA-BRIEF TREATMENTS FOR GAD   289 
 
NIM 
Please respond to al the items, there are no right or wrong answers. 
 
 False;       Slightly      Mainly       Very 
   Not at al True        True        True           True 
  1                 2                 3                 4 
 
1. Sometimes I cannot remember who I am. 
 
  1                 2                 3                 4 
 
2. I have visions in which I see myself forced to commit crimes. 
 
  1                 2                 3                 4 
 
3. Since the day I was born, I was destined to be unhappy. 
 
  1                 2                 3                 4 
 
4. I think I have three or four completely diferent personalities inside of me. 
 
  1                 2                 3                 4 
 
5. People don’t understand how much I sufer. 
 
  1                 2                 3                 4 
 
6. Every once in a while I totaly lose my memory. 
 
  1                 2                 3                 4 
 
7. Sometimes my vision is only in black and white. 
 
  1                 2                 3                 4 
 
8. I don’t have any good memories from my childhood. 
 
  1                 2                 3                 4 
 
9. I have severe psychological problems that began very suddenly 
 
  1                 2                 3                 4 
ULTRA-BRIEF TREATMENTS FOR GAD   290 
 
SHAI 
Each question is this section consists of a group of four statements. Please read each group of 
statements carefuly and then select the one which best describes your feelings, over the past 
month. Identify the statement by circling the leter next to the statement. It may be that more 
than one statement applies, in which case, please circle any that are applicable. 
 
1.  (a) I do not wory about my health. 
(b) I occasionaly wory about my health. 
(c) I spend much of my time worying about my health. 
(d) I spend most of my time worying about my health. 
 
2. (a) I notice aches/pains less than most other people (of my age). 
(b) I notice aches/pains as much as most other people (of my age). 
(c) I notice aches/pains more than most other people (of my age). 
(d) I am aware of aches/pains in my body al the time. 
 
3.  (a) As a rule I am not aware of bodily sensations or changes. 
(b) Sometimes I am aware of bodily sensations or changes. 
(c) I am often aware of bodily sensations or changes. 
(d) I am constantly aware of bodily sensations or changes. 
 
4.  (a) Resisting thoughts of ilness is never a problem. 
(b) Most of the time I can resist thoughts of ilness. 
(c) I try to resist thoughts of ilness but am often unable to do so. 
(d) Thoughts of ilness are so strong that I no longer even try to resist them. 
 
5.  (a) As a rule I am not afraid that I have a serious ilness. 
(b) I am sometimes afraid that I have a serious ilness. 
(c) I am often afraid that I have a serious ilness. 
(d) I am always afraid that I have a serious ilness. 
 
6.  (a) I do not have images (mental pictures) of myself being il. 
(b) I occasionaly have images of myself being il. 
(c) I frequently have images of myself being il. 
(d) I constantly have images of myself being il. 
ULTRA-BRIEF TREATMENTS FOR GAD   291 
 
7.  (a) I do not have any dificulty taking my mind of thoughts about my health. 
(b) I sometimes have dificulty taking my mind of thoughts about my health. 
(c) I often have dificulty in taking my mind of thoughts about my health. 
(d) Nothing can take my mind of thoughts about my health. 
 
8.  (a) I am lastingly relieved if my doctor tels me there is nothing wrong. 
(b) I am initialy relieved but the wories sometimes return later. 
(c) I am initialy relieved but the wories always return later. 
(d) I am not relieved if my doctor tels me there is nothing wrong. 
 
9.  (a) If I hear about an ilness I never think I have it myself. 
(b) If I hear about an ilness I sometimes think I have it myself. 
(c) If I hear about an ilness I often think I have it myself. 
(d) If I hear about an ilness I always think I have it myself. 
 
10. (a) If I have a bodily sensation or change I rarely wonder what it means. 
(b) If I have a bodily sensation or change I often wonder what it means. 
(c) If I have a bodily sensation or change I always wonder what it means. 
(d) If I have a bodily sensation or change I must know what it means. 
 
11.  (a) I usualy feel at very low risk for developing a serious ilness. 
(b) I usualy feel at fairly low risk for developing a serious ilness. 
(c) I usualy fel at moderate risk for developing a serious ilness. 
(d) I usualy feel at high risk for developing a serious ilness. 
 
12.  (a) I never think I have a serious ilness. 
(b) I sometimes think I have a serious ilness. 
(c) I often think I have a serious ilness. 
(d) I usualy think that I am seriously il. 
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13.  (a) If I notice an unexplained bodily sensation I don't find it dificult to think about other 
things. 
(b) If I notice an unexplained bodily sensation I sometimes find it dificult to think about 
other things. 
(c) If I notice an unexplained bodily sensation I often find it dificult to think about other 
things. 
(d) If I notice an unexplained bodily sensation I always find it dificult to think about 
other things. 
 
14.  (a) My family/friends would say I do not wory enough about my health. 
(b) My family/friends would say I have a normal atitude to my health. 
(c) My family/friends would say I wory too much about my health. 
(d) My family/friends would say I am a hypochondriac. 
 
For the folowing questions, please think about what it might be like if you had a serious ilness 
of a type which particularly concerns you (such as heart disease, cancer, multiple sclerosis and so 
on). Obviously it may not be possible to know for definite what it would be like; please give 
your best estimate of what you think might happen, basing your estimate on what you know 
about yourself and serious ilness in general. 
 
15.  (a) If I had a serious ilness I would stil be able to enjoy things in my life quite a lot. 
(b) If I had a serious ilness I would stil be able to enjoy things in my life a litle. 
(c) If I had a serious ilness I would be almost completely unable to enjoy things in my 
life. 
(d) If I had a serious ilness I would be completely unable to enjoy life at al. 
 
16.  (a) If I developed a serious ilness there is a good chance that modern medicine would be 
able to cure me. 
(b) If I developed a serious ilness there is a moderate chance that modern medicine 
would be able to cure me. 
(c) If I developed a serious ilness there is a very smal chance that modern medicine 
would be able to cure me. 
(d) If I developed a serious ilness there is no chance that modern medicine would be able 
to cure me. 
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17.  (a) A serious ilness would ruin some aspects of my life. 
(b) A serious ilness would ruin many aspects of my life. 
(c) A serious ilness would ruin almost every aspect of my life. 
(d) A serious ilness would ruin every aspect of my life. 
 
18.  (a) If I had a serious ilness I would not feel that I had lost my dignity. 
(b) If I had a serious ilness I would feel that I had lost a litle of my dignity. 
(c) If I had a serious ilness I would feel that I had lost quite a lot of my dignity. 
(d) If I had a serious ilness I would feel that I had totaly lost my dignity. 
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ACES 
Listed below are a number of statements concerning beliefs about change. Please read each item 
carefuly, and circle one of the five options that best reflect how you feel about the statement 
right now. 
 
Strongly Disagree   Disagree   Undecided      Agree      Strongly Agree 
1              2              3              4              5 
 
1. I feel pessimistic that my anxiety problems could ever change for the beter. 
 
1              2              3              4              5 
 
2. Even though I try, nothing seems to help with my anxiety. 
 
1              2              3              4              5 
 
3. It would be extremely dificult or impossible to solve my problems with anxiety. 
 
1              2              3              4              5 
 
4. I have had some positive experiences with being able to control my anxiety through talking 
positively to myself. 
 
1              2              3              4              5 
 
5. My problems with anxiety are too severe to benefit from treatment. 
 
1              2              3              4              5 
 
6. Self-help methods may help others control their anxiety but they won’t work for me. 
 
1              2              3              4              5 
 
7. I don’t believe I wil ever feel truly relaxed and not woried. 
 
1              2              3              4              5 
 
8. Facing my fears has never helped me to reduce my anxiety. 
 
1              2              3              4              5 
 
9. When I force myself to do something that scares me, often it’s not as bad as I thought. 
 
1              2              3              4              5 
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Strongly Disagree   Disagree   Undecided      Agree      Strongly Agree 
1              2              3              4              5 
 
10. I have had some success in reducing my anxiety. 
 
1              2              3              4              5 
 
11. There is very litle anyone could do to help me solve my anxiety problems. 
 
1              2              3              4              5 
 
12. Even when I try to talk positively to myself, it doesn’t help my anxiety. 
 
1              2              3              4              5 
 
13. Positive thinking is helpful to me in managing my anxiety. 
 
1              2              3              4              5 
 
14. There is no solution to my anxiety problems. 
 
1              2              3              4              5 
 
15. I am optimistic that my anxiety can change for the beter. 
 
1              2              3              4              5 
 
16. I have found that I can reduce my anxiety by teling myself to relax or by using relaxation 
exercises. 
 
1              2              3              4              5 
 
17. I’l never be able to control my anxiety and wory. 
 
1              2              3              4              5 
 
18. I believe it’s quite possible for me to feel less woried and more relaxed. 
 
1              2              3              4              5 
 
19. If I work hard, I can have a positive impact on my problems with anxiety. 
 
1              2              3              4              5 
 
20. There are factors contributing to my anxiety that I can learn to control. 
1              2              3              4              5 
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OCI-R 
The folowing statements refer to experiences that many people have in their everyday lives. 
Circle the number that best describes how much that experience has distressed or bothered you 
during the past month. The numbers refer to the folowing verbal labels: 
 
    Not at al       A litle   Moderately  A lot   Extremely 
0              1              2              3              4 
 
1. I have saved up so many things that they get in the way. 
 
0              1              2              3              4 
 
2. I check things more often than necessary.  
 
0              1              2              3              4 
 
3. I get upset if objects are not aranged properly.  
 
0              1              2              3              4 
 
4. I feel compeled to count while I am doing things.  
 
0              1              2              3              4 
 
5. I find it dificult to touch an object when I know it has been touched by strangers or certain 
people.  
 
0              1              2              3              4 
 
6. I find it dificult to control my own thoughts.  
 
0              1              2              3              4 
 
7. I colect things I don’t need.  
 
0              1              2              3              4 
 
8. I repeatedly check doors, windows, drawers, etc.  
 
0              1              2              3              4 
 
9. I get upset if others change the way I have aranged things.  
 
0              1              2              3              4 
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    Not at al       A litle   Moderately  A lot   Extremely 
0              1              2              3              4 
 
10. I feel I have to repeat certain numbers.  
 
0              1              2              3              4 
 
11. I sometimes have to wash or clean myself simply because I feel contaminated.  
 
0              1              2              3              4 
 
12. I am upset by unpleasant thoughts that come into my mind against my wil.  
 
0              1              2              3              4 
 
13. I avoid throwing things away because I am afraid I might need them later.  
 
0              1              2              3              4 
 
14. I repeatedly check gas and water taps and light switches after turning them of.  
 
0              1              2              3              4 
 
15. I need things to be aranged in a particular order.  
 
0              1              2              3              4 
 
16. I feel that there are good and bad numbers.  
 
0              1              2              3              4 
 
17. I wash my hands more often and longer than necessary.  
 
0              1              2              3              4 
 
18. I frequently get nasty thoughts and have dificulty in geting rid of them.  
 
0              1              2              3              4 
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SCMS 
Please read each of the folowing statements and rate how wel each statement describes you 
over the past month, using the folowing scale: 
 
    Very  Somewhat/mostly  A litle  A litle     Somewhat/mostly   Very 
 undescriptive   undescriptive   undescriptive   descriptive  descriptive     descriptive 
    of me      of me       of me        of me   of me         of me 
      0            1            2            3            4            5 
 
1. When I work toward something, it gets al my atention. 
 
      0            1            2            3            4            5 
 
2. The goals I achieve do not mean much to me. 
 
      0            1             2            3            4            5 
 
3. I become very aware of what I am doing when I am working towards a goal. 
 
      0            1            2            3            4            5 
 
4. I get myself through hard things by planning to enjoy myself afterwards. 
 
      0            1            2            3            4            5 
 
5. I know I can track my behaviour when working toward a goal. 
 
      0            1            2            3            4            5 
 
6. When I set important goals for myself, I usualy do not achieve them. 
 
      0            1            2            3            4            5 
 
7. When I do something right, I take time to enjoy the feeling. 
 
      0            1            2            3            4            5 
 
8. I pay close atention to my thoughts when I am working on something hard. 
 
      0            1            2            3            4            5 
 
9. I silently praise myself even when others do not praise me. 
 
      0            1            2            3             4            5 
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    Very  Somewhat/mostly  A litle  A litle     Somewhat/mostly   Very 
 undescriptive   undescriptive   undescriptive   descriptive  descriptive     descriptive 
    of me      of me       of me        of me   of me         of me 
      0            1            2            3            4            5 
 
10. I do not seem capable of making clear plans for most problems that come up in my life. 
 
      0            1            2            3            4            5 
 
11. I make sure to track my progress regularly when I am working on a goal. 
 
      0            1            2            3            4            5 
 
12. The standards I set for myself are unclear and make it hard for me to judge how I am doing 
on a task. 
 
      0            1            2            3            4            5 
 
13. I congratulate myself when I make some progress. 
 
      0            1            2            3            4            5 
 
14. I keep focused on tasks I need to do even if I do not like them. 
 
      0            1            2            3            4            5 
 
15. I have learned that it is useless to make plans. 
 
      0            1            2            3            4            5 
 
16. I give myself something special when I make some progress. 
 
      0            1            2            3            4            5 
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IDAS 
 
Below is a list of feelings, sensations, problems, and experiences that people sometimes have. Read each 
item to determine how wel it describes your recent feelings and experiences. Then select the option that 
best describes how much you have felt or experienced things this way during the past month, including 
today. Use this scale when answering: 
_________________________________________________________________________ 
 1 2 3 4 5 
 Not at al A little bit Moderately Quite a bit Extremely 
_________________________________________________________________________ 
 
_____  1. I was proud of myself 
_____  2. I felt exhausted 
_____  3. I felt depressed 
_____  4. I felt inadequate 
_____  5. I slept less than usual 
_____  6. I felt fidgety, restless 
_____  7. I had thoughts of suicide 
_____  8. I slept more than usual 
_____  9. I hurt myself purposely 
_____ 10. I slept very poorly 
_____ 11. I blamed myself for things 
_____ 12. I had trouble faling asleep 
_____ 13. I felt discouraged about things 
_____ 14. I thought about my own death 
_____ 15. I thought about hurting myself 
_____ 16. I did not have much of an 
appetite 
_____ 17. I felt like eating less than usual 
_____ 18. I thought a lot about food 
_____ 19. I did not feel much like eating 
_____ 20. I ate when I wasn’t hungry 
_____ 21. I felt optimistic 
_____ 22. I ate more than usual 
_____ 23. I felt that I had accomplished a lot 
_____ 24. I looked forward to things with 
enjoyment 
_____ 25. I was furious 
_____ 26. I felt hopeful about the future 
_____ 27. I felt that I had a lot to look forward to 
_____ 28. I felt like breaking things 
_____ 29. I had disturbing thoughts of 
something bad that happened to me 
_____ 30. Litle things made me mad 
_____ 31. I felt enraged 
_____ 32. I had nightmares that reminded me 
of something bad that happened 
_____ 33. I lost my temper and yeled at people 
_____ 34. I felt like I had a lot of interesting 
things to do 
_____ 35. I felt like I had a lot of energy 
_____ 36. I had memories of something scary 
that happened 
_________________________________________________________________________ 
 1 2 3 4 5 
 Not at al A little bit Moderately Quite a bit Extremely 
_________________________________________________________________________ 
 
_____ 37. I felt self-conscious knowing that 
others were watching me 
_____ 38. I felt a pain in my chest 
_____ 39. I was worried about 
embarrassing myself socialy 
_____ 40. I felt dizzy or light headed 
_____ 41. I cut or burned myself on 
purpose  
_____ 42. I had litle interest in my usual 
hobbies or activities  
_____ 43. I thought that the world would be 
beter of without me 
_____ 44. I felt much worse in the morning 
than later in the day 
_____ 45. I felt drowsy, sleepy 
_____ 46. I woke up early and could not 
get back to sleep 
_____ 47. I had trouble concentrating 
_____ 48. I had trouble making up my 
mind 
_____ 49. I talked more slowly than usual 
_____ 50. I had trouble waking up in the 
morning 
 
 
 
 
 
_____ 51. I found myself worrying al the time 
_____ 52. I woke up frequently during the night 
_____ 53. It took a lot of efort for me to get 
going 
_____ 54. I woke up much earlier than usual 
_____ 55. I was trembling or shaking 
_____ 56. I became anxious in a crowded 
public seting 
_____ 57. I felt faint 
_____ 58. I found it dificult to make eye contact 
with people 
_____ 59. My heart was racing or pounding 
_____ 60. I got upset thinking about something 
bad that happened 
_____ 61. I found it dificult to talk with people I 
did not know wel 
_____ 62. I had a very dry mouth 
_____ 63. I was short of breath 
_____ 64. I felt like I was choking
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RCES________________________________________________________________________ 
We would like you to indicate below how much you believe, right now, that the treatment that 
was described to you has helped to reduce your anxiety. 
 
1. At this point, how logical does the therapy ofered to you seem? 
 
Not logical at al    Somewhat Logical     Very Logical 
1         2         3         4         5         6         7         8         9 
 
2. At this point, how successful do you think this treatment has been in reducing your wory? 
 
Not at al useful    Somewhat Useful      Very Useful 
1         2         3         4         5         6         7         8         9 
 
3. How confident would you be in recommending this treatment to a friend who has similar 
problems? 
 
Not at al confident    Somewhat Confident        Very Confident 
1         2         3         4         5         6         7         8         9 
 
4. Compared to when you first began the study, how much worsening or improvement in your 
wory and anxiety symptoms did you experience? 
 
Symptoms        No symptom        Symptoms 
becoming worse      change        improving 
-100%    -80%    -60%    -40%    -20%    0%   20%   40%   60%    80%   100% 
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RHCS  
 
On how many days in the last week did you use the wory scheduling? 
 
0 days     1 day     2 days     3 days     4 days     5 days     6 days     7 days 
 
 
In the last week: 
How much actual time did you spend doing the wory scheduling? 
 
    None       A litle     Some      Quite a   A whole 
                   bit       lot 
0              1              2              3              4 
 
 
In the last week: 
How much efort did you put into the wory scheduling? 
 
    None       A litle     Some      Quite a   A whole 
                   bit       lot 
0              1              2              3              4 
 
 
How dificult to start or complete in the last week was the wory scheduling? 
 
    Not at       A litle   Somewhat       Quite    Extremely 
   al dificult      dificult        dificult      dificult    dificult 
0              1              2              3              4 
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Appendix K 
Treatment Scripts and Associated Handouts 
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Cognitive Avoidance Wory Scheduling Script 
 
I’m going to introduce you to a technique caled wory scheduling. The rationale for this 
treatment is that when you wory throughout the day, the worying becomes associated with the 
places, times, and situations you tend to wory in. Over time being in those places, times, and/or 
situations come to elicit spontaneous wory. For example, let’s say that you tend to wory a lot 
at your desk. Over time, your body wil associate the desk with worying. So, you may sit at 
your desk someday without any reason to wory, but your desk now has the ability to cause you 
to start worying – even though there is nothing to wory about at that very moment.  
 
Let’s take another example. A lot of people say that they tend to wory in their cars on the way 
to work in the morning. Now, someone who wories al the time in his or her car might just hop 
in the car to go to the beach, and find that he or she is worying! The reason for this is that the 
car has become associated with wory, so that it can elicit wory al by itself, even when there is 
nothing to wory about that day.  
 
Now, you can imagine that this creates a big problem, because as a person continues to wory, 
over time almost every place, time, or situation can come to elicit wory! 
 
Does this make sense? Do you notice that you tend to wory in specific places or at specific 
times? What are those places or times? 
 
The good news is that psychologists have developed a way to stop this cycle. What they’ve 
developed is caled wory scheduling. The goal of wory scheduling is to limit the amount of 
wory that occurs throughout the day by training people to do al of their worying in a specific 
location and at a specific time, so that only a chosen time and location elicits wory.  
 
Specificaly, I want you to identify a 30-minute period each day to engage in wory. It is 
recommended you chose a period in the evening, but not too close to bed time. Remember - this 
“wory period” wil occur at the same time every day and in the same location. This is 
important, because as I just said, wory can become associated with lots of diferent places, 
situations, and times of day. During your 30-minute wory period, you should wory as you 
normaly do, but try to make it as intense as possible. I want you to do this so that you are realy 
able to focus al of your atention on your wories without trying to minimize them or make them 
seem less important. You might also think about writing things down or making lists if you are 
woried about something in particular. Just make sure that you do al of this worying in the 
same location, at the same time of day, and that you wory intensely for the entire 30 minutes, if 
possible.  
 
At other times during the day, or if your wory continues beyond the 30 minute period, if you 
begin to wory, try to delay that wory to the next wory period. In order to take your mind away 
from the worying at that moment, you should try to focus your atention outside of your body 
and in the present moment. Focus on things happening outside of yourself or things you are 
doing. Watch what other people are doing around you, look at the diferent colours around you, 
focus on your breathing, or on what you are eating… just try to distract yourself by being aware 
of what is happening around you at the moment. You’l have lots of time later to wory to your 
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heart’s content, but we’re going to try to make the wories associated with that one time and one 
location.  
 
One final thing, any time you are able to successfuly distract yourself from worying during the 
day, it is important that you reward yourself for doing that. Try to reward yourself by silently 
giving yourself a pat on the back, buy something nice for yourself at the end of the week, or any 
other way that you can reward yourself. I want you to be your own motivational coach, and 
encourage yourself to continue using this treatment. Realy try to congratulate yourself as you 
are able to stop the worying during the day, and congratulate yourself for restricting the 
worying to that single wory period. 
 
It is important to also remember that this technique takes time to master, so please try to use it 
every day for the next four weeks. It may take a few days or weeks to become efective, but if 
you continue to use the technique, it wil help to decrease your stress, anxiety, and how often you 
wory. 
 
Does al of this make sense? Do you understand what the purpose of the treatment is? Just to 
make sure we are on the same page, can you explain the purpose of this treatment in your own 
words? If you begin to wory outside of the wory period, what wil you do? Do you have any 
questions? 
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Cognitive Avoidance Wory Scheduling Handout 
 
Wory Scheduling 
 
Some tips to get the most out of this treatment: 
 
For the wory period: 
• Wory at the same place, at the same time, every day. 
• Try to choose a comfortable chair to sit in while you wory. 
• Do not purposefuly wory in bed, as this may make it dificult to sleep later. 
• Try to wory in the evening, after supper, but an hour or two before bed. 
• Try to wory as intensely as possible. 
• If you live with other people, ask that they do not disturb you during your wory period. 
• If you cannot be at home in time for your wory period, wait until the next day, rather 
than worying at a diferent location. 
• You may write things down or create lists if it helps you wory. 
• Try to wory for the entire 30 minutes. If you start thinking about other topics, try to 
bring your mind back to the wories. 
 
If wories occur outside of the wory period: 
• Try to delay the wory until the next wory period. 
• Try to focus outside of your body. 
• You could focus on other people’s clothes or conversations. 
• You could focus on how your clothes feel against your skin, your breathing, or the taste 
of the food you are eating. 
• If helpful, write your wory down on a piece of paper, so that you wil remember to 
wory about it later. 
• Remember to praise yourself anytime you notice that you are able to shift your focus 
away from your wories. Try to be your own coach. 
• Try not to get mad at yourself when it is dificult to delay the wory. Encouraging 
yourself when you have success wil be more beneficial than criticizing yourself when it 
is dificult. 
 
Remember, the purpose of this technique is to remove the associations between wory and many 
places you go in your life. Instead, we want only one location that is able to elicit the wory. 
 
Try to use this technique every day for at least the four weeks! 
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Metacognitive Wory Scheduling Script 
 
I’m going to introduce you to a technique caled wory scheduling. The rationale for this 
treatment is that a lot of people who experience chronic wory or anxiety believe that they have 
no control over how much they wory and that worying is dangerous for them. When someone 
believes that they cannot control their wory, that causes them stress, and then they begin to 
wory about how much they wory. Obviously, this just creates more wory and anxiety.  
 
For example, let’s say that someone used to only wory for a few minutes each day. However, 
after a while, they start to wory a litle more. Once they notice this increase in wory, they 
begin to believe they cannot stop worying. As wel, when they notice the iritability, poor sleep, 
racing thoughts, or muscle tension that comes with worying, they start to believe that the wory 
is damaging their body or mind. As you might expect, believing that you cannot stop worying, 
or that worying is dangerous, is likely to lead to someone worying about their wory even 
more. 
 
Sometimes, people wory about how much they wory, or wory about the dangers of worying, 
without even realizing it. The belief may be inside your mind, without you even realizing it.  
 
Does this make sense? Do you ever find yourself worying about how much you wory? Do you 
believe that wory can be dangerous to your health or mind? 
 
The good news is that wory itself is in no way damaging or uncontrolable, even though it may 
feel like it. Further, psychologists have developed a way for you to experience more control over 
your wories, and discover that they are not dangerous to your health or mind. What they’ve 
developed is caled wory scheduling. The goal of wory scheduling is to limit the amount of 
wory that occurs throughout the day by training people to do al of their worying in a specific 
location and at a specific time. 
 
Specificaly, I want you to identify a 30-minute period each day to engage in wory. It is 
recommended you chose a period in the evening, but not too close to bed time. Remember - this 
“wory period” wil occur at the same time every day and in the same location. This is 
important, because as I just said, I want you to experience control over your wories.  During 
your 30-minute wory period, you should wory as you normaly do, but try to make it as intense 
as possible. By making the worying intense, and doing this repeatedly, that your body and mind 
wil discover that worying is not dangerous. Over time, worying wil cause you less anxiety, 
tension, and stress, because you won’t be seeing the wory as dangerous. You might think about 
writing things down or making lists if you are woried about something in particular. Just make 
sure that you do al of this worying in the same location, at the same time of day, and that you 
wory intensely for the entire 30 minutes, if possible.  
 
At other times during the day, or if your wory continues beyond the 30 minute period, if you 
begin to wory, try to just observe your thoughts, without reacting to them. Rather than trying to 
stop the worying, or trying to argue against the wories, or trying to problem solve for every 
possible wory, I want you to simply observe how your mind works. When people step back, 
and casualy observe their wories, the worying tends to be shorter and less stressful.  For 
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example, if you begin to wory about your finances, just watch your thoughts, and after a couple 
of minutes, your thoughts wil automaticaly shift to diferent topics. Again, try not to try to 
fight the wories, but rather just see them as a string of words in your mind. Doing this wil lead 
to you worying less, and finding the wories you do experience to be less stressful. 
 
It is important to also remember that this technique takes time to master, so please try to use it 
every day for the next four weeks. It may take a few days or weeks to become efective, but if 
you continue to use the technique, it wil help to decrease your stress, anxiety, and how often you 
wory. 
 
Does al of this make sense? Do you understand what the purpose of the treatment is? Just to 
make sure we are on the same page, can you explain the purpose of this treatment in your own 
words? If you begin to wory outside of the wory period, what wil you do? Do you have any 
questions? 
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Metacognitive Wory Scheduling Handout 
 
Wory Scheduling 
 
Some tips to get the most out of this treatment: 
 
For the wory period: 
• Wory at the same place, at the same time, every day. 
• Try to choose a comfortable chair to sit in while you wory. 
• Do not purposefuly wory in bed, as this may make it dificult to sleep later. 
• Try to wory in the evening, after supper, but an hour or two before bed. 
• Try to wory as intensely as possible. 
• If you live with other people, ask that they do not disturb you during your wory period. 
• If you cannot be at home in time for your wory period, wait until the next day, rather 
than worying at a diferent location. 
• You may write things down or create lists if it helps you wory. 
• Try to wory for the entire 30 minutes. If you start thinking about other topics, try to 
bring your mind back to the wories. 
 
If wories occur outside of the wory period: 
• Simply observe the worying process. 
• Become an independent observer of how your mind works. 
• Do not try to control the wories, argue with the wories, or problem solve every wory. 
• Alow your mind to casualy move away from the wories to other topics. 
• If helpful, write your wory down on a piece of paper, so that you wil remember to 
wory about it later. 
 
Remember, the purpose of this technique is to become aware that worying is not dangerous, and 
that you can control how much you wory.  
 
Try to use this technique every day for at least the four weeks! 
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Appendix L 
Treatment Adherence Checklists 
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CAWS Adherence Checklist 
The therapist DID: 
• Discuss how wory becomes ASSOCIATED with places, times, situations: ______ 
• Discuss how the association comes to ELICIT SPONTANEOUS wories: ______ 
• Give at least one EXAMPLE of how wory can become associated: ______ 
• Emphasize how the TRAINING makes wory associated with ONE location: ______ 
• Emphasize worying in ONE LOCATION AT ONE TIME EVERY DAY: ______ 
• Emphasize worying in the EVENING, but before bed time: ______ 
• Emphasize worying as INTENSELY as possible: ______ 
• Emphasize trying to DELAY wories outside of the wory period: ______ 
• Emphasize focusing OUTSIDE OF THE BODY/BEING PRESENT IN THE MOMENT 
when worying during the day: ______ 
• Give at least one EXAMPLE of how to focus outside of the body/being present: ______ 
• Emphasize SELF-PRAISE/SELF-COACHING: ______ 
• Give at least one EXAMPLE of self-praise/self-coaching: ______ 
• Encourage using the technique for at least the next FOUR weeks: ______ 
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The therapist DID NOT: 
• Discuss how people believe that WORRY IS UNCONTROLLABLE and 
DANGEROUS: ______ 
• Discuss how these beliefs lead to MORE WORRY AND ANXIETY: ______ 
• Give any EXAMPLES of how these beliefs increase wory: ______ 
• Emphasize how the TRAINING helps GAIN CONTROL over wories and discover that 
WORRIES ARE NOT DANGEROUS : ______ 
• Emphasize trying to NON-JUDEGEMENTALLY OBSERVE wories outside of the 
wory period: ______ 
• Emphasize SIMPLY WATCHING wories that occur during the day: ______ 
• Give any EXAMPLES of simply observing the thought process: ______ 
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MWS Adherence Checklist 
The therapist DID: 
• Discuss how people believe that WORRY IS UNCONTROLLABLE and 
DANGEROUS: ______ 
• Discuss how these beliefs lead to MORE WORRY AND ANXIETY: ______ 
• Give at least one EXAMPLE of how these beliefs increase wory: ______ 
• Emphasize how the TRAINING helps GAIN CONTROL over wories and discover that 
WORRIES ARE NOT DANGEROUS : ______ 
• Emphasize worying in ONE LOCATION AT ONE TIME EVERY DAY: ______ 
• Emphasize worying in the EVENING, but before bed time: ______ 
• Emphasize worying as INTENSELY as possible: ______ 
• Emphasize trying to NON-JUDGMENTALLY OBSERVE wories outside of the wory 
period: ______ 
• Emphasize SIMPLY WATCHING wories that occur during the day: ______ 
• Give at least one EXAMPLE of simply observing the thought process: ______ 
• Encourage using the technique for at least the next FOUR weeks: ______ 
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The therapist DID NOT: 
• Discuss how wory becomes ASSOCIATED with places, times, situations: ______ 
• Discuss how the association comes to ELICIT SPONTANEOUS wories: ______ 
• Give at least one EXAMPLE of how wory can become associated: ______ 
• Emphasize how the TRAINING makes wory associated with ONE location: ______ 
• Emphasize trying to DELAY wories outside of the wory period: ______ 
• Emphasize focusing OUTSIDE OF THE BODY/BEING PRESENT IN THE MOMENT 
when worying during the day: ______ 
• Give at least one EXAMPLE of how to focus outside of the body/being present: ______ 
• Emphasize SELF-PRAISE/SELF-COACHING: ______ 
• Give at least one EXAMPLE of self-praise/self-coaching: ______ 
